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1. Introduction 
In the last decades, the need for efficient and fast syntheses and functionalization 
of important condensed heterocycles such as indoles, quinolines, carbazoles and other 
derivatives has received great attention in organic chemistry. The presence of cheap and 
commercially available metals such as copper or iron enables the development of several 
coupling reactions via the formation of carbon-carbon or carbon-heteroatom bonds. With 
the utilization of hypervalent diaryliodonium salts in the presence of transition-metal 
catalysts several arylations, C-H arylation and cyclization reactions were developed in 
the last few years. In some cases, especially in arylation of carbon nucleophiles or 
heteroatoms, the reactions were able to realize in the absence of transition-metals. 
This doctoral thesis aims to discuss the results achieved in the development of the 
copper-catalyzed synthesis of important condensed heterocycles, such as 
iminobenzoxazines, chromenoquinolines and indenoquinolines from different nitriles and 
diaryliodonium salts. In collaboration, the geometry of the chromenoquinoline frame was 
established by single crystal X-ray diffraction, furthermore intermolecular interactions 
were investigated from different homologue sequences. 
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2. Literature review 
In the following five chapters, the literature of iminobenzoxazines and 
chromenoquinolines focusing on the synthetic methods for the construction of these two 
heterocyclic cores and on their biological activities (chapters 2.1-2.4) is aimed to be 
summarized. In section 2.5 the literatures of diaryliodonium salts are collected including 
their structural properties, reactivity, methods for their preparation and their 
applications in organic syntheses. 
2. 1. Benzoxazines and their derivatives: structure and biological 
activity 
Benzoxazine is an aromatic heterocyclic compound composed of a benzene and 
an oxazine ring, from which the latter is a six-membered ring with an oxygen and a 
nitrogen atom. There are several benzoxazine derivatives depending on the position of 
the oxygen and the nitrogen atoms in the ring, for example benzo[1,4]oxazine (1a) or 
benzo [1,3]oxazine (1b) are two out of them (Figure 1). Moreover, the oxygen atom can 
be replaced with other heteroatoms in the ring, for example the sulfur-containing 
derivatives are known as benzothiazines. One representative of this compound class is 
benzo[1,4]thiazine (2). Benzoxazinones are the oxidized form of benzoxazines equipped 
with a C=O double bond such as benzo[1,3]oxazine-4-one (3). Imino[1,3]- and 
[1,4]benzoxazines (4a and 4b) can be derived from benzoxazinones by the replacement 
of the carbonyl group with an imino group. The functionalization of the NH group enables 
the opportunity of versatile syntheses.  
 
Figure 1. General structure of benzoxazine derivatives 
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Benzoxazines and their derivatives are synthetically useful compounds and are 
employed in organic synthesis for building natural products and designed synthetic 
compounds. They have been frequently utilized as suitable skeletons for the design of 
biologically active compounds.1. The versatility of the benzoxazine skeleton, in addition 
to its relative chemical simplicity and accessibility, makes these chemicals amongst the 
most promising sources of bioactive compounds. Thanks to this fact, the number of 
publications related to the biological activity of this compound class has increased 
significantly in the last decade. Therefore, in this chapter some selected examples are only 
given as indicative examples and not exhaustive. 
For example, several benzoxazine derivatives were found to show antimicrobial2 
and antimycobacterial3 activity. Novel 6-chloro-2,4-diphenyl-3,4-dihydro-2H-1,3-
benzoxazine4 derivatives (5) were evaluated against S. Aureus, E. Coli and C. Albicans, 
while a series of 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones5 (6) were 
synthesized and exhibited in vitro activity against Mycobacterium tuberculosis, M. 
kansasii and M. avium (Figure 2a). Some representatives of benzoxazines such as 6-
bromo-2,2-dimethyl-benzo[1,4]thiazine-4-acetamide (7, Figure 2b) can act as potassium 
channel openers6 as they have vasorelexant activity, whereas a number of benzoxazinones 
have enzyme inhibitor activity7. For example, 2-cyclohexyl-4H-benzo[1,3]oxazin-4-one 
(8, Figure 2c) showed inhibitor activity against C1r serine protease8. 
 
Figure 2. Biologically active benzoxazine derivatives 
In case of some benzoxazine derivatives, receptor agonist9 or antagonist10 activity 
was also observed: a series of 6-(2, 4 diaminopyrimidinyl)-benz[1,4]oxazin-3-ones (9, 
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Figure 2d) were synthesized by Powell et al. and was found that compounds with a 2-
methyl-2-aryl substitution pattern exhibit potent renin inhibition and good permeability-
solubility and metabolic stability11. Additionally, some derivatives of iminobenzoxazines, 
iminobenzothiazines and iminoquinazolines can be used for controlling invertebrate 
pests12 (10, Figure 2e). 
2. 2. Synthesis of iminobenzoxazines 
The compound class of benzoxazines has numerous derivatives, and some of them 
were already presented in Chapter 2. 1. Thanks to the large number of representatives, 
this chapter is limited to the preparation methods and syntheses for only 
iminobenzoxazines (1,3- and 1,4-derivatives). 
The first preparation of imino[1,3]benzoxazines (13) was reported by Metlesics13 
et al. in 1967 during the synthesis of quinazolines and 1,4-benzodiazepines. In the 
presence of HgO the methylthiourea derivative 11 was converted to an oxadiazepine 
derivative (12), which was than treated with hydrochloric acid in ether to form the desired 
product (13) in 87% yield (Scheme 1). 
 
Scheme 1. Preparation of imino[1,3]benzoxazines from oxadiazepines 
In 1989, the synthesis of 4-imino-4H-3,1-benzoxazines (15) was described by 
Mazurkiewicz14 from N-acylanthranilamides (14) in the presence of Ph3PBr2 reagent. If 
2-methyl-4-imino-4H-3,1-benzoxazines (15a and 15b) were treated with hydrochloric 
acid, a rearrangement was occurred giving 4-quinazolones (16a and 16b) in high yields. 
In contrast, the phenyl-substituted derivatives did not undergo any essential changes 
(Scheme 2). Similarly, iminobenzoxazine-quinazolone rearrangement was observed by 
Snider15 and co-workers during the investigation of the total synthesis of Fumiquinazoline 
G reported previously by Ganesan16 et al. 
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Scheme 2. Synthesis and rearrangement of imino-3,1-benzoxazines 
In the following years, the total synthesis of further Fumiquinazoline17 derivatives 
and other important alkaloids such as Alantrypinone18 (18), Circumdatin19 (19) or 
Luotonin20 (20) via the formation of imino[1,3]benzoxazine intermediates (15) were also 
published by Snider, Hart, Bergman and Batey (Scheme 3). 
 
Scheme 3. Iminobenzoxazines: intermediates of the total synthesis of different alkaloids 
The three-component synthesis of 4-imino-4H-3,1-benzoxazines (24) was 
developed by Zhu21 and co-workers in 2005. Heating a toluene solution of an aldehyde 
(23), an amine (22), and an isonitrile (21) in the presence of stoichiometric amount of 
ammonium chloride produced the title compound in good to excellent yields (Scheme 4). 
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Scheme 4. Three-component synthesis of imino-1,3-benzoxazines 
Recently, the microwave-assisted palladium-catalyzed synthesis of imino-1,3-
benzoxazines was reported by Batra22 et al. They also utilized isonitriles as starting 
materials which were reacted with 2-bromophenylureas in the presence of Pd-ligand and 
cesium carbonate base. 
The first synthesis of imino-1,4-benzoxazines (27) was reported by Weidinger and 
Kranz23 in 1964 by the condensation of ortho-aminophenols (25) with oxalyl 
bismethylimidate (26) under acidic conditions (Scheme 5). 
Scheme 5. Preparation of 2-imino-3-amino-1,4-benzoxazines 
In 2009, González24 et al. developed a three-component synthesis for the 
construction of 2-imino-1,4-benzoxazine derivatives (31) from salicylaldehydes (28), 
ortho-aminophenols (29) and arylisocyanides (30) in toluene in the presence of 
ammonium-chloride (Scheme 6). The desired iminobenzoxazine derivatives could also 
be obtained by preparing the putative Schiff base intermediate followed by addition of 
the isonitrile, but in that case, more vigorous conditions were required. 
 
Scheme 6. Three-component synthesis of imino-1,4-benzoxazines 
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Another approach for the synthesis of imino-1,4-benzoxazines with the utilization 
of ortho-aminophenols and isocyanides was published by Liu25 and co-workers in 2013. 
Palladium chloride was used as a catalyst and the reactions were conducted in dioxane 
solvent. The applicability of the developed procedure was demonstrated on 28 examples 
in good to high yields. 
2. 3. Chromenoquinolines and their derivatives: structure and 
biological activity 
Chromenoquinolines are condensed heterocyclic compounds built from a 
chromene (32) and a quinoline core (33). Depending on the mode of the anellation 
between the basic and the prefix ring, the formed four-ring system can be chromeno[4,3]- 
or chromeno[3,4]quinolines. Two representatives, chromeno[4,3-b]quinoline (34a) and 
chromeno[3,4-b]quinoline (35a) are shown on Figure 3. 
 
Figure 3. Different chromenoquinoline derivaties built from chromene and quinoline ring 
Although, the number of publications according to the biological aspects of 
chromenoquinolines is not widespread as in the case of benzoxazine derivatives, their 
applications in medical chemistry have increased notably in the last decade. For example, 
6H-chromeno[4,3-b]quinolines can act as estrogen receptor β–selective ligands26 and 
they can be used also for bioimaging due to their fluorescent properties27. Moreover, the 
spiro analogues of benzothiazolylchromeno derivatives have shown cytotoxic activity28 
against MCF-7 (breast cancer) and HeLa (cervical cancer) cell lines. 
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2. 4. Synthesis of chromenoquinolines 
In contrast to benzoxazines, the literatures according to the synthetic methods for 
the construction of chromenoquinoline core are more limited. However, the first synthesis 
of 6H-chromeno[4,3-b]quinoline (34a) was described nearly 80 years ago by Pfeiffer29 in 
1938 via the Friedländer30 synthesis of ortho-aminobenzaldehyde (36a) and chromanone 
(37a) in methanol in the presence of sodium hydroxide (Scheme 7). The fluorescent 
property of the title compound in solution with green color was even then observed. In a 
similar way, the synthesis of other benzopyarano- and benzothiopyrano[4,3-b]quinoline 
derivatives including the preparation of 7-methyl-6H-chromeno[4,3-b]quinoline (34b) 
and 7-methyl-6-phyenyl-6H-chromeno[4,3-b]quinoline (34c) from ortho-
aminoacetophenone (hydrochloric acid salt) (36b) and chroman-4-one derivatives (37a, 
37b) was published in 1965 by Kempter31 et al. They also utilized methanol as a solvent 
and the title products were prepared in 77% and 78% yield after recrystallization. 
 
Scheme 7. Synthesis of chromeno[4,3-b]quinoline derivatives via Friedländer synthesis 
In 1977, Balasubramanian32 and co-workers reported a convenient route for the 
selective synthesis of chromeno[4,3-b]quinolines (34a, 34d-34f) based on the thermal 
transformation of enaminoimines (38). According to their publication, the formation of 
the chromeno[3,4-c]quinoline core (35) was not observed in these type of reactions 
(Scheme 8). 
20 
 
 
Scheme 8. Thermal transformation of enaminoimines to chromenoquinolines 
In 1983, the same research group published the preparation of chromeno[4,3-
b]quinolines by the photocyclization of chloroimines.33 The photochemical 
transformation may proceed either through the intermediacy of enaminoimine or through 
the anilino-aldehyde derivative. In the same year, another synthesis was developed by 
Rougeot34 et al. for the construction of chromeno[4,3-b]quinolines by heating 
propargyloxysalicylanilides (39) in the presence of phosphoryl chloride. The reaction is 
proposed to undergo via a nitrilium salt intermediate (40) (Scheme 9). 
 
Scheme 9. Synthesis of chromenoquinolines from propargyloxysalicylanilides with POCl3 
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In 1999, Sabitha35 reported the microwave-assisted, clay-catalyzed Friedländer30 
condensation of chromeno[4,3-b]quinolines. Propylphosphonic anhydride (T3P) can also 
catalyze the reaction, described later by Jida36. Nine years later, another approach for the 
synthesis of this compound class was realized by Bera37 et al from β-chloroacroleins (41) 
and aminophenols (42) in dimethylformamide solvent (Scheme 10). 
 
Scheme 10. Chromeno[4,3-b]quinoline synthesis from β-chloroacroleins and aminophenols 
The preparation of chromenoquinolines via cyclization of differently substituted 
anilines or naphthylamine with O-propargylated salicylaldehydes using CuI/La(OTf)3 as 
an efficient catalyst in refluxing acetonitrile was published by Nagarajan38 and co-
workers in 2010. The desired products were isolated in good and high yields. 
One year later, the palladium-mediated intramolecular coupling reaction of 2-[(3-
substituted-phenoxy)methyl]quinolines (43) for preparing chromeno[3,4-b]quinolines 
was explored by Jackson39 et al. Potassium carbonate was utilized as a base and the 
reactions were conducted in acetonitrile, while the products (35a-f) were obtained in 
moderate yields (Scheme 11). The results of the cyclizations gave convincing evidence 
for an electrophilic aromatic substitution mechanism under standard Heck conditions. 
22 
 
 
Scheme 11. Synthesis of chromeno[3,4-b]quinolines via Heck reaction 
2. 5. Diaryliodonium salts 
In the last decades, hypervalent iodine compounds – the iodine atom contains 
more than eight electrons in the valence shell required for the octet rule - have received 
significant attention in organic syntheses40 due to the fact that they are efficient reagents41 
for several organic reactions. Moreover, they can be employed as alternative oxidizing 
agents of various toxic heavy-metal-based oxidants such as mercury, arsenic, cadmium 
and nickel compounds. Amongst the hypervalent iodine compounds, iodine(III) and 
iodine(V) reagents are distinguished. The versatility of these λ3- and λ5-iodine reagents is 
becoming firmly established by the numerous transformations in which these reagents 
were involved. For example, 2-iodobenzoic acid (IBX) or Dess-Martin periodinane 
(DMP) are now routinely used in oxidative C-C couplings, oxidative cyclizations, 
oxidative rearrangements, oxidative deoximations, oxidative ring expansions and 
contractions, C-N bond formations and especially in oxidation of alcohols.42 
In contrast, diaryliodine(III) reagents43 can be utilized in reaction pathways which 
are similar to metal-catalyzed reactions. Owing to the highly electron-deficient nature of 
diaryliodonium salts at the iodine center and excellent leaving-group ability of the 
iodobenzene, they serve as versatile arylating agents with a variety of nucleophiles. Thus, 
as they are capable to transfer aryl group, their use enables the functionalization of 
different aromatic and heteroaromatic substrates. Moreover, they can also be used in 
sequential cyclizations for the synthesis of several important heterocyclic compounds. 
23 
 
2. 5. 1. Structural properties and reactivity 
Diaryliodonium salts have been known for more than 100 years. They were 
described by Meyer44 in 1894 as air- and moisture-stable compounds. Their structure 
consists of two aryl moieties connected to the iodine and a “counterion” X, being mainly 
halogen, triflate, tosylate or tetrafluoroborate (Figure 4a). The triflate and 
tetrafluoroborate salts have good solubility in many organic solvents, moreover, the week 
or non-existent nucleophilicity of these anions make these iodonium salts easily 
applicable in organic syntheses. In contrast, diaryliodonium salts with halide anions are 
generally sparingly soluble, thus, there are less applications according to diaryliodonium 
chlorides or bromides. 
 
Figure 4. a) General structure of diaryliodonium salts; b) T-shaped form determined by X-ray structure 
analysis 
According to the lambda (λ) convention, they are classified as λ3-compounds,45 
where the iodine and two apical ligands (L) share a hypervalent, three-center four-electron 
(3c–4e) bond (Figure 4b). Hence, as it was mentioned previously, the electron 
configuration of the iodine in hypervalent iodine compounds is not conventional: instead 
of eight electrons, ten or twelve are located around the iodine center. The X-ray structures 
of these iodine(III) compounds show a T-shaped molecular geometry.46 Thus, the Ar–I–
Ar bond angle is close to 90°, which is believed to retain also in solution. The degree of 
dissociation to Ar2I
+ and X– in solution depends on both the solvent and the counterion47. 
For example, di-p-tolyliodonium tetrafluoroborate is much less dissociated in 
dichloromethane than the closely related bis(4-(tert-butyl)phenyl)iodonium 
hexafluorophosphate. 
The reactivity of iodine(III) compounds is based on the electrophilic nature of the 
iodine, which is derived from the electron distribution in the 3c–4e bond. In reactions 
with Ar2IX, one aryl group is transferred to the nucleophile, resulting diverse arylated 
compounds, while the other one is reductively eliminated as ArI. The high reactivity of 
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aryliodonium salts in these reactions is explained by the ‘hyperleaving group ability’ of 
the ArI group.48 In metal-free reactions the nucleophile first attacks the electrophilic 
iodine of the diaryliodonium salt to give a T-shaped intermediate in a ligand exchange. 
In the subsequent step, the nucleophile and the equatorial aryl moiety are reductively 
eliminated in a ligand coupling, resulting ArNu and ArI (Scheme 12a).49 Arylations under 
metal-catalyzed conditions are generally suggested to proceed by transfer of one aryl 
group to the metal to create a high oxidation state aryl metal complex (ArMX), followed 
by reductive elimination with the nucleophile (Scheme 12b). 
 
Scheme 12. General mechanism for a) metal-free arylation; b) metal-catalyzed reaction 
The drawbacks of the application of diaryliodonium salts in organic synthesis are the 
formation of a stoichiometric amount of iodoarene in the reaction, and the selectivity of 
possible aryl transfers. With the utilization of symmetric diaryliodonium salts (R1 = R2, 
Figure 4a) selectivity problems can be solved in aryl-transfer reactions. However, this 
structural requirement may limit the scope of the transformations. Arylations with 
unsymmetric diaryliodonium salts (Ar1 ≠ Ar2) are often desired, both because these salts 
are more easily synthesized, they enable the possibility of wide substrate scope and 
because an inexpensive ’dummy’ aryl moiety is wasted as ArI. The most frequently used 
non-transferable ‘dummy-group’ for metal-catalyzed reactions is the mesityl group. 
2. 5. 2. Synthetic strategies to diaryliodonium salts 
Since the first synthesis of diaryliodonium salts was described by Meyer44, a large 
variety of synthetic routes to diaryliodonium salts have been reported. Owing to the large 
number of publications, without exhaustive, only selected examples are given in this 
chapter focusing on the different synthetic strategies. Most of them are typically 
stepwised, with initial oxidation of an aryl iodide (Ar1I) to iodine(III) (preformed iodine 
(III) reagent) and then ligand exchange with an arene (Ar2H) or an organometallic reagent 
(Ar2M) to obtain the diaryliodonium salt (Scheme 13a). In many cases a subsequent anion 
exchange step is necessary. To shorten the number of steps, inorganic(III) iodine reagents 
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can be employed (Scheme 13b). Recent progresses focus onto the development of one-
pot methods to obtain the diaryliodonium salts directly from arenes and iodoarenes or 
molecular iodine (Scheme 13c and 13d). 
 
Scheme 13. Synthetic strategies for preparing diaryliodonium salts 
The substitution of the arene (ArH) onto an iodine(III) intermediate undergoes via 
electrophilic aromatic substitution, which limits the number of possible products. In case 
of o/p directing substituents, mostly para-substituted diaryliodonium salts are formed, 
whereas m-directing substituents often lead to poor yields and byproduct formation. Thus, 
the aryl iodide should contain o/m substituents or lithiated arenes, arylboronic acids, 
stannanes, or silanes should be employed during the transformation. 
One of the most common synthetic routes to the access of diaryliodonium salts is 
generally performed with preformed organic iodine(III) compounds (Scheme 13a). The 
aryl iodide (Ar1I) is converted into an aryliodine(III) compound (Ar1IL2) by its treatment 
with an inorganic oxidant under acidic conditions. Then the desired iodonium salt can be 
obtained after isolation of the aryliodine(III) followed by ligand exchange with an arene, 
an arylstannane or an arylsilane. The first synthesis of diaryliodonium salts reported 
previously by Meyer44 was prepared from iodosylbenzene. In the 1950s Beringer50,51 et 
al. published a large number of synthetic methods for the preparation of symmetric and 
unsymmetric diaryliodonium salts (46). In their transformations a wide range of 
hypervalent iodine(III) compounds were utilized such as iodosylarenes (44), 
(diacetoxyiodo)arenes and iodoxyarenes which were reacted with arenes (45) in the 
presence of different acids (Scheme 14a). The first regiospecific synthesis of 
diaryliodonium tosylates was discovered by Koser52 and co-workers in 1980 by the 
reaction of hydroxy(tosyloxy)iodobenzene (47) (Koser’s reagent) with arylsilanes (48) 
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under neutral conditions (Scheme 14b). Electron-rich thiophenes53 were also suitable 
substrates of the developed method, but in that case the reaction was completed without 
the need of the trimethylsilyl (TMS) activating group. 
 
Scheme 14. Preparation of diaryliodonium salts from a) iodosylarene and b) Koser reagent 
In 1994, Kitamura54 et al developed the triflic acid-mediated synthesis of 
diaryliodonium salts with the utilization of (diacetoxyiodo)benzene (DIB) (49). In the 
first step of the reaction, [PhI(OAc)2·2TfOH] is formed in situ, followed by the 
subsequent addition of electron-rich arenes to give the desired diaryliodonium triflates in 
good to high yields (46) (Scheme 15a). This method was further developed by 
Widdowson55 and co-workers, who reacted DIB with arylboronic acids (50) in the 
presence of triflic acid, giving diaryliodonium triflates in 74-97% yields (Scheme 15b). 
 
Scheme 15. Synthesis of diaryliodonium triflates from diacetoxyiodobenzenes 
Another opportunity for the construction of diaryliodonium salts can be 
accomplished from preformed inorganic hypervalent iodine reagents (Scheme 13b). 
With this strategy, the synthesis of iodonium salts can be shortened, moreover, it is 
generally efficient in the synthesis of symmetric diaryliodonium salts. The disadvantage 
of this process is that the inorganic iodine reagents must be prepared beforehand and some 
of them are not storable. Masson56 and Beringer50 reported that arenes (45) could be 
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treated with iodic acid or iodosyl sulfate (51) to form diaryliodonium salts (46) in 
modarate yields (Scheme 16a). As described by Zhdankin57, the desired products can also 
be synthesized in better yields utilizing iodosyl triflates (52) and arylsilanes (48) at low 
temperatures (Scheme 16b). 
 
Scheme 16. Preparation of diaryliodonium salts from a) iodosyl sulfate and b) iodosyl triflate 
In case of acid-sensitive substituents or heteroatoms that are prone to oxidation or 
protonation, the two strategies presented above cannot be employed. The utilization of 
very reactive iodine(III) reagents such as vinyl iodine(III) can solve this problem. As an 
advantage, applying them under strongly basic conditions such as in reactions with 
metallated arenes, both symmetric and unsymmetric diaryliodonium salts can be 
synthesized in a regiospecific manner. The drawbacks of this approach are that the 
unstable iodine(III) reagents are commercially not available and during their preparation 
strong bases should be used at low temperatures. In 1969, Beringer and Nathan58 reported 
the application of highly unstable trans-chlorovinyliodoso dichloride (53) in the synthesis 
of diaryliodonium salts. In the presence of lithiated arenes (54) symmetric diaryliodonium 
salts could be obtained at low temperatures in moderate to good yields (Scheme 17a). In 
1990, a variety of aryl(vinyl)iodonium triflates59 (56) have been prepared by the reaction 
of (diacetoxy)iodoarenes (49) with alkynes (55) and utilized60 for the synthesis of 
diaryliodonium salts treating them with lithiated arenes (54) (Scheme 17b). 
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Scheme 17. Synthesis of diaryliodonium salts from reactive iodine(III) reagents 
The most attractive ways to prepare diaryliodonium salts are the one-pot syntheses 
(Scheme 13c and 13d). Advantages include reduced reaction time and diverse substrate 
scope. To achieve a successful one-pot reaction, the arene should be carefully selected. 
For example, too electron deficient arenes cannot be employed in order to avoid the 
formation of byproducts. Due to the numerous publications according to this synthetic 
method, only selected examples are discussed in the followings. In 1953, Beringer51 et al. 
reported that certain diaryliodonium salts (46) could be prepared directly from alkyl-
substituted arenes (45) with the commercial oxidant potassium iodate (Scheme 18a). 
Three years later, Sandin61 described that the preparation of cyclic diaryliodonium salts 
can also be realized with the utilization of peracetic acid. In the presence of potassium 
persulfate or barium peroxide the synthesis of acyclic diaryliodonium salts was reported 
by Beringer51 in 1959. This method was further developed by Kitamura62-64 et al. utilizing 
K2S2O8 in various reaction conditions. For example, they synthesized diaryliodonium 
triflates from aryl iodides (57) and arenes (45) in the presence of potassium persulfate62 
and TFA followed by an anion exchange induced by NaOTf (Scheme 18b). Hence, these 
conditions were suitable for a direct synthesis of diaryliodonium triflates from iodine63 
and arenes (45) too. Moreover, the anion-exchange step was later avoided by adding triflic 
acid64 to the reaction. The employment of chromium trioxide oxidant with the reagent 
combination acetic anhydride, acetic acid, and sulfuric acid under anhydrous conditions 
for the construction of diaryliodonium bromides was published by Skulski65 and 
Kaźmierczak in 1995 (Scheme 18c). An elegant electrochemical synthesis of 
diaryliodonium salts was also reported by Pletcher66 and Peacock in 2000. 
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Scheme 18. One-pot synthesis of diaryliodonium salts with a) KIO3 b) K2S2O8 and c) CrO3 
Similar to Kitamura,62-64 Olofsson and co-workers recently developed several 
syntheses for the preparation of diaryliodonium salts, but in their transformations m-
chloroperbenzoic acid (mCPBA) was employed as an oxidizing agent. With their 
methodologies a wide range of diaryliodonium salts were able to prepare in short reaction 
times and in high yields without the need for excess reagents (Scheme 19). The reactions 
were performed in DCM, in combination with triflic acid (TfOH), toluenesulfonic acid 
(TsOH), or boron trifluoride etherate (BF3·OEt2), depending on the structure of the 
iodonium salt. The TfOH based method (Scheme 19a),67 which applies aryl iodides (57) 
and arenes (45), is the most versatile, while the utilization of TsOH68 is more suitable for 
the synthesis of electron-rich salts. Both of them could be extended to the synthesis of 
symmetric diaryliodonium salts directly from and arenes (45) and iodine.67,68 The 
employment of BF3·OEt2 together with arylboronic acids69 (50) allows a regiospecific 
synthesis of iodonium salts with otherwise inaccessible substitution patterns (Scheme 
19b). Gaunt70 et al. modified the TfOH method (Scheme 19a) by using tetrafluoroboric 
acid instead of triflic acid. The obtained diaryliodonium tetrafluoroborates were 
converted into the corresponding triflates by treatment with TMSOTf. 
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Scheme 19. Olofsson’s one pot syntheses of diaryliodonium salts with mCPBA 
As reported by Olofsson71 in 2009, the use of environmentally more benign urea-
hydrogen peroxide in combination with triflic anhydride instead of mCPBA also serves 
as an efficient oxidation system delivering a wide range of diaryliodonium triflates in 
good yields from aryl iodides (57) and arenes (45) (Scheme 20). 
 
Scheme 20. Preparation of diaryliodonium salt with urea-hydrogen peroxide 
2. 5. 3. Application of diaryliodonium salts in organic syntheses 
In the last decades, transformations including diaryliodonium salts have become 
an important and widespread research field of organic syntheses. Therefore, numerous 
applications have been developed such as metal-catalyzed cross-couplings, C–H 
activation, aryne generation or dearomatization of phenols. Recently, diaryliodonium 
salts have been recognized as efficient reagents in arylation reactions with a wide range 
of nucleophiles under both metal-free and metal-catalyzed conditions. In these kinds of 
transformations, diaryliodonium salts implement the aryl transfer, providing diverse 
arylated aromatic and heteroaromatic substrates. In the followings, we aim to resume the 
arylation reactions accomplished with the employment of diaryliodonium salts with 
nucleophilic systems (C-, O-, N- and S-nucleophiles) under both metal-free conditions 
and with the utilization of copper catalyst. 
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2. 5. 3. 1. Transition-metal free arylations of heteroatom and carbon nucleophiles 
The application of diaryliodonium salts in the functionalization of carbon and 
heteroatoms opens new possibilities to access the target compounds. The report of 
Beringer50 in 1953 can be considered as a pioneering study, in which he demonstrated 
that diaryliodonium bromides are useful reagents for the phenylation of versatile organic 
and inorganic bases including alkoxides, phenoxides, benzoates, nitrites, sulfonamides, 
amines, sulfites, sulfonates, and cyanides under relatively mild conditions. Hence, the 
publications according to this research field have been increasing significantly from the 
1950s, therefore only assorted articles are presented in the followings. 
According to arylation of oxygen nucleophiles, we can find examples for the 
transition metal-catalyzed synthesis of aromatic, heteroaromatic and aliphatic alcohols 
too. In 1963, Crowder72 reported the preparation of diaryl ethers by the SN2-type reactions 
of phenols (58) in the presence of sodium hydroxide base in aqueous conditions (Scheme 
21a). Diaryliodonium bromides (46) were employed as arylating agents and the reactions 
were carried out at 100°C. Electron-donating methyl or methoxy groups as well as 
electron-withdrawing carbonyl group were tolerated in the reaction providing the 
appropriate products (59) in 63-86% yields. 
In the last few years, Olofsson and co-workers developed a few examples for 
metal-free O-arylations, for example in 2011 they published the preparation of diaryl 
ethers (59) from phenols (58) under mild conditions in short reaction times (compared to 
Crowder’s work, 25-40 °C reaction temperature was employed in 15-60 min) and in good 
to high yields (Scheme 21b).73 In the reaction potassium-tert butoxide was utilized as a 
base and the reactions were conducted in tetrahydrofurane. Sterically crowded, ortho-
substituted phenol derivatives and heteroaromatic pyridines were also able to transform 
to the desired products (59). 
Similar to Crowder, Olofsson also realized the metal-free synthesis of aryl ethers 
(59) in aqueous medium under mild conditions (instead of 100 °C lower temperature, 25-
50 °C was applied). Both allylic, benzylic alcohols and phenols were active in the reaction 
providing the desired products in good to high yields.74 The functionalization of phenol 
substrates worked with the best efficiency, the appropriate arylated products were isolated 
in up to 98% yield. 
Very recently, Gaunt et al. also developed a mild and transition metal-free counter 
anion triggered electrophilic O-arylation strategy by using diaryliodonium fluorides.75 
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Sodium hydroxide base was used in dichloromethane solvent and a wide range of diaryl 
ethers (59) were synthesized in high yields (Scheme 21c). Beside the aromatic substrates, 
heteroaromatic compounds such as pyridine and quinoline derivatives were also able to 
functionalize. Not only phenols and pyridine derivatives, but compounds containing two 
nitrogen atoms such as 2-oxo-pyrimidines were also suitable substrates for O-arylations, 
as described by Karade76 in 2014. The reactions were conducted in toluene in the presence 
of potassium carbonate base. The reaction was selective, while the two nitrogen atoms of 
the heteroaromatic ring did not change under the employed reaction conditions. 
 
Scheme 21. Preparation of diaryl ethers with a) NaOH b) KOtBu c) NaHCO3 base 
According to the arylation of aliphatic alcohols, after the work of Beringer,50 
McEwen77 reported an etherification reaction induced by sodium ethoxide and 
diphenyliodonium tetrafluoroborate (Scheme 22a) for the preparation of ethoxybenzene 
(61). With the utilization of 1,1-diphenylethylene (DPE) additive selectivity problems 
could be solved and only the desired O-arylated product was obtained and was isolated 
in 77% yield. In 2006, Fujita and Okuyama78 described the solvolysis of diaryliodonium 
tetrafluoroborates occurred in alcohol solvent at elevated temperature (130 °C) in the 
absence of base. Only poor yields were achieved as both aryl groups of unsymmetrical 
diaryiodonium salts were transferred in the reaction. Another approach for the synthesis 
of alkyl-aryl ethers (61) from aliphatic alcohols (60) with diaryliodonium salts (46) was 
developed by Olofsson79 in 2014. As a base, sodium tert-butoxide or sodium hydride was 
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utilized in toluene and the products were isolated in 43-98% yields (Scheme 22b). 
Amongst the alcohol derivatives, primary alcohols were the most efficient reaction 
partners providing the appropriate products in high yields. However, secondary, benzylic 
and allylic alcohols were also able to transform to the corresponding alkyl-aryl ether 
derivatives. 
 
Scheme 22. Synthesis of alkyl-aryl ethers with diaryliodonium salts 
In the presence of sodium hydride base Stuart80 and co-workers reported another 
transition metal-free approach for the preparation of alkyl-aryl ethers (61) from aliphatic 
alcohols (60) and unsymmetric arylmesityliodonium bromides. In their reactions methyl 
tert-butyl ether (MTBE) was used as a solvent. Primary, secondary, tertiary, allylic, and 
benzylic aliphatic alcohols were all suitable substrates for the transformation obtaining 
the desired products in 44-83% yields. The applicability of the developed procedure was 
also employed in the synthesis of Pioglitazone, active ingredient of the antidiabetic Actos. 
The arylation of acids with the employment of diaryliodonium salts were also 
discussed in the literature. For example, the preparation of aryl esters (63) from carboxylic 
acids (62) and diaryliodonium salts in the presence of potassium tert-butoxide in toluene 
solvent was realized by Olofsson81 in 2011 (Scheme 23a). Aromatic as well as aliphatic 
substates were suitable for the transformation providing the corresponding products in 
good to high yields. With the utilization of t-BuOK base in toluene solvent, other acid 
derivatives such as sulfonic acids (64) were also suitable reaction partners for the 
iodonium salts and the desired arylsulfonates (65) were isolated in moderate to good 
yields (Scheme 23b).82 
One year later, the microwave-assisted metal-free arylation of sulfinate salts for 
the construction of diaryl sulfones in was developed by Kumar and co-workers.83 The 
reactions were performed in PEG-400 solvent at 50 °C and the appropriate products were 
synthesized in good to high yields. Beside the arylation of carboxylic and sulfonic acids, 
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the base-promoted arylation of phosphoric acid derivatives (66) with diaryliodonium 
triflates (46) was also realized and recently reported by Yin84 et al. The reactions were 
performed in toluene solvent at its reflux temperature in the presence of triethylamine and 
the arylated phorphorus compounds (67) were obtained in 82-96% yields (Scheme 23c). 
 
Scheme 23. Arylation of acids with iodonium salts 
Besides the O-arylation reactions, the arylation of nitrogen nucleophiles in the 
absence of transition-metal catalysts was also demonstrated on numerous examples in the 
last few years. For example, in 2007, Carrol85 and Wood published a transition-metal-
free N-arylation for the preparation of diarylamines (69) using anilines (68) and 
diphenyliodonium trifluoroacetate in dimethylformamide at 130 °C (Scheme 24a). The 
appropriate products were isolated in 50-92% yields. Chen86 and co-workers recently 
described the metal-free arylation of ortho-acylanilines for the construction of acridine 
derivatives. The reactions were accomplished in dichloroethane (DCE) also at elevated 
temperature and the condensed heteroaromatic compounds were obtained in good to high 
yields. Another approach was developed by Wang87 et al. in 2014 for the N-arylation of 
hydroxylamines (70) with iodonium salts (46) in toluene solvent under mild conditions. 
The cesium-carbonate promoted direct arylation provided the corresponding products 
(71) in good to high yields (Scheme 24b). 
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Scheme 24. N-arylation of a) anilines b) hydroxylamines and c) acyclic amides  
One year later, the synthesis of α,β-unsaturated N-aryl ketonitrones from oximes 
and diaryliodonium salts via metal-free N-arylation process under mild conditions was 
described by Mo88 and co-workers. Potassium hydroxide base was utilized as a base in 
carbon tetrachloride solvent at room temperature. Based on DFT calculations, the 
products were presumed to form via [1,3]-phenyl migration. The N-arylation of non-
aromatic systems, such as alkyl amides was alsoable to realize in the presence of 
iodonium salts. Very recently, the sodium hydride-mediated N-arylation of secondary 
acyclic amides (72) using iodonium salts in toluene at room temperature was reported by 
Olofsson (Scheme 24c).89 The desired arylated products (73) were isolated in high yields. 
Results of the substrate scope revealed that amides equipped with electron-donating 
groups provided the tertiary acyclic amides (73) in high yields, whereas in the case of the 
iodonium salts electron-deficient aryl groups were more efficiently transferred. 
Amongst the N-arylation reactions, in the last decade, a few methodologies were 
developed focusing on N-functionalization of different heterocyclic compounds with 
diaryliodonium salts under metal-free conditions. As an example, the potassium tert-
butoxide-mediated synthesis of N-arylated carbazoles (75) using diaryliodonium tirflates 
(46) in toluene was described by Han and Wang in 2012 (Scheme 25a).90 The arylated 
heterocyclic compounds were isolated in 55-92% yields. Employing the same reaction 
conditions for the N-H functionalization of tetrahydrocarbazole derivatives, in that case 
of substrates C-arylation reaction occurred. 
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Very recently, the metal-free N-arylation of pyrazole derivatives (76) under mild 
conditions in short reaction times was also realized and published in our research group91 
employing a wide range of diaryliodonium salts. The reactions were conducted in 
aqueous ammonia-toluene 1:1 mixture at room temperature providing the arylated 
products (77) in up to 95% yield (Scheme 25b). Iodonium salts containing sterically more 
hindered and more electron-deficient aryl groups were the most suitable reagents in the 
transformation. In the same year, according to the N-functionalization of heterocyclic 
compounds, the synthesis of N-arylated indolines (80) and 2-arylated benzotriazoles (81) 
using diaryliodonium triflates was realized by Riedmüller92 et al. The reactions were 
accomplished in trifluoroethanol (TFE) at higher temperature (70 °C) without the use of 
any additional additive affording the corresponding products in moderate to good yields 
(Scheme 25c). 
 
Scheme 25. N-arylation of heterocycles with diaryliodonium triflates 
The arylation of sulfur nucleophiles with diaryliodonium salts in the absence of 
transition-metal catalysts has been known for 1947, when Sandin93 reported the reaction 
of diphenyliodonium chloride (46) with thioglycolic acid (82), thiophenol and cysteine. 
However, S-phenylthioglycolic acid (83) was isolated in only 21% yield (Scheme 26a). 
In 2001, Huang94 et al. published another S-arylation reaction for the synthesis of diaryl 
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sulfides (86) from benzenethiolates (84) utilizing polymeric diaryliodonium salts (85). 
The reactions were carried out in dimethylformamide solvent at 100 °C and the desired 
products were obtained in 46-88% yields (Scheme 26b). Beside the employment of 
aromatic thiolates in S-arylation reactions, the application of alkyl thiolate derivatives in 
these kinds of transformations was also achieved. In 2006, the S-arylation of n-hexyl 
thiolate (87) with diphenyliodonium triflate was attained by Krief95 and co-workers in 
dimethylsulfoxide solvent at lower temperature. The reaction provided the arylated 
product (88) in 93% yield (Scheme 26c). 
The typical disadvantages of the examples presented above are the relatively low 
yields or poor functional group tolerance. Amongst these transformations the work of 
Sandin presents the most synthesized S-arylated products, in which only 7 examples are 
given. The solution to these problems was achieved by Sanford96 by the development of 
a novel metal free acid-mediated synthesis for the construction of diaryl and alkyl-aryl 
sulfides (90) from thiols and thioethers (89) with high functional group tolerance and 
good to excellent yields (Scheme 26d). In contrast with previous examples, the 
applicability of the developed reaction was demonstrated on 16 examples. 
 
Scheme 26. Arylation of sulfur nucleophiles with diaryliodonium salts 
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The arylation of carbon nucleophiles using diaryliodonium salts in the absence of 
transition-metal catalysts was an underdeveloped research field of organic syntheses after 
the early work of Beringer50. However, in recent years, besides the arylation of 
heteroatom nucleophiles, this process has received considerable attention, thus, the 
arylation of several aromatic and heteroaromatic systems was achieved via C-arylation 
processes. In 2011, Ackermann97 developed the metal-free C3-arylation of indoles (91) 
and pyrroles using diaryliodonium salts in dimethylformamide solvent at high 
temperature (100 °C). Without the use of any additives nitrogen-protected and free indole 
derivatives were also able to transform to the desired products (92) in moderate to good 
yields (Scheme 27a). 
One year later, the C-arylation of different aromatic and heteroaromatic substrates 
including substituted pyrroles (93), pyridine (94), pyrazine (95) and benzene derivatives 
(96) in the absence of transition-metal catalysts was published by Yu98 et al. Sodium 
hydroxide was utilized as a base at elevated temperature (Scheme 27b). C-arylation of 
pyridine derivatives provided isomers, while in the case of pyridazine and benzene 
derivatives the corresponding arylated products (97-100) could be isolated selectively. 
 
Scheme 27. C-arylation of electron-rich heterocycles with diaryliodonium salts 
Besides the arylation of different heterocyclic cores, carbonyl compounds were 
also suitable substrates for these kinds of transformations. The metal-free arylation of 
silyl enol ethers for the construction of α-arylated carbonyl compounds was published by 
Koser99 in 1991. The arylation with diaryliodonium salts took place at low temperature (-
40 °C) in tetrahydrofuran solvent. The products were obtained in moderate to good yields 
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(20-88%). The metal-free arylation of other carbonyl compounds such as alkyl malonates 
(101) and alkyl β-keto esters (102) under mild conditions was also realized by Oh100 et 
al. As a base, sodium hydride was utilized while the solvent of the transformation was 
dimethylformamide. The appropriate arylated products (103 and 104) were isolated in 
moderate to good yields (Scheme 28a). The reactions could be selectively accomplished 
with the employment of diaryliodonium salts containing trimethoxyphenyl ‘dummy’ 
group promoting the transfer of the less electron-deficient and less hindered aryl group. 
A similar approach was followed by Manetsch101 for the C-arylation of β-ketocarboxylic 
acids in the presence of t-BuOK base in DMF. The synthesis of ELQ-300 was also 
realized with the developed method, an antimalarial compound currently in preclinical 
development phase. Olofsson102 et al. published the first enantioselective transition-
metal-free arylation of cyclohexanones with the utilization of Simpkin’s base, which 
allows the generation of the nucleophilic enolate intermediate. The appropriate arylated 
products were isolated in 41-70% yields. 
According to the arylation of cyclic carbonyl compounds, the C2-
functionalization of quinones and naphthoquinones (105 and 106) was also achieved by 
Wang103 and co-workers with diaryliodonium triflate reagents (46) and sodium hydroxide 
base in DCE at elevated temperature (Scheme 28b). In the presence of electron-donating 
groups, the reaction provided the desired arylated quinones (107) in good yields. 
However, electron-withdrawing groups had deleterious effects on the transformation and 
the expected products could be isolated only in lower yields. Other heterocyclic 
compounds such as indolines (109) were also suitable substrates for metal-free arylations. 
Employing diaryliodonium salts with the combination of t-BuOK base in THF 
under mild conditions, Zhang104 described a C2-arylation method for the construction of 
arylated indolinones (110). Various products were synthesized, although in moderate 
yields (Scheme 28c). 
Not also carbonyl, but nitro compounds were also able to transform to the 
appropriate arylated derivatives. Very recently, Olofsson’s group105 reported the metal-
free arylation of nitrocycloalkanes (111) and nitroesters (112) in the presence of 
potassium-tert butoxide or cesium carbonate bases in DME and toluene solvents. The 
applicability of the developed procedure was demonstrated on numerous examples and 
the products (113 and 114) could be isolated in up to 93% yields (Scheme 28d). 
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Scheme 28. Metal-free arylation of carbonyl and nitro compounds with diaryliodonium salts 
2. 5. 3. 2. Copper-catalyzed functionalization of aromatic and heteroaromatic molecules 
with diaryliodonium salts 
The publications according to transition-metal-catalyzed arylations have been 
increasing noteworthy in the last decade. As our researches carried out during my PhD 
are involving copper-catalyzed transformations, thus, in the followings only those articles 
of the literatures are discussed, which were performed in the presence of copper catalyst. 
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2. 5. 3. 2. 1. Copper-catalyzed C-H arylations 
Functionalization of aromatic and heteroaromatic systems via copper-catalyzed 
C–H activation106 is an important and intensively studied area of current organic 
chemistry. Diaryliodonium salts (46) are efficient reagents in these types of 
transformations due to the fact that their employment enables the introduction of aryl 
moiety into aromatic and heteroaromatic substrates. 
According to the publications owing to this research field, Gaunt and co-workers 
marked an era in copper-catalyzed C-H arylations. They reported in 2008 that Cu(I) or 
Cu(II) catalysts could be oxidized in the presence of diaryliodine(III) reagent affording a 
highly electrophilic arylcopper(III) intermediate.107 The generation of this aromatic 
electrophile equivalent species (115) allows the transfer of the aryl group, thereby enables 
the functionalization of aromatic C–H bonds via C–H arylation processes (Scheme 29). 
 
Scheme 29. The formation of Ar-Cu(III) intermediate and its employment in C-H arylations 
With the utilization of this strategy several arylations were described by Gaunt et 
al. For example, the selective arylation of indoles107 at either the C3 or C2 position under 
mild conditions was realized using diaryliodonium triflates or tetrafluoroborates (46), 
copper triflate catalyst and 2,6-di-tert-butylpyridine base in DCM or DCE solvents 
(Scheme 30a). Unprotected and N-alkyl indole derivatives (91a) delivered the C3-
arylated products (116), while N-acetylindoles (91b) afforded the C2 isomers in moderate 
to good yields (117). 
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Scheme 30. Gaunt’s copper-catalyzed arylations with diaryliodonium salts 
This fact can be explained by the migration of the Cu(III)-aryl group from C3 to 
C2. In the case of N-acetylindoles, the carbonyl oxygen of the acetyl group can coordinate 
to the copper and may steer the Cu(III) species to the C2 position. One year later, the 
meta-selective arylation of pivalanilides108 (118) utilizing diarylidonium salts was 
described by Gaunt et al. The reactions were performed in DCE and as a catalyst, copper 
triflate was employed (Scheme 30b). The corresponding meta-arylated products were 
obtained in 11-93% yields. According to the mechanism of the developed transformation, 
the reaction was proposed to undergo via the formation of a highly active arylcopper(III) 
intermediate. As an extension, the copper-catalyzed meta-selective direct arylation of α-
aryl carbonyl compounds109 was also reported by Gaunt and co-workers two years later. 
Moreover, an enantioselective α-arylation procedure of N-acyloxazolidinones110 with 
copper(II)-bisoxazoline catalysts and diaryliodonium salts was also achieved in the same 
year. In 2012, the copper-catalyzed arylation of alkenes111 (120) was demonstrated by 
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this research group. Diaryliodonium triflates, copper chloride or triflate and di-tert-
butylpyridine base were employed in DCE or DCM solvents (Scheme 30c). Two alkene 
isomers (121 and 122) were formed and the selectivity was influenced by the structure of 
the starting alkene and the diaryliodonium salt. The developed method was demonstrated 
on numerous examples. 
Beside the pioneering works of Gaunt, the C-H functionalization of aromatic and 
heteroaromatic cores using diaryliodonium salts was discussed by other research groups 
too. For example, Modha112 and Greaney also developed a copper-catalyzed procedure 
for the arylation of indoles. In their methodology tandem C–H and N–H arylation 
occurred. Very recently, the copper-catalyzed selective ortho-arylation of 2-naphtol and 
phenol derivatives (123) with diaryliodonium triflates was reported by Wang113 et al. 
Copper triflate was employed in DCE at 80 °C (Scheme 31a). Another C–H arylation 
approach for the construction of arylated 1,3-azoles (129 and 130) and benzoxazoles (131 
and 132) was reported by Kumar114 and co-workers in 2014. The reactions were 
accomplished with the utilization of copper bromide or iodide catalyst in dimethyl 
sulfoxide solvent at room temperature and a wide range of products were synthesized in 
good yields (Scheme 31b). Similarly to the publications of Gaunt, 109-110 the α-arylation 
of carbonyl compounds was also accomplished by Stang and MacMillan. In 1997, 
Stang115 reported the copper cyanide mediated arylation of cyclic ketones with 
diaryliodonium triflates. The disadvantages of this reaction are low yields and the need 
of equivalent amount of copper. The enantioselective α-arylation of aldehydes116 (133) 
and silyl enol ethers117 in the presence of catalytic amount of copper could be also 
achieved by MacMillan in 2011. In the first transformation, copper bromide was utilized 
in the presence of amine catalyst (134). The appropriate α-aryl aldehydes (135) were 
isolated in 67-95% yields and in high enantioselectivity (Scheme 31c). The C-arylation 
of cyclic enamide and naphthyl-acetamide substrates (136 and 137) was also 
demonstrated by Kesavan118 et al. for the synthesis of β-aryl cyclic enamides (138 and 
139) with the employment of copper bromide catalyst in DCM solvent (Scheme 31d). 
The appropriate products were obtained in 71-93% yields. 
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Scheme 31. Copper-catalyzed arylation of a) phenole b) azole c) aldehyde and d) enamide derivatives 
Another example for the synthesis of non-aromatic cyclic enamide derivatives was 
reported by Gillaizeau.119 In this transformation, instead of copper bromide, copper 
triflate was employed as the catalyst in the same solvent (DCM) and di-tert-butylpyridine 
(dtbpy) base was also added to the reaction mixture. 
2. 5. 3. 2. 2. Copper-catalyzed cyclizations of unsaturated compounds 
With the functionalization of unsaturated systems such as electron-rich alkenes, 
alkynes and nitriles via copper-catalyzed arylation processes in the presence of iodonium 
salts diverse heterocyclic skeletons can be constructed. Due to this fact, the synthesis of 
several complex heterocyclic compounds was accomplished in the last few years. The 
mechanism of these kinds of transformations is presumed to involve the formation of a 
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highly active arylcopper(III) species. In the presence of this aromatic electrophile 
equivalent (115) activation of triple bonds or generation of carbocationic species from 
alkynes and nitriles can occur inducing different cyclization reactions. 
According to the ring closures of alkene derivatives, in 2013, Gaunt and co-
workers reported the copper-catalyzed endo-selective oxyarylation and oxyvinylation of 
allylic amide substrates120 (140) using diaryliodonium triflates (46) and CuTC (TC = 
thiophene-2-carboxylate) catalyst in dioxane solvent. The applicability of the developed 
transformation was demonstrated on numerous examples. A wide range of endo-oxazine 
products (141) were synthesized in up to 97% yield (Scheme 32a). The method was 
further developed and recently the catalytic both enantioselective and regiodivergent 
arylation of allylic amides was reported.121 The arylation can be controlled by the 
electronic nature of the diaryliodonium salt enabling the preparation of nonracemic 
diaryloxazines or β,β-diaryl enamides. In 2013, two very similar approaches were 
published by Zhao122 and Li123 for the preparation of oxindoles (143) from acrylamides 
(142). The first transformation utilizes CuCl catalyst in combination with di-tert-
butylpyridine (dtbpy) base in DCM at 60 °C, while in the second one inorganic NaHCO3 
base was employed with the same copper source in DCE solvent at 80 °C (Scheme 32b). 
The products were obtained in moderate to good yields (42-86% and 42-93% yields, 
respectively). 
 
Scheme 32. Copper-catalyzed arylation of different amides with diaryliodonium triflates 
Besides the alkynes, electron-rich alkynes were also suitable substrates for copper-
catalyzed ring closures with diaryliodonium salts. In 2013, Gaunt et al. described the 
copper-catalyzed carboarylation of alkynes124 (144) with diaryliodonium triflates (46) in 
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the presence of copper chloride catalyst and dtbpy base. The reactions were conducted in 
DCE at 50 °C and the desired tetrasubstituted alkenes (145) were isolated in up to 97% 
yield (Scheme 33a). 
 
Scheme 33. Gaunt’s copper-catalyzed arylation-cyclization reactions of functionalized alkenes and 
alkynes 
One year later the developed methodology was extended to the synthesis of 
different carbocycles such as tetraline (148) and cyclopentene (149) derivatives.125 
Instead of CuCl CuTC was utilized as a copper source in DCE solvent (Scheme 33b). 
The corresponding cyclic products were obtained in moderate to good yields. Both 
reactions are supposed to undergo via the formation of arylcopper(III) species. A very 
similar arylcarbocyclization approach was published simultaneously by Chen et al. from 
alkyl alkynes for the construction of carbocycles and spirocycles.126 Diaryliodonium 
hexafluorophosphates were utilized in the reaction as coupéing partners along with 
copper triflate catalyst in dichloroethane solvent. Moderate to good yields were achieved.  
Copper-catalyzed transformations by the functionalization of electron rich 
substrates such as alkynes employing diaryliodonium salts were developed in our research 
group, too. In 2015, using this cyclization strategy the preparation of new oxazoline127 
derivatives (151) from propargyl amides (150) and arylmesitylidonium triflates (46) was 
achieved in our laboratory. Copper chloride was employed as copper source in ethyl 
acetate solvent at 50 °C. The products were obtained in 35-85% yields (Scheme 34a). 
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According to the mechanism, the reaction is presumed to involve a 5-endo-dig cyclization 
step via the formation of arylcopper(III) intermediate (115). 
 
Scheme 34. Copper-catalyzed ring closures of electron rich alkynes with diaryliodonium salts 
Recently, a very similar approach was realized and published by Chen and co-
workers by the intramolecular aryl etherification of alkoxy-alkynes128 (152) via C-O bond 
cleavage in the presence of diaryliodonium hexafluorophosphates. Copper triflate was 
used as a copper source in dichloroethane solvent at 60 °C, while the oxo-heterocyclic 
products (153) were prepared in moderate to good yields (Scheme 34b). According to the 
high reactivity of alkyne substrates observed in these kinds of arylation-ring closures, in 
2013, a novel copper-catalyzed oxidative cyclization reaction was achieved in our 
laboratory for the synthesis of benzoxazine129 derivatives (155) from 2-ethynylanilides 
(154). Similarly to the publication just presented this reaction also applies copper triflate 
in DCE. The desired products were isolated in 35-88% yields (Scheme 34c). The 
mechanism of the transformation is proposed to involve a 6-exo-dig cyclization step. 
In the last few years, some examples were also reported demonstrating the 
applicability of electron rich nitriles in copper-catalyzed oxidative arylation-cyclization 
reactions with diaryliodonium salts. For example, the copper triflate-mediated synthesis 
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of phenanthridine130 derivatives (157) via cascade annulation of diaryliodonium salts (46) 
and nitriles (156) was recently realized by Li et al. The reactions were performed in DCE 
at high temperature (150°C) and numerous products were prepared in 30-80% yields 
(Scheme 35a). According to the plausible mechanism of the transformation, the reaction 
is supposed to undergo via the formation of a highly active copper(III)-aryl intermediate 
(115), the same species which was assumed to generate when alkynes were employed as 
substrates in the copper-catalyzed arylation-ring closing reactions. Another approach for 
the construction of quinazolinimine131 and acridine scaffolds (158 and 159) from diverse 
tandem cyclization reactions of ortho-cyanoanilines (158) and diaryliodonium salts (46) 
in the presence of copper triflate catalyst was reported by Chen and co-workers in 2014. 
The developed methodology provided the products in good to high yields (Scheme 35b). 
The formation of products 159 and 160 could be influenced by the amount of the 
iodonium salt. If 0.5 equivalent of diaryliodonium salt was added to the ortho-
cyanoanilide, quinazolinimine (159) was formed during the reaction. In contrast, the 
employment of 2.0 equivalent of diaryliodonium salt afforded acridines (160). 
 
Scheme 35. Copper-catalyzed ring closures of electron rich nitriles with diaryliodonium salts 
The publications presented above demonstrate the applicability of alkynes and 
nitriles in arylation-cyclization reactions induced by copper catalysts. However, the 
activation of a nitrile group in the presence of a carbon–carbon triple bond with copper 
catalyst and iodonium salt is also possible, as described by Chen et al. The employment 
of alkynes and nitriles altogether in oxidative arylation-cyclization reactions enables the 
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construction of various heterocyclic compounds. Utilizing this strategy, the synthesis of 
diverse heterocyclic skeletons such as quinolines132, quinazolines,133 dihydro-
cyclopentaquinolines and tetrahydroacridines134 were accomplished by Chen and co-
workers in the last few years. In these reactions, copper triflate was utilized as a copper 
source in dichloroethane solvent with diaryliodonium hexafluorophosphates (46) and 
triflates. The synthesis of quinoline derivatives (162) was presented on numerous 
examples (34 products were prepared) and moderate to high yields were achieved 
(Scheme 36). The possible mechanism of these transformations was presumed to involve 
the formation of arylcopper(III) intermediate (115). 
Scheme 36. Copper-catalyzed arylation-cyclization reaction for the synthesis of quinolines 
These methods were further developed and were found that instead of nitriles134 
azydes can also be employed for the synthesis of polycyclic quinolines. Therefore, in 
2014 Chen realized the tandem annulation of ω-azido-1-alkynes (164) with 
diaryliodonium salts (46) for the preparation of polycyclic quinolines.135 The reaction 
utilizes copper(I) catalyst (CuI or Cu2O) in DCE solvent at 60 °C. A wide range of 
products were synthesized and the desired polycyclic quinolines (165) 
(dihydrocyclopenta- and heptaquinolines, tetrahydroacridines) were obtained in moderate 
to high yields (Scheme 37). 
Scheme 37. Chen’s syntheses of polycyclic quinolines from cyano-alkynes and azido-alkynes 
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3. Objectives 
The goal of the presented PhD research is to develop novel copper-catalyzed 
transformations for the construction of condensed heterocyclic skeletons via arylation-
ring closure procedures with the employment of diaryliodonium salts. 
From electron rich substrates such as nitriles, in the presence of diaryliodonium 
salts and copper catalysts the formation of a highly active arylcopper(III) species can 
occur, described previously in the literature. This aromatic equivalent species is supposed 
to interact with the nitrile moiety affording an N-arylnitrilium intermediate, which enables 
the construction of diverse heterocylic compounds both in an intramolecular and in an 
intermolecular manner (Scheme 38). 
 
Scheme 38. Synthesis of heterocycles from nitriles and diaryliodonium salts via intramolecular and 
intermolecular cyclizations 
Our aim is to realize the construction of novel heterocyclic skeletons from 
diversely functionalized nitriles and diaryliodonium salts via intramolecular and 
intermolecular cyclizations. The outcome of the ring closures is investigated in the case 
of nitriles equipped with different nucleophilic functional groups and in the presence of 
nucleophilic reagents (amides, amines, acetylenes or heterocycles). The structure of the 
synthesized products is purposed to prove by NMR and by SXRD methods. 
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4. Results and discussion 
In the following sections, we aim to summarize our results achieved in copper-
catalyzed functionalizations (especially cyclizations) of aromatic and heteroaromatic 
substrates with the employment of diaryliodonium salts. We successfully developed two 
copper-catalyzed oxidative arylation-ring closure strategies for the construction of 
iminobenzoxazine (Chapter 4.2) and chromenoquinoline (Section 4.3.2) frames utilizing 
arylmesityliodonium triflates (Chapter 4.1). Moreover, the geometry of the 
chromenoquinoline skeleton was established by single crystal X-ray diffraction, which 
initiated a collaboration providing further results in crystallographic researches (Section 
4.4). 
4. 1. Synthesis of diaryliodonium salts 
As described in Chapter 2.5.2, several approaches were published for the 
preparation of diaryliodonium salts. Out of these synthetic strategies, in our researches 
the modified129 one-pot method of Olofsson67 was utilized for the synthesis of 
arylmesityliodonium triflates. Thus, the appropriate aryl iodides (57) were reacted with 
mesitylene (166) in the presence of m-chloroperbenzoic acid (mCPBA) oxidant in 
dichloromethane solvent. Then trifluoromethanesulfonic acid (triflic acid) was added to 
the reaction mixture to ensure the anion exchange and providing the desired 
arylmesityliodonium triflates (46a-46n) in 34-95% yields (Scheme 39). 14 examples 
were prepared with different electronical properties on the aromatic ring. Out of these 
reagents, some were prepared previously in our research group129 and these salts were 
used in the ring closure reactions discussed in the following chapters (marked with 
asterisk), others were prepared during the work according to this doctoral thesis. 
Diaryliodonium triflates bearing both electron-donating and electron-withdrawing 
substituents in ortho, meta and para positions were synthesized to investigate the study 
of their influence on the ring closure reactions. 
The first representative compound was the phenymesityliodonium derivative 
(46a), which was isolated in 90% yield. With the application of the synthetic procedure, 
further arylmesityliodonium triflates bearing electron-donating methyl group in the ortho, 
meta and para positions (46b, 46c and 46d) were prepared in 93%, 73% and 95%, 
respectively. Diaryliodonium salts containing halogens (Cl, Br, F) in the ortho, meta and 
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para positions (46e-46l) were also prepared in moderate to good yields (47-76%). 
Arylmesityliodonium salts bearing COOEt group in the ortho position (46m) could be 
isolated in only 34% yield. However, the para-ester derivative (46n) was synthesized in 
68% isolated yield. 
 
Scheme 39. Prepared diaryliodonium salts in one-pot synthesis from mesitylene and aryl iodides (* these 
iodonium salt was prepared by other member of the research group) 
The synthesized arylmesityliodonium triflates were utilized in copper-catalyzed 
oxidative cyclizations for the construction of important heterocycles such as 
iminobenzoxazines and chromenoquinolines. These results will be discussed in the 
following chapters. 
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4. 2. Synthesis of iminobenzoxazines 
4. 2. 1. Base of the developed methodology 
The utilization of electron rich alkenes, alkynes or nitriles in the presence of 
copper catalyst and diaryliodonium salts enables the construction of diverse heterocyclic 
compounds via oxidative arylation processes.120-135 Therefore, several approaches were 
achieved in the last few years for the synthesis of different heterocyclic skeletons such as 
quinolines, quinazolines or tetrahydroacridines. 
In 2013, a novel arylation-ring closure strategy was developed in our laboratory 
for the construction of benzoxazine derivatives129 (155) from ortho-ethynylanilides (154) 
and diaryliodonium triflates (46) using the concept of aromatic electrophile generation 
via the intermediacy of Cu(III) species discussed previously by Gaunt et al.107 Similarly 
to acetylene moiety, nitriles were also found to be suitable substrates for these kinds of 
transformations. Thus, we assumed that the replacement of the C≡C triple bond with a 
nitrile group in the ortho position to the amide moiety should provide iminobenzoxazines 
through a similar cyclization path (Scheme 40). 
 
Scheme 40. Arylation–ring closure strategies to benzoxazine derivatives via Ar-Cu(III)-mediated 
transformations 
For investigating our hypothesis, a test reaction was performed. N-(2-
cyanophenyl)acetamide (167a) model substrate was reacted with phenylmesityliodonium 
triflate (46a) (1.2 equiv.) in the presence of 10 mol% copper triflate in dichloroethane 
solvent at 75 °C. We found that after 16 h reaction time total consumption of the 
cyanoanilide (167a) was reached, while the formation of a new product was observed, 
based on GC-MS measurement. After isolation of the appropriate product (168aa) in 51% 
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yield its structure was identified by 1H and 13C NMR measurement to be (Z)-2-methyl-
N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (Scheme 41). 
 
Scheme 41. Formation of iminobenzoxazine product by the reaction of cyanoacetanilide and 
mesitylphenyliodonium triflate 
After these results, for the examination of the transformation comprehensive 
optimization studies had to be done. The following chapters aim to present the broad 
optimization studies, the preparation of the different cyanoanilide derivatives, then their 
application in copper-catalyzed synthesis of iminobenzoxazines with 
arylmesityliodonium triflates. 
4. 2. 2. Optimization of the reaction conditions and design of the substrate 
scope 
For the optimization of the reaction parameters, we chose N-(2-
cyanophenyl)acetamide (167a) as the substrate which was prepared from 2-
aminobenzonitrile (169) and acetic anhydride according to the modified procedure of 
Fagnou.136 As the arylating agent, phenylmesityliodonium triflate (46a) was utilized (1.2 
equiv). 
As described above, when the reaction was performed at 75 °C in 1,2-DCE, full 
conversion was reached after 16 reaction time (Table 1, Entry 1). We attempted to 
implement the oxidative coupling reaction at lower temperature, but at 60 °C only 50% 
conversion could be reached in 12 h reaction time (Entry 2). Therefore, 75 °C temperature 
was utilized in the following experiments. 
We also aimed to reduce the reaction time and we were pleased to observe that 
during the preparation of compound 168aa full conversion could be reached in 2 h in 
DCE solvent in the presence of 10 mol% Cu(OTf)2 catalyst (Entry 3). However, the 
utilization of other cyanoanilide derivatives for example benzamides in the ring closure 
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reactions required longer reaction times in order to reach total consumption of the starting 
materials. 
We also aimed to reduce the amount of copper catalyst used in the reaction, but 
we found that after 2 h only 50% or 30% conversion could be reached utilizing 5 mol% 
or 2 mol% of Cu(OTf)2. With the reduced amount of catalysts, full conversions could also 
be reached after 24 h and 6 h, respectively (Entries 4-8). 
 
Entry Catalyst Amount of 
cat. (mol%) 
Solvent Temp.  
(°C) 
Reaction 
time (h) 
Conv. 
(%) 
1 Cu(OTf)2 10 1,2-DCE 75 16 100 
2 Cu(OTf)2 10 1,2-DCE 60 12 50 
3 Cu(OTf)2 10 1,2-DCE 75 2 100 
4 Cu(OTf)2 2 1,2-DCE 75 2 30 
5 Cu(OTf)2 2 1,2-DCE 75 6 68 
6 Cu(OTf)2 2 1,2-DCE 75 24 100 
7 Cu(OTf)2 5 1,2-DCE 75 2 50 
8 Cu(OTf)2 5 1,2-DCE 75 6 100 
9 Cu(OTf)2 10 EtOAc 75 2 100 
10 Cu(OTf)2 10 DCM 75 2 100 
11 Cu(OTf)2 10 CHCl3 75 2 52 
12 Cu(OTf)2 10 CHCl3 75 6 100 
13 Cu(OTf)2 10 THF 75 2 100 
14 Cu(OTf)2 10 MeOH 75 8 56 
15 Cu(OTf)2 10 DMF 75 8 9 
16 Cu(OTf)2 10 toluene 75 8 100* 
17 CuCl 10 EtOAc 75 2 100 
18 CuBr 10 EtOAc 75 2 100 
19 CuI 10 EtOAc 75 2 35 
20 CuI 10 EtOAc 75 6 100 
21 Me(CN)4Cu(OTf) 10 EtOAc 75 2 100 
22 CuO 10 EtOAc 75 2 5 
23 CuO 10 EtOAc 75 6 18 
24 CuSO4 10 EtOAc 75 2 16 
25 CuSO4 10 EtOAc 75 6 16 
26 Cu(acac)2 10 EtOAc 75 2 16 
27 Cu(acac)2 10 EtOAc 75 6 100 
* product mixture was formed 
Table 1. Optimization studies for the ring closure of 167a 
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Examination of the effect of solvent on the reaction conversion showed that the 
reaction is slow in DMF or MeOH (9%and 56% conversions after 8 h reaction time, 
respectively) and provides a complex reaction mixture in toluene. The employment of 
CHCl3 solvent resulted full conversion in 6 h. In contrast, full conversion could be 
reached in 2 h, when the reaction was conducted in THF, DCM, EtOAc or DCE solvents 
(Entries 9-16). 
Comparison of the activity of different copper catalysts revealed that both 
copper(I) and copper (II) sources, such as CuCl, CuBr, (MeCN)4CuOTf and Cu(OTf)2 
are suitable catalysts for the transformation, whilst in the presence of CuI, CuO, CuSO4 
or Cu(acac)2 only poor conversions was reached in 2 h reaction time. However, in the 
case of CuI and Cu(acac)2 100% conversion could be observed after 8 h, while no 
particular effect of the longer reaction time was noticed on the conversion values in case 
of CuO and CuSO4 (Entries 17–27). 
According to the amount of phenylmesityliodonium triflate, there is no need for 
the addition of larger excess of the reagent than 1.2 equivalents to reach full conversion 
in the reaction after 2 h.  
With the optimal conditions in hand, we designed the scope of the developed 
methodology. The desired iminobenzoxazine skeleton can be modified in three ways. 
First of all, different aminonitriles can be prepared and used in the reactions. Moreover, 
the scope of the obtainable products can be extended with the utilization of different acyl 
chlorides or anhydrides for the synthesis of the amide compounds. Thereby, beside the 
cyanoanilide 167a other amide compounds (for example thiophene or cyclic β-
acetylaminoacrylonitrile derivatives) could be synthesized. Finally, further 
iminobenzoxazines can be obtained with the application of substituted 
arylmesityliodonium triflates in the ring closing reactions (Scheme 42). 
Scheme 42. Designed substrate scope of iminobenzoxazines 
57 
 
4. 2. 3. Synthesis of the amide substrates 
The desired N-(2-cyanophenyl)amide136,137 derivatives were prepared according 
to the modified procedure of Fagnou and Zhdankin. Aromatic and heteroaromatic 
acetamide derivatives were synthesized from 2-aminobenzonitrile and 2-
aminothiophene-3-carbonitrile in the presence of acetic anhydride or acetyl chloride and 
TEA base in DCM at rt (Scheme 43). Cyanophenyl acetamide (167a) was synthesized in 
90% yield. Substrates bearing chloro substituents (167b and 167c) were obtained in 69% 
and 73% yields after recrystallization. Heteroaromatic thiophene derivative (167d) was 
isolated in moderate yield (46%). 2-aminobenzonitrile (169) was also reacted with 
different acyl chlorides under the same reaction conditions to prepare further amide 
derivatives (167e-167n). Alkyl-substituted anilides (167e-167g) were obtained in 54%, 
63% and 55% yields, respectively. 
 
Scheme 43. Synthesis of different N-(2-cyanoaryl)amide derivatives 
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Cyclohexanecarboxamide derivative (167h) was isolated in 62% after 
recrystallization from ethanol. Furthermore, different benzamides (167i-167m) equipped 
with both electron-donating and electron-withdrawing substituents were also synthesized 
with the employed method. Moreover, cinnamamide derivative (167n) was prepared in 
50% yield after recrystallization from ethanol then from toluene. 
We also aimed to explore the applicability of non-aromatic systems in the ring 
closure reaction. Thus, we prepared non aromatic cyclic β-acetylaminoacrylonitriles 
(167o, 167p and 167q) from the appropriate β-enaminonitriles (170a-170c), which were 
synthesized from the corresponding dinitriles (171a-171c) in Ziegler-Thorpe ring closing 
reaction in the presence of potassium tert-butoxide base according to the modified 
procedure of Ma et al.138 The desired cyclic amides (167o-167q) were obtained in various 
yields (79%, 39% and 17% yields, respectively) after acylation of the corresponding 
enaminonitrile substrates with acetic anhydride in pyridine solvent at its reflux 
temperature (Scheme 44). 
 
Scheme 44. Synthesis of cyclic β-acetylaminoacrylonitriles 
4. 2. 4. Copper-catalyzed ring closure of ortho-cyanoanilides and 
arylmesityliodonium triflates 
After preparing the amide substrates and diaryliodonium salts as arylating agents 
we aimed to explore the scope and limitations of the developed methodology. 
First, we reacted N-(2-cyanophenyl)acetamide (167a) with 
phenylmesityliodonium triflate (46a) using 10 mol% of Cu(OTf)2 catalyst in DCE 75 °C. 
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In some cases, the appropriate products were isolated from EtOAc solvent too. Compound 
168aa was synthesized in 51% (53% in EtOAc) after the workup. Then, testing the 
different arylmesityliodonium salts in the ring closure, we found that in the presence of 
methyl substituent in the ortho, meta and para position of the phenyl group of the 
iodonium salt the desired products (168ab, 168ac and 168ad) could be obtained in 53%, 
62% and 56% (40% in EtOAc) yields, respectively (Scheme 45). Utilizing iodonium salts 
containing halogen atom (F, Cl or Br) ortho to the iodine, the ring closing reaction was 
retarded and the desired compounds were detected only with GC-MS (15%, 0% and 17% 
conversions, respectively). This fact can be explained by electronical and sterical 
properties. Comparing our results to similar copper-catalyzed oxidative arylation-
cyclization reactions of the literature,120-135 we can conclude, that fewer examples are 
given in which the corresponding products are synthesized with the employment of 2-
haloaryliodonium salts, mainly from sterically not hindered substrates. However, in most 
cases, similar cyclization reactions were realized in the presence of 3- or 4-
haloaryliodonium salts. According to our results, when the reaction was attempted with 
diaryliodonium salts equipped with halogens in the meta and para positions, the 
appropriate iminobenzoxazines (168af-168al) were isolated in 25% (53% in EtOAc), 
50%, 48% (38% in EtOAc) and 47% yields. The employment of arymesityliodonium salts 
bearing a COOEt group in the ortho and para positions of the aromatic ring provided the 
desired products (168am and 168an) with the similar efficiency (49% and 52% yields). 
The activity of 2-ethoxycarbonylphenyl(mesityl)iodonium triflate in the ring closing 
reaction is quite unexpective compared to the results of 2-haloaryliodonium salts. A 
probable explanation for this fact is that the carbonyl part of the COOEt group is able to 
form a six-membered stable complex coordinating to the copper, while in the presence of 
halogens the formation of this complex is not possible. However, the activity of ortho-
methyl substituted diaryliodonium salt in the cyclization reaction can be explained by the 
electron-donating ability of the methyl group, which can thereby stabilize the forming 
carbocationic species (for details of the mechanism, see Scheme 48). 
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Scheme 45. Ring closure with different arylmesityliodonium triflates 
After investigating the applicability of different arylmesityliodonium triflates, we 
studied the reactivity of different amides in the developed oxidative coupling (Scheme 
46). The reaction of alkyl substituted amides (167e, 167f and 167g) with 
phenylmesityliodonium triflate (46a) provided the desired iminobenzoxazine derivatives 
(168ea, 168fa and 168ga) in 42% (39% in EtOAc), 18% and 46% yields. In contrast, 
when cyclohexane derivative (167h) was utilized, instead of the corresponding 
iminobenzoxazine the formation of by-products was observed. In the case of aromatic 
anilide derivative (167i), the appropriate product (168ia) was obtained in 29% (39% in 
EtOAc). When the reaction was attempted with aromatic amides bearing EWG or EDG 
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groups (167j, 167k, 167l and 167m) in the para position, iminobenzoxazines (168ja-
168ma) were isolated in 33% (47% in EtOAc), 52%, 46% and 34% (52% in EtOAc) 
yields, respectively. Reaction of conjugated amide (167n) with phenylmesityliodonium 
triflate (46a) afforded the desired product (168na) in 27% (38% in EtOAc) yield. Thus, 
in the case of the chloro (168ja) and methoxy derivatives (168ma) with the ulilization of 
EtOAc solvent instead of DCE the isolated yields of the appropriate products could be 
increased in about 15%. 
 
Scheme 46. Synthesis of iminobenzoxazines from different ortho-cyanoanilides 
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In the case of 168ka, the structure was investigated and the Z conformation 
(iminophenyl moiety) was proved by Dr. Tamás Gáti (Servier Research Centre) as no 
interaction was observed between the phenyl group connected to the imino part and the 
phenyl group of the benzoxazine core (based on NOE measurements). 
Finally, the applicability of the developed ring closing reaction was demonstrated 
on amide substrates bearing chloro substituents on the anilide moiety (167b, 167c), with 
a thiophene derivative (167d) and with non-aromatic unsaturated systems (167o, 167p 
and 167q) too (Scheme 47). The presence of halogens on the aromatic ring of the anilide 
was well-tolerated both in meta and para positions, and the desired products (168ba and 
168ca) were obtained in 50% (24% in EtOAc) and 45% yields. Reacting N-(3-
cyanothiophen-2-yl)acetamide (167d) with phenylmesityliodonium triflate (46a) 
afforded the desired sulfur containing heteroaromatic system 168da in 48% (59% in 
EtOAc) yield. 
 
Scheme 47. Preparation of iminobenzoxazines from different ortho-cyanoanilides 
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Utilization of non-aromatic cyclic β-acetylaminoacrylonitriles (167o, 167p and 
167q) also provided the appropriate products. The condensed iminooxazine systems 
containing cyclopentene, cyclohexene and cycloheptene rings (168oa, 168pa and 168qa) 
were obtained in 43% (53% in EtOAc), 37% (47% in EtOAc) and 27% yields, 
respectively. Based on these results, the employment of EtOAc instead of DCE resulted 
in approximately a 10% improvement of isolated yields in the case of iminobenzoxazine 
derivatives 168da, 168oa and 168pa. 
Results of the substrate scope study showed that both DCE and EtOAc are suitable 
solvents of the transformation. Based on the literature of similar arylation reactions, 
unsymmetric diaryliodonium salts are often reported to be less reactive in these kinds of 
transformations compared to the symmetric salts. Therefore, in two cases, we repeated 
the ring closures with the employment of symmetric diaryliodonium salts in order to 
improve the yields. When bis(para-chlorophenyl)iodonium triflate was utilized instead 
of phenymesityliodonium triflate (46a) in EtOAc solvent, the appropriate product (168af) 
was obtained with similar efficiency (47% vs. 53%). As another example, when the ring 
closing reaction was performed with symmetrical diphenyliodonium triflate instead of 
phenylmesityliodonium triflate (46a) 168aa was obtained in 43% yield. Hence, the 
utilization of symmetric iodonium salts did not provided better isolated yields. Based on 
TLC analysis of the reaction mixture we suppose that the desired products are sensitive 
and are able to decompose during the work-up procedure. In accordance with our 
assumption, GC-MS analysis of the reaction mixture revealed fewer side products. The 
only identified side product was 2-methyl-4H-benzo[d][1,3]oxazin-4-one, which could 
be formed via hydrolytic cleavage of the imine. 
Beside the synthetic studies and applications, we also proposed a possible 
mechanism (Scheme 48) for the copper-catalyzed arylation-ring closure reaction, which 
is supposed to undergo via the formation of arylcopper(III) intermediate, presumed 
similarly in these kinds of transformations. According to similar copper-catalyzed 
cyclizations of the literature,132-134 we assume, that the reaction starts with the formation 
of the Cu(I) species from Cu(OTf)2 by reduction
107 or disproportion139, discussed in 
previous reports. However, both Cu(I) and Cu(II) sources were able to initiate the 
oxidative coupling providing the corresponding iminobenzoxazine products. Thus, the 
presence of Cu(I) catalyst or in situ generated Cu(I) catalyst from the appropriate Cu(II) 
source is needed to the transformation. According to the following step, diaryliodonium 
salt (46) can oxidize the resulted Cu(I) species generating the Ar-Cu(III) intermediate 
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(115) and mesityliodide eliminated in the reaction. We suppose that the highly 
electrophilic Cu(III) species - which can be interpreted as an aryl cation equivalent - 
interacts with the nitrile function of compound 167 resulting the formation of a cationic 
species (169) and Cu(I). The formed N-arylnitrilium intermediate 169 readily undergoes 
cyclization with the participation of the amide group via nucleophilic attack of the 
carbonyl oxygen providing the iminobenzoxazine product (168). 
 
Scheme 48. Proposed mechanism of the developed arylation-ring closure 
4. 3. Activation of nitrile and acetylene moiety – route to condensed 
quinoline derivatives 
The previous section involves the synthesis of iminobenzoxazines via nitrile 
activation with the utilization of arylmesityliodonium triflates and copper catalysts. In the 
following chapters we discuss the results achieved by the activation of nitrile moiety in 
the presence of acetylene function. 
4. 3. 1. Synthesis of indeno[2,1-b]quinoline derivative 
As reported previously, Chen et al. developed the synthesis of different 
heterocyclic compounds such as quinoline derivatives with the employment of 
diaryliodonium salts in the presence of alkynes and acetylenes (see Scheme 37).132 
On the basis of these transformations, we aimed to develop novel ring closure 
reactions for the construction of condensed heterocyclic systems from substrates which 
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contain those functional groups together. To realize this approach, we designed a 
bifunctional substrate (171) containing both nitrile and acetylene moiety, which enables 
the activation of nitrile functional group in the presence of C≡C triple bond via copper-
catalyzed oxidative arylation-cyclization path with diaryliodonium salts affording the 
indenoquinoline frame (Figure 5). The desired condensed heterocyclic compound (172) 
can be synthesized starting from 2-(2-iodophenyl)acetonitrile (170) which can be 
transformed to the bifunctional substrate (171) via Sonogashira coupling reaction. We 
supposed that in the presence of copper catalysts and diaryliodonium salts a ring closure 
occurred, providing indenoquinoline derivative (172). 
 
Figure 5. Retrosynthetic path to the designed indenoquinoline derivative 
For testing our hypothesis, first we prepared the required alkynyl substrate (171) 
for the study. To achieve this 2-(2-iodophenyl)acetonitrile (170) was reacted with 
phenylacetylene in diisopropylamine (DIPA) solvent in the presence of catalytic amount 
of copper iodide and PdCl2(PPh3)2 palladium catalysts according to the modified 
procedure of Kotschy.140 The appropriate product (171) was isolated in quantitative yield 
(Scheme 49). Next, bifunctional substrate 171 was reacted with phenylmesityiodonium 
triflate (46a). Copper triflate was used as a copper source and the reaction was conducted 
in dichloroethane at 75 °C (the employed reaction condition was based on results 
achieved according to iminobenzoxazines). Based on GC-MS measurements, we found 
that the reaction mixture is supposed to contain the assumed indeno[2,1-b]quinoline. 
After isolation of the product 172 in 38% yield, its structure was proved by 1H and 13C 
NMR measurements. According to our plausible mechanism, we suppose that in the first 
step, the phenyl group of the iodonium salt interacts with the nitrile group providing a 
carbocationic species (173), which can easily form intermediate 174 by a cyclization step. 
The formation of the desired indeno[2,1-b]quinoline product (172) is presumed to occur 
via an electrophilic aromatic substitution (SEAr) type intramolecular cyclization. 
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Scheme 49. Synthesis of indeno[2,1-b]quinoline derivative via copper catalyzed arylation-ring closure 
reaction 
At the same time, simultaneously with our researches, Chen et al. reported the 
construction of the same skeleton in 83% isolated yield, and demonstrated the 
applicability of this synthetic strategy for the construction of the desired heterocyclic 
frame.134 Followed by the publication of Chen, we designed another bifunctional 
substrate to develop novel ring closure reactions for the construction of further condensed 
heterocyclic molecules. 
4. 3. 2. Synthesis of chromenoquinoline derivatives 
Similar to bifunctional substrate 171, we designed two further molecules (177a, 
181) containing both nitrile and acetylene functional groups. In the presence of copper 
catalysts and diaryliodonium salts these substrates are supposed to be able to afford 
chromeno[4,3-b]- and chromeno[3,4-b]quinoline derivatives via copper-catalyzed 
oxidative arylation-cyclization path. The desired chromenoquinoline frames (178aa and 
182) can be synthesized starting from 2-hydroxybenzonitrile (175a) and 2-iodophenol 
(178) by O-alkylation followed by a Sonogashira coupling then a diaryliodonium salt-
mediated copper-catalyzed ring closure reaction (Figure 6). 
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Figure 6. Retrosynthetic path to the designed chromenoquinoline derivatives 
To realize this approach and test the applicability of our hypothesis, we 
synthesized the bifunctional substrates 177a and 181. Substrate 177a was prepared in the 
reaction of 2-hydroxybenzonitrile (175a) and propargyl bromide in the presence of 
potassium carbonate base in dimethylformamide solvent at 50 °C. The O-alkylated 
product (176a) was isolated in 90% yield (Scheme 50). In the following step, a 
Sonogashira coupling was performed on the propargylic moiety with iodobenzene under 
the typical PdCl2(PPh3)2-CuI Sonogashira reaction conditions. The appropriate coupling 
product (177a) was obtained in 68% yield after the workup. Next, bifunctional substrate 
177a was reacted with phenylmesityiodonium triflate (46a) in the presence of copper 
triflate catalyst in dichloroethane at 75 °C (according to previous test reaction conditions). 
Based on GC-MS measurements, we found that the reaction mixture is likely contains the 
assumed chromeno[4,3-b]quinoline. After isolation of the product 178aa in 33% yield, 
its structure was proved by 1H and 13C NMR measurements. According to our plausible 
mechanism discussed later in details, we suppose that in the first step, the phenyl group 
of the iodonium salt forms a highly electrophilic Ar-Cu(III) species which interacts with 
the nitrile moiety generating a carbocationic intermediate (183), which can induce two 
consecutive cyclizations affording the appropriate product (178aa). 
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Scheme 50. Synthesis of chromeno[4,3-b]quinoline via copper catalyzed arylation-ring closure reaction 
The other target molecule, quinoline (182) was also prepared according to the 
retrosynthetic path presented above. 2-iodophenol (179) was transformed to compound 
180 in high yield by O-alkylation in the presence of 2-bromoacetonitrile (introduction of 
the nitrile moiety), then Sonogashira coupling was performed employing phenylacetylene 
(Scheme 51). The appropriate bifunctional substrate (181) was isolated in 87% yield. 
Next, the prepared substrate 181 was reacted with phenylmesityliodonium salt (46a) 
under the catalytic conditions applied previously. Although, the desired chromeno[3,4-
b]quinoline product (182) was isolated from the reaction mixture, it was obtained only in 
15% yield. We assume that the formation of the appropriate product undergoes via the 
generation of two carbocationic intermediates (185 and 186). 
Whereas during the preparation of chromenoquinoline derivatives better isolated 
yield was achieved in the case of chromeno[4,3-b]quinoline derivative (178aa), our 
following researches focused on the synthesis of the corresponding compound. After 
broad optimization studies and the preparation of the appropriate starting materials, we 
studied the applicability of the developed cyclization for the construction of several 
chromeno[4,3-b]quinoline representatives. 
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Scheme 51. Synthesis of chromeno[3,4-b]quinoline via copper catalyzed arylation-ring closure reaction 
4. 3. 3. Optimization studies and design of the substrate scope 
For the optimization of the reaction parameters we chose 2-(prop-2-yn-1-
yloxy)benzonitrile (177a) as the substrate and phenylmesityliodonium triflate (46a) as 
the arylating agent. 
As described above, when the reaction was performed at 75 °C in 1,2-DCE, full 
conversion was reached after 16 hours reaction time (Table 2, entry 1). We repeated the 
reaction in EtOAc and we were pleased to observe total consumption of 177a within 1 h, 
while instead of Cu(OTf)2 CuCl was utilized (entry 2). We attempted to implement the 
oxidative coupling reaction at lower temperature, but at 50 °C and 60 °C only 8% and 
10% conversions could be reached in EtOAc after 1 h (entries 3-4). Therefore, 75 °C 
temperature and EtOAc solvent was utilized in the following experiments. 
Examining the effect of the solvent on the conversion revealed that the reaction is 
slow in DMF, Et2O, DCM, THF, PhMe, DCE (5%, 5%, 19%, 29%, 35%, 41% 
conversions after 1 h, respectively) and no reaction occurs in MeOH (entries 5-11). 
However, in case of PhMe and DCE full conversion could be reached after 3 h, while 
after the same reaction time the other solvents (MeOH, DMF, Et2O, DCM, THF) provided 
0%, 5%, 20%, 89%, 39% conversions, respectively (entries 12-18). 
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Entry Catalyst Amount of 
cat. (mol%) 
Solvent Temp. 
(°C) 
Reaction 
time (h) 
Conv. 
(%) 
1 Cu(OTf)2 10 1,2-DCE 75 16 100 
2 CuCl 10 EtOAc 75 1 100 
3 CuCl 10 EtOAc 50 1 8 
4 CuCl 10 EtOAc 60 1 10 
5 CuCl 10 MeOH 75 1 0 
6 CuCl 10 DMF 75 1 5 
7 CuCl 10 Et2O 75 1 5 
8 CuCl 10 DCM 75 1 19 
9 CuCl 10 THF 75 1 29 
10 CuCl 10 PhMe 75 1 35 
11 CuCl 10 1,2-DCE 75 1 41 
12 CuCl 10 MeOH 75 3 0 
13 CuCl 10 DMF 75 3 5 
14 CuCl 10 Et2O 75 3 20 
15 CuCl 10 DCM 75 3 89 
16 CuCl 10 THF 75 3 39 
17 CuCl 10 PhMe 75 3 100 
18 CuCl 10 1,2-DCE 75 3 100 
19 CuBr 10 EtOAc 75 1 100 
20 CuI 10 EtOAc 75 1 0 
21 CuO 10 EtOAc 75 1 0 
22 Cu(OTf)2 10 EtOAc 75 1 3 
23 CuSO4 10 EtOAc 75 1 10 
24 Cu(acac)2 10 EtOAc 75 1 12 
25 Me(CN)4Cu(OTf) 10 EtOAc 75 1 40 
26 - 10 EtOAc 75 1 0 
27 Cu(OTf)2 10 EtOAc 75 3 100 
28 Cu(acac)2 10 EtOAc 75 3 100 
29 Me(CN)4Cu(OTf) 10 EtOAc 75 3 100 
30 CuI 10 EtOAc 75 3 18 
31 CuI 10 EtOAc 75 18 100 
32 CuCl 5 EtOAc 75 1 34 
33 CuCl 2.5 EtOAc 75 1 18 
34 CuCl 5 EtOAc 75 3 100 
35 CuCl 2.5 EtOAc 75 3 100 
Table 2. Optimization studies for the ring closure of 177a 
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Comparing the activity of different copper sources in the ring closing reaction 
revealed that both CuCl and CuBr are suitable catalysts for the transformation (entries 2, 
19) as total consumtption of 177a could be achieved within 1 h reaction time. Utilization 
of CuI or CuO showed that no reaction occurs in 1 h (entries 20-21), while the reaction 
was slow when Cu(OTf)2, CuSO4, Cu(acac)2, or (MeCN)4Cu(OTf) were utilized as a 
copper source (entries 22-25). However, in the case of Cu(acac)2 or (MeCN)4Cu(OTf) 
full conversion could be observed after 3 h, while 14% conversion was reached when CuI 
was employed as a catalyst. Otherwise, the utilization of CuI catalyst gave full conversion 
after 18 h (entries 27-31). We also performed the reaction without copper source and we 
found that no reaction was observed in the absence of catalyst (entry 26). 
We also aimed to reduce the amount of copper catalyst used in the reaction, but 
we got only 34% or 18% conversion after 1 h in the presence of 5 mol% or 2.5 mol% of 
CuCl (entries 32-33). Otherwise, 3 h reaction time in both cases afforded the complete 
consumption of compound 177a (entries 34-35). Nevertheless, we utilized 10 mol% of 
CuCl to achieve the key transformation in shorter reaction times. 
According to the amount of phenylmesityliodonium triflate, based on the applied 
quantity used in the synthesis of iminobenzoxazines, we utilized 1.2 equivalents of 
iodonium salt. 
With the optimal conditions in hand, we aimed to extend the developed 
methodology for the construction of diverse chromenoquinoline derivatives. To realize 
this approach, the synthesis of various O-propargylic ortho-cyanophenol derivatives was 
necessary. Beside the 2-arylpropynyloxybenzonitrile (177a) other bifunctional substrates 
can be prepared utilizing different cyanophenols in the propargylation step. Moreover, 
the diversity of the substrates can be extended with the employment of different aryl 
iodides in the Sonogashira coupling of the propargylic moiety. Finally, the prepared 
internal alkynes were ready for the copper catalyzed ring closure reaction achieved in the 
presence of versatile diaryliodonium salts to access the desired chromenoquinolines 
(Scheme 52). 
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Scheme 52. Designed substrate scope of chromenoquinolines 
4. 3. 4. Synthesis of the arylpropynyloxybenzonitrile bifunctional substrates 
The synthesis of the desired arylpropynyloxybenzonitrile derivatives was 
accomplished from 2-hydroxybenzonitrile derivatives in a two-step procedure. First of 
all, 2-(prop-2-yn-1-yloxy)benzonitrile derivatives were synthesized from the appropriate 
2-hydroxybenzonitrile derivatives and propargyl bromide according to the procedure of 
Lingam.141  
The propargylation of 2-hydroxybenzonitrile (175a) afforded the appropriate 
product (176a) in high yield (Scheme 53). Furthermore, 2-(prop-2-yn-1-
yloxy)benzonitrile derivatives bearing chloro and bromo substituents (176b and 176c) on 
the nitrile moiety were also prepared from the appropriate cyanophenoles (175b and 
175c) in 78% and 95% yields. 
 
Scheme 53. Propargylation of hydroxybenzonitrile derivatives 
In the next step, the propargylated compounds were reacted with aryl iodides (57) 
in the presence of copper and palladium catalyst via Sonogashira coupling. Aromatic and 
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heteroaromatic substrates such as thiophene, pyridine and quinoline derivative (177a-
177d) were obtained in 68%, 94%, 70% and 72% yields, respectively (Scheme 54). 
Arylpropynyloxybenzontiriles equipped with electron-donating groups such as methyl 
(177e) or methoxy (177f) group were isolated in 44% and 60%. Compound 177e was 
prepared in a one-pot synthesis from 2-hydroxybenzonitrile (175a). The propargylated 
compound (176a) was not isolated from the mixture, but palladium and copper catalysts, 
DIPA base and 4-iodotoluene were added to the reaction mixture when the propargylation 
reaction completed. After the Sonogashira reaction 177e was isolated in 44% yield (for 
two steps). Bifunctional substrates bearing chloro, bromo, fluoro and iodo substituents 
(177g-177l) in the ortho, meta or para position to the aryl group were also synthesized in 
good to high yields. Arylpropynyloxybenzontiriles equipped with electron-withdrawing 
groups such as nitro (177m), keto (177n), acetoxy (177o) or ester (177p) group were 
obtained in high yields (88-93%) except compound 177o, which was prepared in only 
32% yield in a one-pot procedure from 175a. Compound 177q bearing an amido group 
ortho to the aryl group was also synthesized in 60% yield. The reactivity study of this 
substrate in the key transformation was conceptually important in establishing the 
proposed mechanism of the transformation, discussed later in details. 
The Sonogashira reaction of propargylated compounds 176b and 176c with 
iodobenzene provided the appropriate products (177r, 177s and 177t) in moderate to good 
yields. Bromo-substituted arylpropynyloxy derivative 177t was prepared in a one-pot 
synthesis from compound 175a without the isolation of the corresponding propargylated 
compound. Moreover, we also synthesized a bifunctional substrate (177u) equipped with 
a phenyl group on the nitrile moiety. The preparation of this compound was accomplished 
by the Suzuki reaction of compound 177s with phenylboronic acid, resulting the 
appropriate product (177u) in 86% isolated yield. 
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Scheme 54. Synthesis of bifunctional substrates via Sonogashira coupling 
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4. 3. 5. Synthesis of chromeno[4,3-b]quinolines 
In order to explore the scope and limitations of the developed methodology, we 
reacted the prepared arylpropynyloxybenzonitrile substrates (177a-177u) with 
arymesityliodonium salts (46a-46n) under the optimized reaction conditions (10 mol% 
of CuCl in EtOAc at 75 °C). 
First, we reacted 2-((3-phenylprop-2-yn-1-yl)oxy)benzonitrile (177a) with 
phenylmesityliodonium triflate (46a) in the presence of 10 mol% CuCl catalyst and we 
were pleased to observe that 178aa was obtained in 78% yield (33% isolated yield could 
be reached before the optimization studies) (Scheme 55). When arylmesityliodonium 
triflate containing methyl group ortho to the iodine was utilized, the reaction was slower 
(5 h reaction time was needed) and the desired product (178ab) was isolated only in 32% 
yield. In contrast, when a methyl substituent was present in the meta or para positions of 
the phenyl group of the iodonium salt, the reaction was fast, and the desired 
chromenoquinolines (178ac and 178ad) were synthesized in 65% and 50% yields, 
respectively. When the aryl group of the iodonium salt was equipped with a halogen atom 
(F, Cl, or Br) ortho to the iodine, the ring closure reaction was retarded and the appropriate 
compounds were detected only with GC−MS (5−8% GC−MS conversion). The same 
deactivating effect was observed similar to the synthesis of iminobenzoxazines. When 
diaryliodonium salts containing halogens in the meta or para positions were employed in 
the copper-catalyzed cyclization, 177a was transformed to the corresponding 
chromenoquinoline derivatives (178af−178al) in 47−65% yield. Amongst the 
functionalized arylmesityliodonium salts diaryliodonium triflate bearing a para COOEt 
group worked with the best efficiency and provided the desired product (178an) in 70% 
yield. When meta substituted iodonium salts were applied in the reaction, 
chromenoquinolines 178ac, 178ah, and 178ak were obtained as 1:1 mixtures of possible 
regioisomers. This case can be explained by the last step of the transformation, in which 
- according to our plausible mechanism - an aromatic electrophilic substitution occures 
(for details of the mechanism, see Scheme 59). 
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Scheme 55. Synthesis of chromenoquinolines with different arylmesityliodonium triflates 
Next, we examined the scope of the developed transformation by studying the 
reactivity of different nitriles bearing versatile arylpropargyl function (177b-177u) in the 
ring closure reaction (Scheme 56). Two more examples (178kn and 178pn) are given 
where the cyclization is performed with 4-ethoxycarbonyl-phenylmesityliodonium 
triflate (46n).In the case of nitriles equipped with heteroaromatic ring such as thiophene, 
pyridine or quinoline ring (177b-177d) only substrate 177b afforded the appropriate 
chromenoquinoline derivative (3ba) in 48% yield, while the quinoline (177c) and 
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pyridine (177d) derivatives were not able to transform to the corresponding products (not 
shown). 
 
Scheme 56. Synthesis of chromenoquinolines with different nitriles 
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When the reaction was attempted with nitrile derivative bearing electron donating 
methyl group (177e) in the para position, the desired chromenoquinoline derivative 
(178ea) was isolated in 71%. In the case of strong electron donating methoxy group in 
the para position (177f), the appropriate product (178fa) was isolated in lower yield 
(34%). The presence of halogens (177g−177l) on the aromatic ring of the aryl iodide was 
well-tolerated in the ortho, meta, and para positions, and the corresponding products 
(178ga−178la) were obtained in 54−75% yield. In the case of nitriles bearing electron-
withdrawing groups such as nitro (177m), keto (177n) or acetoxy groups (177o) in the 
para position, substrates 177n and 177o afforded the desired chromenoquinoline 
derivatives (177na and 177oa) in 72% and 48% yields. However, the reaction of the 
substrate containing strong electron withdrawing nitro group (177m) with 
phenylmesityliodonium triflate (46a) did not result the appropriate chromenoquinoline 
derivative, by-product was formed (based on 1H NMR measurements). Nevertheless, the 
presence of an ester group on the aromatic ring of the arylpropynyloxy-benzonitrile 
derivative (177p) was well-tolerated and we could isolate the corresponding product 
(178pa) in good yield (80%). When substrate 177k and 177p were reacted with the para-
ester derivative (46n) of the iodonium salt, the ring closure reaction provided the 
appropriate products (178kn and 178pn) in 51% and 67% yields. 
Finally, the cyclization was also demonstrated on nitrile substrates bearing 
halogen (Cl, Br) and phenyl substituents (177r−177u) on the hydroxybenzonitrile moiety. 
When the aromatic ring of the nitrile contained halogens (177r, 177s, and 177t) the 
appropriate chloro (178ra) and bromo (178sa and 178ta) substituted chromenoquinolines 
were obtained in 78%, 80% and 67% yields, respectively. The presence of phenyl group 
(177u) on the nitrile was also well-tolerated and was active in the ring closure reaction 
affording the desired product (178ua) in 70% yield. 
The reactivity of the substrate containing amide group in the ortho position of the 
aromatic ring (177q) was conceptually important in establishing a plausible mechanism 
for the developed transformation comparing the reactivity of the acetylene and the nitrile 
groups toward the highly electrophilic arylcopper(III) species (Scheme 57). 
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Scheme 57. Ring closure of acetamido substrate 177q 
The ortho ethynyl anilide motif could undergo cyclization in which the amide 
moiety is involved, while alkyne functional group is activated by the diaryliodonium salt 
(Scheme 57b), affording benzoxazines (188) via intermediate 187 as we demonstrated 
earlier (synthesis of benzoxazine derivatives from 2-ethynylanilides).129 The N-
aryliminium ion formation via nitrile activation (Scheme 57a and Scheme 57c) could 
provide quinolines (178qa) or condensed benzoxazines (189). The latter could be formed 
if the generation of the arylnitrilium intermediate (183) is followed by a cyclization 
involved the amido and the alkyne functions. In contrast, if the ring closure occurs with 
the contribution of the N-aryliminium ion and the acetylene moiety, while the amido 
group is retained, quinoline derivative 178qa could be produced. The reaction of substrate 
177q with phenylmesityliodonium triflate (46a) obtained the appropriate 
chromenoquinoline product (178qa) in 46% yield. While we were not able to detect the 
formation of any other by-products (by GC-MS), we can conclude that the nitrile function 
has preferential reactivity over the alkyne moiety. The electrophilic substitution of the 
assumed vinyl cation intermediate by the aromatic ring is preferable to attack by the 
amide part. 
We also aimed to investigate the reactivity of benzonitriles equipped with 
alkylpropargyl substituent instead of arylpropargyl moiety (177a-177u). The 
corresponding ethyl-substituted compound (190) was prepared from 2-
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hydroxybenzonitrile (175a) and 1-bromopent-2-yne according to the procedure of Lu et 
al.142 Furthermore, we examined the reaction of substrate 176c with 
phenylmesityliodonium triflate (46), comparing the reactivity of terminal alkynes to 
internal acetylenes in the copper-catalyzed ring closing reaction (Scheme 58). In the case 
of compound 190 accomplishing the reaction in the presence of phenylmesityliodonium 
triflate (46) and CuCl, we were not able to detect the formation of the appropriate 
chromenoquinoline product (by GC-MS). However, the utilization of substrate 176c in 
the ring closing reaction afforded the corresponding chromenoquinoline derivative (191) 
in 28% yield. Thereby, we can conclude that terminal alkynes are also suitable substrates 
for this transformation, although, compared to most of the chromenoquinoline derivatives 
(178a-178q) lower isolated yield could be reached for compound 191 after the ring 
closing reaction. In contrast, the presence of electron donating ethyl group instead of aryl 
substituents hindered the arylation-cyclization reaction.  
 
Scheme 58. Copper-catalyzed reaction of substrates 190 and 176c with phenylmesityliodonium triflate 
Based on the results according especially to the reactivity of substrates 177q, 190 
and 176c, we also report our plausible mechanism for the transformation, which is 
presumed to begin with the formation of arylcopper(III) species (115) from copper 
catalyst and diaryliodonium salt (46a) (Scheme 59). In the following step, the formed 
copper(III) intermediate interacts with the nitrile function (177) generating a cationic 
species (183) and Cu(I). Then, the acetylene moiety can readily attack the arylnitrilium 
intermediate 183 in an intramolecular fashion, resulting the formation of intermediate 184 
containing a chromene ring with an exo vinyl cation. Finally, this intermediate (184) can 
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undergo an intramolecular cyclization via electrophilic aromatic substitution, affording 
the chromenoquinoline product (178). 
Scheme 59. Proposed mechanism of the developed arylation-ring closure 
According to the substrate scope, when strong electron-donating methoxy-
substituted chromenoquinoline derivative (178fa) was synthesized, only 34% isolated 
yield could be reached, while the reaction of the substrate containing strong electron-
withdrawing nitro group (177m) with phenylmesityliodonium triflate (46a) did not result 
the appropriate chromenoquinoline derivative. This fact is in accordance with our 
proposed mechanism. The formation of intermediate 184 from 183 via nucleophile attack 
is influenced by electronical properties of the arylpropargyl moiety and the nitrilium 
cation. The presence of electron-donating group on the arylpropargyl moiety enhances 
the nucleophilic character of the acetylene, while the occurence of electron-withdrawing 
substituents on the aromatic ring connected to the nitrilium cation is favorable, related to 
the nucleophilic attack. These two opposite facts both contribute to the cyclization, thus, 
the presence of too electron-donating or electron-withdrawing substituents retard or 
hinder the cyclization. 
Furthermore, the structure of the chromenoquinoline frame was established by 
single-crystal X-ray diffraction measurements, discussed in details in the following 
chapter. 
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4. 4. Single crystal X-ray diffraction mesurements of 
chromeno[4,3-b]quinolines 
In a collaboration with the Chemical Crystallography Research Group (Research 
Centre for Natural Sciences of the Hungarian Academy of Sciences), the conformation of 
the chromenoquinoline frame was established by single crystal X-ray diffraction in the 
case of compound 178aa. 
The chromeno (A and B) and quinolino moieties (C and D) of 178aa are nearly 
coplanar, their angle is 8.63(6)o owing to the saturated ring B, where O5 is -0.222(1) Å, 
while C6 is 0.239(2)Å out of the plane of the hetero ring (Figure 7).143 The phenyl ring 
(E) is almost perpendicular to the quinoline moiety (C and D) having the angle of 
85.13(8)o. The crystal structure (Figure 8) (triclinic crystal system, space group P-1) of 
178aa is stabilized by a weak C18-H18…O5 interaction (Figure 9, Table 3). There are 
C-H… intermolecular interactions (Figure 10) between a phenyl hydrogen and a 
chromeno moiety (C17-H17…A, 2-X,1-Y,-Z) on one side, and on the opposite side of 
the phenyl ring from a phenyl hydrogen to a quinoline moiety (C15-H15…D, 2-X,-Y,-Z) 
of another neighboring molecule. Because of the presence of the almost perpendicular 
phenyl group there are no close … contacts in the crystal lattice, the shortest distance 
between the aromatic rings is 4.2082(12)Å. For crystal data and details of the structure 
refinement, as well as the results of the structural analyses, see Table 3 and Table S5 in 
Chapter 7.14. 
The packing coefficient of 178aa is 69.0%, there is no residual solvent accessible 
void in the crystal.144 
 
Figure 7. Molecular structure with ring indications and ORTEP representation of compound 178aa at 
50% probability level of displacement ellipsoids 
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 178aa 178ea 178ka 178ha 178ja 178la 
Functional group - CH3 F Cl Br I 
 C…A distance [Å] and angles (o) of C-H…A interactions 
C14-H14…N12   3.415(2) 3.3849(18) 3.444(3)  
   163 160 163  
C15-H15…F19   3.492(2)    
   162    
C17-H17…N12      3.407(4) 
      159 
C18-H18…N12   3.451(2) 3.3439(19)   
   140 134   
C18-H18…O5 3.521(2) 3.522(2)     
 148 148     
 distances [Å] and angles (o) of C-H…Cg (π-Ring) interactions 
C9-H9… Cg(E)  3.744(2)     
  148     
C6-H6A… Cg(D)   3.7420(17)    
   156    
C6-H6B… Cg(D)    3.7004(16) 3.822(3)  
    154 149  
C10-H10… Cg(E)   3.6655(17) 3.6313(16)   
   132 137   
C15-H15… Cg(D) 3.641(3) 3.699(3)     
 146 141     
C17-H17… Cg(A) 3.706(2) 3.721(2)     
 153 143     
 distances [Å] Cg(I)…Cg(J) ring interactions 
Cg(A)…Cg(A)      3.871(2) 
Cg(C)…Cg(C)   3.8816(8) 3.8285(8) 3.8791(13) 3.7465(14) 
Cg(C)…Cg(C)   3.9661(8) 3.7551(8) 3.8423(13)  
Cg(C)…Cg(D)   3.9615(9) 3.7103(8) 3.8135(14)  
 distances [Å] and angles (o) of halogen-halogen interactions 
I19…I19      3.777 
      140.11 
Table 3. Comparison of the intermolecular interactions in the crystals  
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Figure 8. The crystal packing of 178aa viewed along the a, b and c crystallographic axes, respectively 
(hydrogen atoms are omitted for clarity) 
 
Figure 9. The weak C18-H18…O5 interaction in the crystallographic a direction in 178aa 
 
Figure 10. The weak C-H… (C15-H15…D and C17-H17…A) interactions in the crystallographic b 
direction in 178aa 
Having the results of the SXRD measurement of compound 178aa, numerous 
homologue series of derivatives were included in the structural investigation in order to 
perform and investigate the steric and electrostatic fine tuning of the system. We defined 
five series (Figure 11): EDG-EWG series (green), halogen derivatives 1 and 2 (blue and 
red), ester series (purple) and methyl sequence (orange). We aimed to compare the 
changes occurred in the conformation and the crystal structure (considering the 
intermolecular interactions) by the modification of the atoms or functional groups in the 
corresponding derivatives of homologue series. The evaluation of the methyl derivative 
(178ea) and the halogen series 1 (blue, 178ha-178la) were completed until now. 
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Figure 11. The synthesized homologous series 
In the molecular structure of the methyl derivative (178ea), similarly to 178aa, 
the chromeno (A and B) and quinolino moieties (C and D) are nearly in the same plane, 
their angle is 7.44(6)o owing to the saturated ring B, where O5 is -0.221(1)Å, while C6 is 
0.258(2)Å out of the plane of the hetero ring (Figure 12). The phenyl ring spings 
somewhat more from the perpendicular position to the quinoline group 76.19(10)o in 
178ea than in 178aa. 
 
Figure 12. Molecular structure with ring indications and ORTEP representation of 178ea at 50% 
probability level of displacement ellipsoids 
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In accordance with 178aa, the crystal structure of 178ea (Figure 13) (triclinic 
crystal, space group P-1), is also stabilized by a weak C18-H18…O5 interaction (Figure 
14, Table 3). Isostructurally, there are C-H… intermolecular interactions in 178ea 
between a phenyl hydrogen and a chromeno moiety (C17-H17…A) on one side, and on 
the opposite side of the phenyl ring from a phenyl hydrogen to a quinoline moiety (C15-
H15…D) of another neighboring molecule. Because of the presence of the close to 
perpendicular phenyl group there are no close … contacts in the crystal lattice, the 
shortest distance between the aromatic rings is 4.0954(12)Å in case of rings A and C. 
 
Figure 13. The crystal packing of 178ea viewed from the a, b and c crystallographic axes 
 
    a      b 
 
c 
Figure 14. Week C18-H18…O5 interactions (a left), the weak C-H… (C15-H15…D and C17-H17…A 
and C9-H9…E) interactions (b right and c) in 178ea crystals 
The molecular structure of the fluoro derivative (178ka) from the halogen series 
1 showed that the chromeno (A and B) and quinolino moieties (C and D) are slightly 
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bended, their angle is 15.86(5)o owing to the saturated ring B, where O5 is -0.209(1) Å, 
while C6 is 0.272(2)Å out of the plane of the hetero ring (Figure 15). The phenyl ring 
turns with an angle of 64.12(6)o to the quinoline group. 
 
Figure 15. Molecular structure with ring indications and ORTEP representation of 178ka at 50% 
probability level of displacement ellipsoids 
The crystal structure of 178ka (the only monoclynic crystal in the series, space 
group P21/c) (Figure 16), is stabilized by weak C14-H14…N12 and C18-H18…N12 
interactions and a halogen-hydrogen interaction between C15-H15…F19 (Figure 17, 
Table 3). A dimer is formed around an inversion centre by weak C-H… intermolecular 
interaction via C6-H6A…D at both sides. Another C-H…interaction, C10-H10…E, 
forms a chain of the dimers in the crystallographic a dimension. The C-C and C-D rings 
of the nerby quinolino moieties get close to form week … interactions (< 4.0 Å). 
 
Figure 16. The crystal packing of 178ka viewed from the a, b and c crystallographic axes 
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Figure 17. Week intermolecular interactions in 178ka crystals including C-H…N and C-H…F 
interactions (left). The weak C-H… (C6-H6A…D and C10-H10…E) interactions in the crystallographic 
ab plane in 178ka (right) 
Investigation of the molecular structure of chloro derivative (178ha) showed that 
the chromeno (A and B) and quinolino moieties (C and D) are slightly bended, their angle 
is 14.15(4)o owing to the saturated ring B, where O5 is -0.235(1) Å, while C6 is 0.272(1)Å 
out of the plane of the hetero ring (Figure 18). The phenyl ring turns with an angle of 
59.85(6)o to the quinoline group. 
 
Figure 18. Molecular structure with ring indications and ORTEP representation of 178ha at 50% 
probability level of displacement ellipsoids 
The crystal structure of 178ha (triclinic crystal system, space group P-1) (Figure 
19) is stabilized by weak C14-H14…N12 and C18-H18…N12 interactions (Figure 20, 
Table 3) like in 178ka. A C-H… intermolecular interaction between two molecules via 
C6-H6A…D, vica versa, originates a dimer and another C-H… by C10-H10…E expand 
the connection in the crystallographic dimension a. The C-C and C-D rings of the nerby 
quinolino moieties get close to form week … interactions (< 4.0 Å). 
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Figure 19. The crystal packing of 178ha viewed from the a, b and c crystallographic axes 
 
Figure 20. Week intermolecular interactions in 178ha crystals including C-H…N in the crystallographic 
a axis and C-H… (C6-H6B…D and C10-H10…E) interactions in the crystallographic b axis 
Examining the molecular structure of the bromo derivative (178ja), we found that 
the chromeno (A and B) and quinolino moieties (C and D) are slightly bended, their angle 
is 14.01(8)o owing to the saturated ring B, where O5 is -0.226(2)Å, while C6 is 0.259(3)Å 
out of the plane of the hetero ring (Figure 21). The phenyl ring turns with an angle of 
62.72(12)o to the quinoline group. 
 
Figure 21. Molecular structure with ring indications and ORTEP representation of 178ja at 50% 
probability level of displacement ellipsoids 
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The crystal structure of 178ja (triclinic crystal system, space group P-1) (Figure 22) is 
stabilized by weak C14-H14…N12 and C18-H18…N12 interactions (Figure 23, Table 
3) like in 178ka. A dimer is formed around an inversion centre by weak C-H… 
intermolecular interaction via C6-H6A…D at both sides. Another C-H…interaction, 
C10-H10…E, forms a chain of the dimers in the crystallographic a dimension. The C-C 
and C-D rings of the nerby quinolino moieties get close to form week … interactions 
(< 4.0 Å). 
 
Figure 22. The crystal packing of 178ja viewed from the a, b and c crystallographic axes 
 
Figure 23. Week intermolecular interactions in 178ja crystals including C-H…N in the crystallographic 
a axis and C-H… (C6-H6B…D) interactions in the crystallographic b axis 
Molecular structure of the iodo derivative (178la) was examined and was 
determined that the chromeno (A and B) and quinolino moieties (C and D) are slightly 
bended, their angle is 17.18(9)o owing to the saturated ring B, where O5 is -0.245(3)Å, 
while C6 is 0.266(4)Å out of the plane of the hetero ring (Figure 24). The phenyl ring 
turns with an angle of 63.34(12)o to the quinoline group. 
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Figure 24. Molecular structure with ring indications and ORTEP representation of 178la at 50% 
probability level of displacement ellipsoids 
Owing to the iodo substituent the crystal structure of 178la differs the most from 
the F, Cl and Br derivatives. The crystal structure of 178la (triclinic crystal system 
remains, space group P-1) (Figure 25) is stabilized by weak C17-H17…N12 interactions 
(Figure 26, Table 3). C-H… intermolecular interaction could not be detected. The 
shortest distance between nerby quinolino moieties allow a week … interactions (< 4.0 
Å) between the C-C and A-A rings. Halogen-halogen interaction between I19…I19 could 
be found. 
 
Figure 25. The crystal packing of 178la viewed from the a, b and c crystallographic axes 
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Figure 26. Week intermolecular interactions in 178la crystals 
Conformational comparison of the corresponding molecules showed strong 
similarities for 178aa and its methyl derivative (178ea). In both cases the chromeno (AB) 
and quinolino (CD) moieties are not far to be in the same plane, the angle between the 
AB and CD rings are 8.63(6)o and 7.44(6)o, respectively (Figure 27 and Table 4). 
 
Figure 27. Conformational comparison between 178aa (coloured by element), 178ea (white), 178ka 
(yellow), 178ha (green), 178ja (orange) and 178la (purple) structures 
 
 178aa 178ea 178ka 178ha 178ja 178la 
 - Me F Cl Br I 
AB – CD 8.63(6) 7.44(6) 15.86(5) 14.15(4) 14.01(8) 17.18(9) 
C – E +85.13(8) +76.19(10) -63.45(7) -59.85(6) -62.72(12) -63.34(12) 
A –D 11.95(10) 8.75(10) 18.83(8) 17.24(8) 17.34(15) 21.21(16) 
A – CD 12.17(8) 10.12(9) 19.15(7) 17.32(7) 17.15(14) 20.07(13) 
Table 4. Angles between different ring planes (o) 
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In the non- and the methyl-substituted compounds (178aa and 178ea) the angle 
between the two most distant rings A-D are below 12o. The angle between the phenyl ring 
(E) and the ring C is almost perpendicular 86.88(9)o, which means that it turns 4.87 and 
13.81 degrees from the perpendicular plane. However, the halogen derivatives are much 
more bended, as far as the chromeno and quinolino moieties are concerned. Greater 
turning of the ring systems can be found for the fluoro (178ka) and iodo (178la), and less 
for the chloro (178ha) and bromo (178ja) derivatives. In all four cases the phenyl ring 
(E) turns to the opposite site in comparing with the 178aa and its methyl derivative 
(178ea), and are around 30 degrees. 
Comparing the crystal structures (Table S5) considering the intermolecular 
interactions (Table 3), we can affirm that amongst the investigated structures 
chromenoquinoline 178aa and its methyl derivative (178ea) are very similar, in both 
cases the crystal structure is stabilized by a weak C18-H18…O5 interaction. However, 
investigation of the halogen series showed that the chloro (178ha) and bromo (178ja) 
derivatives are isostructural, the main stabilizing interactions are C14-H14...N12 and 
C18-H18…N12. In the case of the fluoro derivative (178ka), beside the C-H…N 
interactions, the crystal structure is further strengthened by the C15-H15…F19 
interaction. Finally, in the case of the iodo derivative (178la), beside the C17-H17…N12 
interaction, halogen-halogen interaction between I19…I19 is also found. 
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5. Summary 
The present thesis aims to demonstrate the development of novel arylation-ring 
closure reactions based on electrophilic Ar-Cu(III) activation of triple bonds such as 
nitriles and alkynes. 
Thus, we successfully realized the copper-catalyzed synthesis of 
iminobenzoxazines (168) from ortho-cyanoanilides (167) and arylmesityliodonium 
triflates (46). Copper triflate was utilized as a catalyst and the reactions were conducted 
in DCE or EtOAc solvent at 75 °C. 25 derivatives were prepared in 18-62% yields. 
According to our plausible mechanism, the overall transformation includes a 6-exo-dig 
cyclization which is accompanied by the formation of new C−O and C−N bonds. 
 
Scheme 60. Copper-catalyzed synthesis of iminobenzoxazines and quinoline derivatives 
Furthermore, we developed synthetic routes for the construction of condensed 
quinoline frames such as indeno[2,1-b]quinolines (172) and chromenoquinolines (178, 
182) via nitrile activation in the presence of acetylene function with the employment of 
arylmesityliodonium triflates. The transformations are supposed to undergo via the 
formation of arylcopper(III) intermediate (115). The applicability of the synthetic tool to 
the access of chromeno[4,3-b]quinolines (178) was demonstrated on 28 examples. The 
reactions were performed in EtOAc at 75 °C with the employment of CuCl as a copper 
source, and the desired products were isolated in 32-80% yields. 
The structure of the chromeno[4,3-b]quinoline frame was established by single 
crystal X-ray diffraction for compound 178aa. Investigations of the methyl analogue and 
the halogen homologue substituted series revealed strong similarities in the conformation 
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of 178aa and the methyl (178ea) derivative, as well as the comparison of the crystal 
structures of the halogen derivatives proved that the chloro (178ha) and bromo (178ja) 
derivatives are isostructural. 
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6. Összefoglalás 
Doktori munkám során olyan újszerű, arilezési-gyűrűzárási reakciók kerültek 
kidolgozásra, amelyek hármas kötést tartalmazó vegyületek, pl. nitrilek és acetilének 
elektrofil Ar-Cu(III) aktiválásán alapulnak. 
Így, sikeresen valósítottuk meg iminobenzoxazinok (168) rézkatalizált szintézisét 
orto-cianoanildekből (167) és aril-mezitil-jodónium triflátokból (46). Réz-triflát 
katalizátort alkalmaztunk és a reakciókat DCE illetve EtOAc oldószerekben végeztük el 
75 °C-on. 25 származékot állítottunk elő 18-62%-os termelésekkel. Feltételezett 
mechanizmus szerint az átalakítás egy 6-exo-dig ciklizációs lépésen megy keresztül, mely 
által új C-O és C-N kötések alakulnak ki. 
 
60. ábra Iminobenzoxazinok és kinolinszármazékok rézkatalizált szintézise 
Új szintetikus utakat dolgoztunk ki kondenzált kinolin vázas vegyületek 
felépítésére, indeno[2,1-b]kinolinokat (172) és kroménokinolinokat (178, 182) állítottunk 
elő acetilén funkció jelenlétében történő nitril aktiváláson keresztül aril-mezitil-jodónium 
triflátok alkalmazásával. Feltételezéseink szerint az átalakítások aril-réz(III) 
intermedieren (115) keresztül mennek végbe. A kroméno[4,3-b]kinolinok (178) 
szintézisét 28 példán mutattuk be, a kívánt termékeket 32-80%-os termelésekkel 
izoláltuk. A reakciókat EtOAc oldószerben, 75 °C-on kiviteleztük CuCl alkalmazásával. 
A kroménokinolin váz szerkezetét a 178aa vegyületre egykristály 
röntgendiffrakciós módszerrel határoztuk meg. Ezentúl, a metil analóg és a halogénes 
homológ sor vizsgálatával megállapítottuk, hogy a 178aa vegyület és a metilszármazék 
(178ea) térszerkezete erős hasonlóságot mutat, míg a halogénszármazékok 
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kristályszerkezetét összehasonlítva azt kaptuk, hogy a klór (178ha) és a 
brómszármazékok (178ja) izostrukturálisak. 
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7. Appendix - Experimental data 
7. 1. General information 
Ring closure reaction of substrates 167a-167q and 177a-177u with the 
appropriate iodonium salt (2a-2n) were performed under argon atmosphere. All solvents 
used were distilled using standard methods. Ethyl acetate was distilled from calcium 
hydride. All other chemicals were used as received without further purification. 
All reactions were monitored by TLC using Merck DC pre coated TLC plates with 
0.25 mm Kieselgel 60 F254. Visualization was performed with a 254 nm UV lamp. 
mCPBA was dried under high vacuum at room temperature and was stored under argon. 
Unless otherwise noted, all reagents were ordered and used without further purification. 
1H-NMR and 13C-NMR spectras were recorded on a Bruker Avance-250 spectrometer 
operating at 250 MHz and 62.5 MHz using CDCl3 or DMSO-d6 as solvent. Chemical 
shifts are given in ppm relative to TMS for CDCl3, or the residual solvent peak of DMSO 
as internal standards. Coupling constants (J) are reported in Hertz (Hz). Infrared spectras 
were recorded on Bruker Alpha spectrometer on a single-reflection diamond ATR 
spectrometer as solids or thin films. In the IR spectras only the strongest/structurally most 
important peaks (n, cm-1) are listed. HRMS data for new compounds were obtained using 
a Waters Q-TOF Premier high resolution mass spectrometer. Melting points were 
recorded on Buchi 501 apparatus and are reported uncorrected. 
7. 2. Synthesis and analytical data of arylmesityliodonium triflates 
Arylmesityliodonium triflates (46a−46n) were synthesized in a one-pot procedure 
from the appropriate iodoarene (57) and mesitylene (166) according to the modified 
procedure129 of Olofsson.67  
General procedure for the one-pot synthesis of aryl-mesityliodonium triflates 
m-Chloroperbenzoic acid (65% active oxidant, 1.32 g, 5.00 mmol) and the appropriate 
iodoarene (4.50 mmol) were dissolved in dichloromethane (20 mL). Mesitylene (696 μL, 
5.00 mmol) was added, and the solution was cooled to 0 °C. Trifluoromethanesulfonic 
acid (825 mg, 486 μL, 5.50 mmol) was added dropwise in 5 min, and the resulting reaction 
mixture was allowed to warm to room temperature over 2 h. The volatile components 
were removed under reduced pressure, and the resulting material was suspended in 
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diethyl ether (40 mL). The suspension was stored at -20 °C for 2 h. The resulting crystals 
were filtered off and were washed with ether to give the appropriate arylmesityliodonium 
triflate as a solid, which was dried at 100 °C under vacuum. 
Mesityl(phenyl)iodonium Trifluoromethanesulfonate (46a) 
 
Prepared according to the general procedure from iodobenzene. The product was obtained 
as a white solid (1.91 g, 4.04 mmol, 90%). M. p. 147-148°C; 1H NMR (250 MHz, DMSO-
d6) δ 7.99 (d, 2H, J = 7.7 Hz), 7.64 (t, 1H, J = 7.3 Hz), 7.50 (t, 2H, J = 7.4 Hz), 7.22 (s, 
2H), 2.60 (s, 6H), 2.29 (s, 3H); 13C NMR (62.5 MHz, DMSO-d6) δ 143.1, 141.5, 134.5, 
131.8, 131.7, 129.7, 122.5, 114.5, 26.2, 20.5; IR νmax/cm-1 (solid): 1443, 1246, 1157, 
1025, 856, 742, 632, 572, 515, 454; HRMS m/z [M-OTf]+ Calculated for C15H16I: 
323.0291; found 323.0289. 
4-Metylphenyl(mesityl)iodonium Trifluoromethanesulfonate (46d) 
 
Prepared according to the general procedure from 4-iodotoluene. The product was 
obtained as a white solid (2.07 g, 4.26 mmol, 95%). M. p. 183-184 °C; 1H NMR (250 
MHz, DMSO-d6) δ 7.88 (d, 2H, J = 8.4 Hz), 7.30 (d, 2H, J = 8.2 Hz), 7.20 (s, 2H), 2.60 
(s, 6H), 2.32 (s, 3H), 2.28 (s, 3H); 13C NMR (62.5 MHz, DMSO-d6) δ 142.9, 142.2, 141.4, 
134.5, 132.4, 129.7, 122.7, 110.8, 26.2, 20.7, 20.4; IR νmax/cm-1 (solid): 1452, 1246, 1157, 
1024, 804, 632, 481; HRMS m/z [M-OTf]+ Calculated for C16H18I: 337.0448; found 
337.0444. 
3-Bromophenyl(mesityl)iodonium Trifluoromethanesulfonate (46h) 
 
Prepared according to the general procedure from 3-bromoiodobenzene. The product was 
obtained as an off-white solid (1.35 g, 2.45 mmol, 55%). M. p. 167-168 °C; 1H NMR 
(250 MHz, DMSO-d6) δ 8.18 (dd, 1H, J = 7.9 and 1.4 Hz), 7.95 (dd, 1H, J = 7.9 and 1.4 
Hz), 7.59 (td, 1H, J = 7.9 and 1.4 Hz), 7.47 (td, 1H, J = 7.9 and 1.4 Hz), 7.22 (s, 2H) 2.62 
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(s, 6H), 2.29 (s, 3H); 13C NMR (62.5 MHz, DMSO-d6) δ 143.2, 141.8, 139.0, 134.1, 
130.4, 130.0, 126.5, 119.4, 26.3, 20.4; IR νmax/cm-1 (solid): 1442, 1276, 1241, 1160, 1025, 
757, 631, 516; HRMS m/z [M-OTf]+ Calculated for C15H15BrI: 400.9396; found 
400.9386. 
4-Bromophenyl(mesityl)iodonium Trifluoromethanesulfonate (46i) 
 
Prepared according to the general procedure from 4-bromoiodobenzene. The product was 
obtained as a white solid (1.69 g, 3.07 mmol, 68%). M. p. 179-180 °C; 1H NMR (250 
MHz, DMSO-d6) δ 7.90 (d, 2H, J = 8.5 Hz), 7.70 (d, 2H, J = 8.5 Hz), 7.22 (s, 2H), 2.60 
(s, 6H), 2.29 (s, 3H); 13C NMR (62.5 MHz, DMSO-d6) δ 143.2, 141.5, 136.3, 134.6, 
129.8, 125.7, 122.7, 113.0, 26.2, 20.5; IR νmax/cm-1 (solid): 1473, 1245, 1232, 1024, 807, 
631, 518, 475; HRMS m/z [M-OTf]+ Calculated for C15H15BrI: 400.9396; found: 
400.9399. 
2-Fluorophenyl(mesityl)iodonium Trifluoromethanesulfonate (46j) 
 
Prepared according to the general procedure from 2-fluoroiodobenzene. The product was 
obtained as an off-white solid (1.04 g, 2.12 mmol, 47%). M. p. 161-162 °C; 1H NMR 
(250 MHz, DMSO-d6) δ 8.27 (m, 1H), 7.72 (m, 1H), 7.56 (td, 1H, J = 8.8 Hz and 1.3 Hz), 
7.35 (td, 1H, J = 7.9 Hz and 1.3 Hz), 7.20 (s, 2H), 2.62 (s, 6H), 2.27 (s, 3H); 13C NMR 
(62.5 MHz, DMSO-d6) δ 143.2, 141.5, 137.4, 135.3 (d, J = 8.3 Hz), 129.8, 127.5 (d, J = 
2.6 Hz), 122.7, 117.3, 116.9, 101.6, 101.3, 26.0, 20.4; IR νmax/cm-1 (solid): 1476, 1279, 
1236, 1161, 1027, 770, 635, 515; HRMS m/z [M-OTf]+ Calculated for C15H15FI: 
341.0197; found: 341.0194. 
3-Fluorophenyl(mesityl)iodonium Trifluoromethanesulfonate (46k) 
 
Prepared according to the general procedure from 3-fluoroiodobenzene. The product was 
obtained as an off-white solid (1.31 g, 2.67 mmol, 59%). M. p. 177-178 °C; 1H NMR 
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(250 MHz, DMSO-d6) δ 7.97 (d, J = 8.0 Hz, 1H), 7.75 (d, J = 7.5 Hz, 1H), 7.53 (t, J = 
9.6 Hz, 2H), 7.22 (s, 2H), 2.60 (s, 6H), 2.29 (s, 3H); 13C NMR (62.5 MHz, DMSO-d6) δ 
143.70, 142.05, 133.87, 133.75, 130.94, 130.90, 130.19, 123.05, 122.17, 121.77, 119.67, 
119.33, 114.16, 26.65, 20.83; IR νmax/cm-1 (solid): 2045, 1592, 1582, 1471, 1286, 1239, 
1225, 1168, 1025, 839, 735, 668; HRMS m/z [M-OTf]+ Calculated for C15H15FI: 
341.0197; found: 341.0217. 
4-Fluorophenyl(mesityl)iodonium Trifluoromethanesulfonate (46l) 
 
Prepared according to the general procedure from 4-fluoroiodobenzene. The product was 
obtained as an off-white solid (1.63 g, 3.33 mmol, 74%). M. p. 178-179 °C; 1H NMR 
(250 MHz, DMSO-d6) δ 7.37 (t, 2H, J = 8.7 Hz), 7.22 (s, 2H), 2.60 (s, 6H), 2.29 (s, 3H); 
13C NMR (62.5 MHz, DMSO-d6) δ 143.1, 141.5, 137.4, 137.2, 129.7, 119.4, 119.0, 26.2, 
20.5; IR νmax/cm-1 (solid): 1575, 1483, 1224, 1168, 1024, 849, 632, 508; HRMS m/z [M-
OTf]+ Calculated for C15H15FI: 341.0197; found: 341.0195. 
4-(Ethoxycarbonyl)phenyl(mesityl)iodonium trifluoromethanesulfonate (46n) 
 
Prepared according to the general procedure from ethyl 4-iodobenzoate with the 
exception that 3-chloroperoxybenzoic acid, mesitylene and the aryl iodide were stirred 
together at room temperature for 4 hours before the addition of the 
trifluoromethanesulfonic acid. The product was obtained as a white solid (1.159 g, 47%). 
M. p. 174-175 °C; 1H NMR (250 MHz, DMSO-d6): δ 8.09 (d, 2H, J = 8.4 Hz), 7.99 (d, 
2H, J = 8.4 Hz), 7.24 (s, 2H), 4.31 (q, 2H, J = 6.9 Hz), 2.59 (s, 2H), 2.30 (s, 1H), 1.29 (t, 
3H, J = 7.0 Hz); 13C NMR (62.5 MHz, DMSO-d6): δ 164.5, 143.4, 141.7, 134.7, 132.7, 
131.9, 129.9, 122.6, 119.3, 61.4, 26.3, 20.5, 14.0; IR νmax/cm-1 (solid): 1723, 1584, 1458, 
1395, 1272, 1238, 1161, 1103, 1025, 849, 753, 634, 516; HRMS m/z [M-OTf]+ 
Calculated for C18H20IO2: 395.0502; found: 395.0504. 
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7. 3. Optimization studies of the ring closure of compounds 167a 
and 46a: implementation of the experiments 
General procedure for the optimization reactions 
N-(2-cyanophenyl)acetamide (167a) (20.0 mg, 0.125 mmol), phenylmesityliodonium 
triflate (46a) (70.9 mg, 0.150 mmol, 1.2 equiv.) and copper catalyst (0.013 mmol, 10 
mol%) were added to a 4 ml vial then the system was charged with argon. Solvent 250 
μl) was added under argon atmosphere then the reaction mixture was stirred at 75°C for 
the appropriate time. 
7. 4. Synthesis and analytical data of 2-cyanoanilides 
N-(2-cyanophenyl)acetamides were synthesized from 2-aminobenzonitrile 
derivative and the appropriate acyl chloride or anhydride according to the modified 
procedure of Fagnou.136 
General procedure for the synthesis of N-(2-cyanophenyl)acetamides 
2-aminobenzonitrile (1.00 g, 8.47 mmol) was added to a 100 ml round bottom flask fitted 
with a rubber septum then the system was charged with argon. Dichloromethane (25 ml) 
was added under argon atmosphere then acetic anhydride (1.30 g, 12.7 mmol, 1.20 ml) 
was added dropwise. The reaction mixture was stirred at room temperature for 24 h. The 
reaction mixture was washed with saturated sodium hydrogen carbonate solution (3 x 20 
ml), with brine (2 x 20 ml), dried over anhydrous sodium sulfate, filtered and evaporated 
to yield white or yellow solids. 
N-(2-cyanophenyl)acetamide (167a) 
 
Prepared according to the general procedure from 2-aminobenzonitrile and acetic 
anhydride. After evaporation of the solvent under reduced pressure the product was 
afforded as a white solid (1.21 g, 7.59 mmol, 90%). Rf  = 0.45 (hexane-ethyl acetate, 3:1).
 
1H NMR (250 MHz, CDCl3): δ 8.29 (d, J = 8.8 Hz, 1H), 7.71 (br s, 1H), 7.57 – 7.44 (m, 
2H), 7.10 (t, J = 7.9 Hz, 1H), 2.20 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 169.1, 140.9, 
134.6, 132.7, 124.5, 121.9, 116.8, 102.4, 25.0; IR νmax/cm-1 (solid): 3322, 2229, 1710, 
1579, 1523, 1445, 1372,1293, 1252, 1229, 751, 634, 599, 575, 535, 495, 475. 
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N-(5-chloro-2-cyanophenyl)acetamide (167b) 
 
Prepared according to the general procedure from 2-amino-4-chlorobenzonitrile (1.00g, 
6.55 mmol) and acetic anhydride (2.00 g, 19.66 mmol, 1.86 ml). The reaction mixture 
was stirred at room temperature for 3 days. The product was obtained as a yellow solid 
(880 mg, 4.54 mmol, 69%). Rf  = 0.35 (hexane-ethyl acetate, 7:3).
 1H NMR (250 MHz, 
DMSO-d6): δ 10.30 (br s, 1H), 7.83 (d, J = 8.4 Hz, 1H), 7.76 (d, J = 1.9 Hz, 1H), 7.39 
(dd, J = 8.4, 2.0 Hz, 1H), 2.11 (s, 3H); 13C NMR (62.5 MHz, DMSO-d6): δ 169.4, 142.0, 
138.6, 135.1, 125.8, 125.0, 116.5, 105.4, 23.7; IR νmax/cm-1 (solid): 3332, 2918, 2849, 
2224, 1702, 1598, 1567, 1520, 1410, 1251, 1219, 887, 822, 655, 609, 596, 527514, 424. 
N-(4-chloro-2-cyanophenyl)acetamide (167c) 
 
Prepared according to the general procedure from 2-amino-4-chlorobenzonitrile (250 mg, 
1.64 mmol) and acetic anhydride (251 mg, 2.46 mmol, 232 µl) in 8 ml dichloromethane. 
The reaction mixture was stirred at room temperature for 4 days. The product was 
obtained as a white solid (234 mg, 1.21 mmol, 73%). Rf  = 0.30 (hexane-ethyl acetate, 
7:3). 1H NMR (250 MHz, DMSO- d6): δ 10.24 (s, 1H), 7.96 (d, J = 2.1 Hz, 1H), 7.72 (dd, 
J = 8.8, 2.2 Hz, 1H), 7.60 (d, J = 8.8 Hz, 1H), 2.09 (s, 3H); 13C NMR (62.5 MHz, DMSO- 
d6): δ 169.2, 139.7, 134.2, 132.8, 129.5, 127.2, 116.0, 108.7, 23.5; IR νmax/cm-1 (solid): 
3340, 2228, 1698, 1583, 1516, 1288, 833, 646, 574, 489, 437. 
 
N-(2-cyanophenyl)amides were synthesized from 2-aminobenzonitrile and the 
appropriate acyl chloride or anhydride according to the modified procedure of 
Zhdankin.137 
General procedure for the synthesis of N-(2-cyanophenyl)amides 
2-aminobenzonitrile (1.00 g; 8.47 mmol) and triethylamine (9.73-19.1 mmol, 1.15-2.25 
equiv.) were dissolved in 50-80 ml dichloromethane and cooled to 0°C. A solution of acyl 
chloride (9.73-19.1 mmol, 1.15-2.25 eq.) and dichloromethane (7 ml) was added 
dropwise then the resulted mixture was stirred at room temperature for the appropriate 
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time. After that the pH of the reaction mixture was adjusted to 7-8 with saturated sodium 
hydrogen carbonate solution, the separated organic layer was washed with distilled water 
(3 x 50 ml) and with brine (2 x 50 ml), dried over anhydrous magnesium sulfate, filtered 
and evaporated. Purification of the crude product afforded the appropriate amides as 
white or yellow solids. 
N-(3-cyanothiophen-2-yl)acetamide (167d) 
 
Prepared according to the general procedure from 2-aminothiophene-3-carbonitrile (261 
mg, 2.10 mmol), triethylamine (319 mg, 3.15 mmol, 440 µl, 1.50 equiv.) and acetyl 
chloride (247 mg, 3.15 mmol, 224 µl, 1.50 equiv.) in 12 ml dichloromethane. The reaction 
mixture was stirred at room temperature for 18 h. The product was obtained as a yellow 
crystalline solid after recrystallization from ethanol (161 mg, 0.970 mmol, 46%). Rf  = 
0.40 (hexane-ethyl acetate, 7:3). 1H NMR (250 MHz, DMSO-d6):
 δ 11.66 (s, 1H), 7.11 
(s, 2H), 2.19 (s, 3H); 13C NMR (62.5 MHz, DMSO-d6): δ 168.7, 149.8, 125.0, 119.0, 
115.2, 92.1, 22.7; IR νmax/cm-1 (solid): 3269, 2217, 1692, 1545, 1496, 1363, 1280, 1238, 
730, 720, 685, 670, 638, 593, 535, 486. 
N-(2-cyanophenyl)pivalamide (167e) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (985 mg, 9.73 mmol, 1.36 ml, 1.15 equiv.) and pivaloyl chloride 
(1.17 g, 9.73 mmol, 1.20 ml) in 80 ml dichloromethane. The reaction mixture was stirred 
at room temperature for 2 days. Purification of the crude product by column 
chromatography on silica gel afforded the product as a white solid. (925 mg, 4.58 mmol, 
54%). Rf  = 0.60 (hexane-ethyl acetate, 3:1). 
1H NMR (250 MHz, CDCl3): δ 8.36 (d, J = 
8.5 Hz, 1H), 7.90 (br s, 1H), 7.51 (t, J = 7.4 Hz, 2H), 7.09 (t, J = 7.4 Hz, 1H), 1.29 (s, 
9H); 13C NMR (62.5 MHz, CDCl3): δ 177.3, 141.2, 134.6, 132.3, 124.3, 121.4, 116.8, 
102.4, 40.6, 27.8; IR νmax/cm-1 (solid): 3329, 2973, 2229, 1666, 1509, 1447, 1296, 1163, 
755, 613. 
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N-(2-cyanophenyl)-2,2,2-trifluoroacetamide (167f) 
 
2-aminobenzonitrile (1.00 g; 8.47 mmol) was dissolved in 45 ml dichloromethane then 
2,2,2-trifluoroacetic anhydride (2.13 g; 10.2 mmol; 1.43 ml) was added dropwise. The 
reaction mixture was stirred at room temperature overnight. After that the pH of the 
reaction mixture was adjusted to 7-8 with saturated sodium hydrogen carbonate, the 
separated organic layer was washed with distilled water (1 x 50 ml) and with brine (1 x 
50 ml), dried over anhydrous magnesium sulfate, filtered and evaporated. The product 
was obtained as a white crystalline solid after recrystallization from toluene (1.15 g, 5.37 
mmol, 63%). Rf  = 0.40 (hexane-ethyl acetate, 3:1). 
1H NMR (250 MHz, CDCl3): 8.38 (br 
s, 1H), 8.22 (d, J = 8.6 Hz, 1H), 7.62 (d, J = 6.2 Hz, 2H), 7.29 (t, J = 7.5 Hz, 1H); 13C 
NMR (62.5 MHz, CDCl3): δ 156.6, 156.0, 155.4, 154.8, 137.6, 134.8, 133.2, 127.0, 123.0, 
118.0, 115.8, 113.5, 104.9; IR νmax/cm-1 (solid): 3263, 2229, 1714, 1546, 1286, 1251, 
1203, 1156, 1094, 917, 763, 716, 653, 494. 
2-Chloro-N-(2-cyanophenyl)acetamide (167g) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (1.07 g, 10.6 mmol, 1.48 ml, 1.25 equiv.) and chloroacetyl chloride 
(1.20 g, 10.6 mmol, 842 µl, 1.25 equiv.) in 50 ml dichloromethane. The reaction mixture 
was stirred at room temperature for 2 days. Purification of the crude product by column 
chromatography on silica gel afforded the product as a white solid. (909 mg, 4.69 mmol, 
55%). Rf  = 0.30 (hexane-ethyl acetate, 3:1). 
1H NMR (250 MHz, CDCl3): δ 8.79 (br s, 
1H), 8.30 (d, J = 8.8 Hz, 1H), 7.57 –7.52 (m, 2H), 7.17 (t, J = 7.6 Hz, 1H), 4.18 (s, 2H); 
13C NMR (62.5 MHz, CDCl3): δ 164.8, 139.6, 134.6, 132.8, 125.5, 121.6, 116.2, 103.3, 
43.3; IR νmax/cm-1 (solid): 3313, 2229, 1698, 1604, 1535, 1446, 1402, 1250, 766, 619, 
495. 
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N-(2-cyanophenyl)cyclohexanecarboxamide (167h) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (1.29 g, 12.7 mmol, 1.77 ml, 1.50 equiv.) and cyclohexanecarbonyl 
chloride (1.86 g, 12.7 mmol, 1.71 ml, 1.50 equiv.) in 50 ml dichloromethane. The reaction 
mixture was stirred at room temperature for 2 days. The product was obtained as a white 
crystalline solid after recrystallization from ethanol (1.20 g, 5.26 mmol, 62%). Rf  = 0.60 
(hexane-ethyl acetate, 7:3). 1H NMR (250 MHz, CDCl3): δ 8.33 (d, J = 7.2 Hz, 1H), 7.67 
(s, 1H), 7.50 (s, 2H), 7.08 (s, 1H), 2.27 (s, 1H), 2.09 – 0.96 (m 10H); 13C NMR (62.5 
MHz, CDCl3): δ 175.0, 141.1, 134.6, 132.5, 124.3, 121.7, 116.9, 102.3, 46.8, 29.9, 25.9; 
IR νmax/cm-1 (solid): 3294, 2925, 2852, 2230, 1664, 1602, 1511, 1492, 1447, 1437, 1250, 
1198, 955, 776, 759, 671, 489. 
N-(2-cyanophenyl)benzamide (167i) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (1.29 g, 12.7 mmol, 1.77 ml, 1.50 equiv.) and benzoyl chloride 
(1.78 g, 12.7 mmol, 1.47 ml, 1.50 equiv.) in 80 ml dichloromethane. The reaction mixture 
was stirred at room temperature for 2 days. Recrystallization of the crude product from 
ethanol gave a white solid (992 mg, 4.47 mmol, 53%). Rf  = 0.35 (hexane-ethyl acetate, 
5:1). 1H NMR (250 MHz, CDCl3): δ 8.49 (d, J = 8.3 Hz, 1H), 8.36 (br s, 1H), 7.86 (d, J 
= 7.2 Hz, 2H), 7.59 – 7.41 (m, 5H), 7.13 (t, J = 7.5 Hz, 1H); 13C NMR (62.5 MHz, CDCl3): 
δ 165.9, 141.0, 134.7, 134.1, 133.0, 132.6, 129.5, 127.6, 124.7, 121.7, 116.8, 102.7; IR 
νmax/cm-1 (solid): 3285, 2231, 1649, 1601, 1508, 1481, 1436, 1310, 1286, 1261, 1245, 
794, 708, 686, 675, 488. 
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4-Chloro-N-(2-cyanophenyl)benzamide (167j) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (1.29 g, 12.7 mmol, 1.77 ml, 1.50 equiv.) and 4-chlorobenzoyl 
chloride (2.22 g, 12.7 mmol, 1.63 ml, 1.50 equiv.) in 50 ml dichloromethane. The reaction 
mixture was stirred at room temperature for 24 h. The product was obtained as a white 
solid after recrystallization from ethanol (1.34 g, 5.23 mmol, 62%). Rf  = 0.45 (hexane-
ethyl acetate, 4:1). 1H NMR (250 MHz, CDCl3): δ 8.46 (d, J = 7.3 Hz, 1H), 8.29 (s, 1H), 
7.90 (dd, J = 48.9, 6.6 Hz, 4H), 7.68 – 7.28 (m, 4H), 7.17 (d, J = 6.5 Hz, 1H).13C NMR 
(62.5 MHz, CDCl3): δ 164.8, 161.7, 141.8, 140.8, 139.5, 134.8, 132.6, 132.3, 129.8, 
129.1, 127.4, 124.9, 121.7, 116.8, 102.8; IR νmax/cm-1 (solid): 3282, 2223, 1653, 1590, 
1579, 1523, 1485, 1445, 1307, 1091, 1007, 855, 754, 649, 622, 537, 500, 483, 470. 
N-(2-cyanophenyl)-4-nitrobenzamide (167k) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (1.93 g, 19.0 mmol, 2.66 ml, 2.25 equiv.) and 4-nitrobenzoyl 
chloride (3.53 g, 19.0 mmol, 2.25 equiv.) in 50 ml dichloromethane. The reaction mixture 
was stirred at room temperature for 2 days. Purification of the crude product by column 
chromatography on silica gel then recrystallization from 2-propanol afforded a yellow 
solid (223 mg, 0.835 mmol, 26%). Rf  = 0.30 (hexane-ethyl acetate, 7:3).
 1H NMR (250 
MHz, DMSO-d6): δ 10.97 (br s, 1H), 8.26-7.60 (m, 8H); 13C NMR (62.5 MHz, DMSO-
d6): δ 170.8, 149.9, 140.9, 139.4, 135.4, 134.5, 131.2, 130.5, 130.3, 124.2, 124.1, 111.8; 
IR νmax/cm-1 (solid): 3113, 2232, 1676, 1524, 1334, 1316, 1228, 1143, 1109, 911, 859, 
847, 765, 718, 702, 439. 
  
108 
 
N-(2-cyanophenyl)-4-fluorobenzamide (167l) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (1.93 g, 19.0 mmol, 2.66 ml, 2.25 equiv.) and 4-fluorobenzoyl 
chloride (3.02 g, 19.0 mmol, 2.25 ml, 2.25 equiv.) in 50 ml dichloromethane. The reaction 
mixture was stirred at room temperature for 24 h. The product was obtained as a white 
crystalline solid after recrystallization from ethanol then from toluene (368 mg, 1.53 
mmol, 37%). Rf  = 0.50 (hexane-ethyl acetate, 4:1).
 1H NMR (250 MHz, DMSO-d6): δ 
10.66 (s, 1H), 8.07 – 7.42 (m, 1H); 13C NMR (62.5 MHz, DMSO-d6): δ 166.7, 164.9, 
140.6, 134.2, 133.5, 131.0, 130.9, 130.3, 127.2, 126.8, 117.3, 116.1, 115.8, 109.7; IR 
νmax/cm-1 (solid): 3278, 2225, 1652, 1601, 1579, 1525, 1504, 1444, 1310, 1296, 1224, 
762, 620, 501. 
N-(2-cyanophenyl)-4-methoxybenzamide (167m) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g; 8.47 
mmol), triethylamine (1.93 g, 19.0 mmol, 2.66 ml, 2.25 equiv.) and 4-methoxybenzoyl 
chloride (3.25 g, 19.0 mmol, 2.58 ml, 2.25 equiv.) in 50 ml dichloromethane. The reaction 
mixture was stirred at room temperature for 2 days. The product was obtained as a white 
crystalline solid after recrystallization from ethanol (1.19 g, 4.72 mmol, 56%). Rf  = 0.80 
(hexane-ethyl acetate, 3:1). 1H NMR (250 MHz, CDCl3): δ 8.50 (d, J = 8.3 Hz, 1H), 8.28 
(br s, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.55 (t, J = 8.2 Hz, 2H), 7.11 (t, J = 7.5 Hz, 1H), 6.92 
(d, J = 8.4 Hz, 2H), 3.80 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 165.3, 163.5, 141.3, 
134.7, 132.5, 129.6, 126.2, 124.4, 121.4, 117.0, 114.7, 102.3, 55.9; IR νmax/cm-1 (solid): 
3277, 2227, 1649, 1605, 1579, 1525, 1508, 1444, 1302, 1251, 1176, 1022, 840, 762, 623, 
503. 
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N-(2-cyanophenyl)cinnamamide (167n) 
 
Prepared according to the general procedure from 2-aminobenzonitrile (1.00 g, 8.47 
mmol), triethylamine (1.29 g, 12.7 mmol, 1.77 ml, 1.50 equiv.) and cinnamoyl chloride 
(2.12 g, 12.7 mmol, 1.50 equiv.) in 50 ml dichloromethane. The reaction mixture was 
stirred at room temperature for 24 h. The product was obtained as a white crystalline solid 
after recrystallization from ethanol then from toluene (550 mg, 2.22 mmol, 50%). Rf  = 
0.50 (hexane-ethyl acetate, 7:3). 1H NMR (250 MHz, CDCl3): δ 8.57 (d, J = 7.7 Hz, 1H), 
7.94 (s, 1H), 7.81 (d, J = 15.0 Hz, 1H), 7.60 (d, J = 6.5 Hz, 4H), 7.41 (s, 3H), 7.26 – 7.08 
(m, 1H), 6.67 (d, J = 15.3 Hz, 1H); 13C NMR (62.5 MHz, CDCl3): δ 164.6, 144.5, 141.2, 
134.7, 134.6, 132.8, 130.9, 129.4, 128.6, 124.5, 121.8, 120.3, 117.0, 102.2; IR νmax/cm-1 
(solid): 3341, 2226, 1686, 1634, 1583, 1531, 1448, 1290, 1155, 976, 763, 710, 620, 550, 
483. 
7. 5. Synthesis and analytical data of cyclic β-enaminonitriles 
β-enaminonitriles were synthesized from the appropriate dinitrile and potassium 
tert-butoxide according to the modified procedure of Ma et al.138 
2-aminocyclopent-1-ene-1-carbonitrile (170a) 
 
A mixture of powdered tBuOK (3.36 g; 30.0 mmol) and adiponitrile (2.70 g, 25.0 mmol, 
2.84 ml) in toluene (40 ml) was stirred at room temperature overnight. Solvent was 
removed under reduced pressure, than distilled water was added to the reaction mixture 
and the product was extracted with dichloromethane (4 x 40 ml), the combined organics 
were washed with brine (1 x 100 ml), dried over anhydrous sodium sulfate, filtered and 
evaporated. The residual yellow solid was recrystallized from MeOH to give 2-
aminocyclopent-1-ene-1-carbonitrile as a white solid (1.15 g; 10.6 mmol; 43%). Rf  = 0.30 
(hexane-ethyl acetate, 7:3). 1H NMR (250 MHz, CDCl3): δ 4.54 (s, 1H), 2.44 (s, 2H), 1.86 
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(s, 1H). 13C NMR (62.5 MHz, CDCl3): δ=163.0, 119.5, 74.5, 34.6, 31.6, 22.4; IR νmax/cm-
1 (solid): 3434, 3346, 2947, 2172, 1636, 1604, 1401, 1209, 1147, 887, 492, 468, 448. 
2-amino-1-cyclohexene-1-carbonitrile (170b) 
 
A mixture of powdered tBuOK (6.73 g; 60.0 mmol) and pimelonitrile (6.11 g; 50.0 mmol; 
6.43 ml) was kept at 80 °C for 3 h then at room temperature overnight. Distilled water 
was added to the reaction mixture and the product was extracted with ether (3 x 40 ml), 
dried over anhydrous magnesium sulfate, filtered and evaporated. The residual yellow 
solid was recrystallized from MeOH to give 2-amino-1-cyclohexene-1-carbonitrile as a 
white solid (1.32 g; 10.8 mmol; 22%). Rf  = 0.40 (hexane-ethyl acetate, 7:3).
 1H NMR 
(250 MHz, CDCl3): δ 4.28 (s, 2H), 2.12 (s, 4H), 1.59 (s, 4H); 13C NMR (62.5 MHz, 
CDCl3): δ 156.7, 121.3, 74.3, 28.5, 24.6, 22.4, 22.0; IR νmax/cm-1 (solid): 3421, 3348, 
3232, 2179, 1640, 1604, 1410, 490, 457. 
2-aminocyclohept-1-ene-1-carbonitrile (170c) 
 
A mixture of powdered tBuOK (3.36 g; 60.0 mmol) and 1,6-dicyanohexane (3.41 g, 25.0 
mmol, 3.57 ml) in toluene (40 ml) was stirred at 100°C for 2 days. Solvent was removed 
under reduced pressure, than distilled water was added to the reaction mixture and the 
product was extracted with dichloromethane (4 x 40 ml), the combined organics were 
washed with brine (1 x 100 ml), dried over anhydrous sodium sulfate, filtered and 
evaporated. Purification of the crude product by column chromatography on silica gel 
afforded the product as a yellow solid (825 mg, 6.07 mmol, 24%). The obtained product 
(not totally pure) was brought into the next step (acylation) without further purification. 
Rf  = 0.74 (hexane-ethyl acetate, 1:1). 
1H NMR (250 MHz, CDCl3):
 δ 4.50 (s, 2H), 2.74-
2.08 (m, 6H), 1.91 – 1.32 (m, 9H); 13C NMR (62.5 MHz, CDCl3): δ 164.6, 122.8, 120.0, 
76.0, 35.7, 32.1, 28.9, 28.4, 28.2, 25.7, 25.4, 17.4, IR νmax/cm-1 (solid): 3464, 3360, 2925, 
2852, 2246, 2173, 1634, 1596, 1448, 1192. 
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7. 6. Synthesis and analytical data of cyclic β-
acetylaminoacrylonitriles 
β-acetylaminoacrylonitriles were synthesized from the appropriate cyclic β-
enaminonitrile and acetic anhydride according to the modified procedure of Ma et al.138  
General procedure for the synthesis of β-acetylaminoacrylonitriles 
To a solution of cyclic-β-enaminonitrile (4.09 mmol) in pyridine (5 ml), acetic anhydride 
(8.19 mmol, 2.0 eq.) was added. The reaction mixture was heated at reflux for 16 h and 
cooled to room temperature. It was then poured onto 2 molar hydrochloric acid solution 
and extracted with chloroform (5 x 10 ml). The combined organics were washed with 
distilled water (2 x 50 ml), with brine (1 x 50 ml), dried over anhydrous sodium sulfate, 
filtered and evaporated. Purification of the crude product by column chromatography on 
silica gel afforded the product as a solid. 
N-(2-cyanocyclopent-1-en-1-yl)acetamide (167o) 
 
Prepared according to the general procedure from 2-aminocyclopent-1-ene-1-carbonitrile 
(170a) (811 mg, 7.50 mmol) and acetic anhydride (1.53 g, 15.0 mmol, 1.42 ml). 
Purification of the crude product by column chromatography on silica gel afforded the 
product as a grey solid (884 mg, 5.90 mmol, 79%). Rf  = 0.60 (hexane-ethyl acetate, 1:1). 
1H NMR (250 MHz, CDCl3): δ 8.54 (s, 1H), 3.26 – 2.88 (m, 2H), 2.54 – 2.36 (m, 2H), 
2.06 (s, 3H), 1.99 – 1.83 (m, 2H). 13C NMR (62.5 MHz, CDCl3): δ 169.0, 157.5, 117.0, 
87.5, 34.1, 30.5, 24.3, 22.5; IR νmax/cm-1 (solid): 3276, 2202, 1713, 1631, 1510, 1367, 
1230, 1203, 995, 740, 604, 522, 467. 
N-(2-cyanocyclohex-1-en-1-yl)acetamide (167p) 
 
Prepared according to the general procedure from 2-amino-1-cyclohexene-1-carbonitrile 
(170b) (500 mg, 4.09 mmol) and acetic anhydride (836 mg, 8.19 mmol, 774 µl). 
Purification of the crude product by column chromatography on silica gel afforded the 
product as a white solid (260 mg, 1.59 mmol, 39%). Rf  = 0.30 (hexane-ethyl acetate, 3:2). 
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1H NMR (250 MHz, CDCl3): δ 7.61 (s, 1H), 2.73 (s, 2H), 2.21 (s, 2H), 2.05 (s, 3H), 1.60 
(s, 4H); 13C NMR (62.5 MHz, CDCl3): δ 168.8, 152.2, 118.4, 91.4, 28.1, 26.0, 24.9, 21.8, 
21.4; IR νmax/cm-1 (solid): 3230, 3148, 2932, 2210, 1667, 1520, 1440, 1422, 1366, 1281, 
1267, 1229, 1032, 756, 583, 430. 
N-(2-cyanocyclohept-1-en-1-yl)acetamide (167q) 
 
Prepared according to the general procedure from 2-aminocyclohept-1-ene-1-carbonitrile 
(170c) (732 mg, 5.38 mmol) and acetic anhydride (1.10 g, 10.8 mmol, 1016 µl). 
Purification of the crude product by column chromatography on silica gel afforded the 
product as a drab solid (160 mg, 0.899 mmol, 17%). M. p. 112-114 °C. Rf  = 0.35 (hexane-
ethyl acetate, 7:3). 1H NMR (250 MHz, CDCl3): 7.75 (s, 1H), 2.82 – 2.56 (m, 2H), 2.39 
– 2.23 (m, 3H), 2.05 (s, 3H), 1.78 – 1.40 (m, 5H).13C NMR (62.5 MHz, CDCl3) δ 169.6, 
158.8, 119.3, 99.7, 32.1, 32.0, 29.7, 26.6, 24.8, 24.6. IR νmax/cm-1 (solid): 3223, 2997, 
2932, 2919, 2852, 2203, 1657, 1627, 1517, 1445, 1366, 1350, 1289, 1275, 1264, 1044, 
998, 880, 725, 692, 665, 610. 
7. 7. Synthesis and analitical data of imino-1,3-benzoxazines 
General procedure for the synthesis of (Z)-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-
ylidene)anilines 
N-(2-cyanophenyl)acetamide (167a) (80.1 mg, 0.500 mmol), diaryl iodonium salt (0.600 
mmol, 1.2 equiv.) and copper(II)triflate (18.08 mg; 0.050 mmol, 10 mol%) were added 
to a 4 ml vial then the system was charged with argon. Solvent (1,2-dichloroethane or 
ethyl acetate, 1000 μl) was added under argon atmosphere then the reaction mixture was 
stirred at 75°C for the appropriate time. Saturated sodium hydrogen carbonate solution 
(10 ml) was added to the mixture, the aqueous layer was extracted with dichloromethane 
(4 x 10 ml) the combined organics were dried over anhydrous sodium sulfate, filtered and 
evaporated. Purification of the crude products by column chromatography on silica gel 
afforded the products as solids. 
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(Z)-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168aa) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and phenyl(mesityl) iodonium trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 
2 h. Purification of the crude product by column chromatography on silica gel afforded 
the product as a drab solid (60.0 mg, 0.254 mmol, 51%). M. p. 142-145 °C. Rf  = 0.30 
(hexane-ethyl acetate, 3:2). 1H NMR (250 MHz, CDCl3): δ 8.19 (d, J = 7.9 Hz, 1H), 7.78 
– 7.55 (m, 2H), 7.55 – 7.28 (m, 4H), 7.19 (d, J = 6.8 Hz, 2H), 2.16 (s, 3H); 13C NMR 
(62.5 MHz, CDCl3): δ 162.6, 154.6, 147.9, 138.2, 135.0, 130.4, 129.7, 128.4, 127.5, 
127.2, 127.0, 121.2, 24.8; IR νmax/cm-1 (solid): 2923, 1676, 1606, 1585, 1572, 1470, 1265, 
1116, 760, 692, 659, 622, 507. 
(Z)-2-methyl-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168ab) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and 2-methylphenyl(mesityl)iodonium trifluoromethanesulfonate (46b) (292 mg, 0.600 
mmol) for 16 h. Purification of the crude product by column chromatography on silica 
gel afforded the product as a drab solid (66.5 mg, 0.266 mmol, 53%). M. p. 115-117 °C. 
Rf  = 0.35 (hexane-ethyl acetate, 2:1).
 1H NMR (250 MHz, CDCl3): δ 8.27 (d, J = 8.0 Hz, 
1H), 7.82 – 7.60 (m, 2H), 7.53 – 7.28 (m, 4H), 7.15 (d, J = 6.2 Hz, 1H), 2.17 (s, 3H), 2.11 
(s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 162.0, 154.7, 148.1, 137.2, 135.7, 135.0, 131.9, 
130.0, 128.3, 128.0, 127.5, 127.2, 127.0, 121.1, 24.2, 17.8; IR νmax/cm-1 (solid): 2921, 
1673, 1607, 1597, 1567, 1468, 1325, 1279, 1269, 1123, 776, 759, 720, 702, 657, 624, 
458; HRMS m/z [M+H]+ Calculated for C16H15N2O: 251.1179; found 251.1175. 
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(Z)-3-methyl-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168ac) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and 3-methylphenyl(mesityl)iodonium trifluoromethanesulfonate (46c) (292 mg, 0.600 
mmol) for 16 h. Purification of the crude product by column chromatography on silica 
gel afforded the product as a drab solid (77.0 mg, 0.308 mmol, 62%). M. p. 96-98 °C. Rf  
= 0.25 (hexane-ethyl acetate, 2:1). 1H NMR (250 MHz, CDCl3): δ 8.26 (d, J = 7.9 Hz, 
1H), 7.89 – 7.57 (m, 2H), 7.44 (dd, J = 11.8, 7.7 Hz, 2H), 7.30 (d, J = 7.7 Hz, 1H), 7.06 
(d, J = 7.5 Hz, 2H), 2.42 (s, 3H), 2.24 (s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 162.7, 
154.7, 147.9, 140.5, 138.1, 134.9, 130.5, 130.2, 128.9, 127.4, 127.1, 127.0, 125.3, 121.2, 
24.7, 21.7; IR νmax/cm-1 (solid): 2923, 2249, 1673, 1596, 1584, 1567, 1471, 1376, 1340, 
1320, 1278, 726, 694, 659, 646, 630, 444; HRMS m/z [M+H]+ Calculated for C16H15N2O: 
251.1179; found 251.1180. 
(Z)-4-methyl-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168ad) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and 4-methylphenyl(mesityl)iodonium trifluoromethanesulfonate (46d) (292 mg, 0.600 
mmol) for 16 h. Purification of the crude product by column chromatography on silica 
gel afforded the product as a drab solid (70.5 mg, 0.282 mmol, 56%). M. p. 145-146 °C. 
Rf  = 0.30 (hexane-ethyl acetate, 2:1).
 1H NMR (250 MHz, CDCl3): δ 8.24 (d, J = 7.7 Hz, 
1H), 7.88 – 7.68 (m, 1H), 7.65 (d, J = 7.8 Hz, 1H), 7.42 (t, J = 7.3 Hz, 1H), 7.33 (d, J = 
7.8 Hz, 2H), 7.13 (d, J = 7.9 Hz, 2H), 2.42 (s, 3H), 2.23 (s, 3H). 13C NMR (62.5 MHz, 
CDCl3): δ 162.7, 154.9, 147.9, 139.7, 135.5, 134.9, 131.0, 128.1, 127.4, 127.1, 126.9, 
121.2, 24.8, 21.6; IR νmax/cm-1 (solid): 2922, 1680, 1605, 1589, 1566, 1512, 1468, 1342, 
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1321, 1267, 1109, 817, 776, 697, 615, 520; HRMS m/z [M+H]+ Calculated for 
C16H15N2O: 251.1179; found 251.1180. 
(Z)-4-chloro-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168af) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and (4-chlorophenyl)(mesityl)iodonium trifluoromethanesulfonate (46f) (304 mg, 0.600 
mmol) for 4 h. Purification of the crude product by column chromatography on silica gel 
afforded the product as a white solid (71.5 mg, 0.265 mmol, 53%). M. p. 153-155 °C. Rf  
= 0.28 (hexane-ethyl acetate, 7:3). 1H NMR (250 MHz, CDCl3): δ 8.18 (d, J = 7.4 Hz, 
1H), 7.81 – 7.67 (m, 1H), 7.62 (d, J = 7.7 Hz, 1H), 7.50 (d, J = 7.8 Hz, 2H), 7.45 – 7.33 
(m, 1H), 7.19 (d, J = 7.8 Hz, 2H), 2.21 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 162.5, 
154.1, 147.7, 136.6, 135.7, 135.1, 130.6, 129.9, 127.4, 127.2, 127.1, 121.0, 24.8; IR 
νmax/cm-1 (solid): 3094, 1685, 1602, 1590, 1571, 1466, 1343, 1330, 1268, 1110, 1087, 
1036, 864, 827, 764, 695, 629, 513, 444; HRMS m/z [M+H]+ Calculated for 
C15H12ClN2O: 271.0633; found 271.0629. 
(Z)-3-bromo-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168ah) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and 3-bromophenyl(mesityl)iodonium trifluoromethanesulfonate (46h) (331 mg, 0.600 
mmol) for 16 h. Purification of the crude product by column chromatography on silica 
gel afforded the product as a drab solid (78.0 mg, 0.248 mmol, 50%). M. p. 124-126 °C. 
Rf  = 0.22 (hexane-ethyl acetate, 2:1).
 1H NMR (250 MHz, CDCl3): δ 8.15 (dd, J = 7.9, 
0.8 Hz, 1H), 7.74 – 7.63 (m, 1H), 7.62 – 7.52 (m, 2H), 7.43 – 7.36 (m, 2H), 7.33 (d, J = 
8.0 Hz, 1H), 7.18 – 7.10 (m, 1H), 2.17 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 162.4, 
154.0, 147.7, 139.3, 135.2, 133.0, 131.7, 131.6, 128.4, 127.4, 127.4, 127.23, 127.22, 
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123.7, 120.9, 24.7; IR νmax/cm-1 (solid): 3612, 2923, 1665, 1604, 1569, 1340, 1327, 1273, 
1254, 765, 691, 420; HRMS m/z [M+H]+ Calculated for C15H12BrN2O: 315.0128; found 
315.0124. 
(Z)-4-bromo-N-(2-methyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168ai) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and 4-bromophenyl(mesityl)iodonium trifluoromethanesulfonate (2i) (331 mg, 0.600 
mmol) for 16 h. Purification of the crude product by column chromatography on silica 
gel afforded the product as a drab solid (76.0 mg, 0.242 mmol, 48%). M. p. 166-168 °C. 
Rf  = 0.24 (hexane-ethyl acetate, 2:1).
 1H NMR (250 MHz, CDCl3): δ 8.12 (d, J = 7.9 Hz, 
1H), 7.71 – 7.62 (m, 1H), 7.62 – 7.52 (m, 3H), 7.35 (t, J = 7.5 Hz, 1H), 7.11 – 7.01 (m, 
2H), 2.14 (s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 162.4, 154.0, 147.7, 137.1, 135.1, 
133.7, 130.2, 127.4, 127.23, 127.17, 123.8, 121.0, 24.7; IR νmax/cm-1 (solid): 2923, 1678, 
1601, 1572, 1491, 1467, 1343, 1267, 1015, 822, 763, 692, 626, 508; HRMS m/z [M+H]+ 
Calculated for C15H12BrN2O: 315.0128; found 315.0124. 
(Z)-N-(4H-benzo[d][1,3]oxazin-4-ylidene)-4-fluoroaniline (168al) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and 4-fluorophenyl(mesityl)iodonium trifluoromethanesulfonate (46l) (294 mg, 0.600 
mmol) for 16 h. Purification of the crude product by column chromatography on silica 
gel afforded the product as a brown solid (60.0 mg, 0.236 mmol, 47%). M. p. 128-130 
°C. Rf  = 0.30 (hexane-ethyl acetate, 2:1). 1H NMR (250 MHz, CDCl3): δ 8.14 (dd, J = 
7.9, 1.0 Hz, 1H), 7.73 – 7.62 (m, 1H), 7.58 (d, J = 8.1 Hz, 1H), 7.43 – 7.30 (m, 1H), 7.16 
(d, J = 6.0 Hz, 4H), 2.15 (s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 165.1, 162.7, 161.1, 
154.4, 147.7, 135.1, 134.0, 130.4, 130.2, 127.4, 127.2, 121.0, 117.6, 117.3, 24.7; IR 
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νmax/cm-1 (solid): 3051, 2923, 1675, 1609, 1592, 1505, 1469, 1269, 1208, 849, 765, 693, 
649, 612, 524, 507; HRMS m/z [M+H]+ Calculated for C15H12FN2O: 255.0928; found 
255.0924. 
(Z)-ethyl-2-(4H-benzo[d][1,3]oxazin-4-ylideneamino)benzoate (168am) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and (2-(ethoxycarbonyl)phenyl)(mesityl)iodonium trifluoromethanesulfonate (46m) 
(326 mg, 0.600 mmol) for 16 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a brown solid (75.5 mg, 0.245 mmol, 
49%). M. p. 120-122 °C. Rf  = 0.40 (hexane-ethyl acetate, 1:1). 1H NMR (250 MHz, 
CDCl3): δ 8.16 (d, J = 7.6 Hz, 1H), 7.72 – 7.58 (m, 2H), 7.52 (td, J = 7.7, 1.2 Hz, 1H), 
7.44 – 7.30 (m, 1H), 7.23 (dd, J = 7.7, 1.0 Hz, 1H), 4.04 (q, J = 7.1 Hz, 2H), 2.12 (s, 3H), 
0.89 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 164.9, 162.7, 154.6, 147.9, 138.2, 
135.0, 134.3, 132.9, 130.2, 130.0, 128.8, 127.3, 127.1, 126.9, 121.1, 61.9, 24.3, 14.0; IR 
νmax/cm-1 (solid): 2985, 1711, 1678, 1607, 1594, 1569, 1470, 1291, 1258, 1119, 1084, 
1018, 780, 756, 696, 622, 515; HRMS m/z [M+H]+ Calculated for C18H17N2O3: 309.1234; 
found 309.1231. 
(Z)-ethyl-4-(4H-benzo[d][1,3]oxazin-4-ylideneamino)benzoate (168an) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)acetamide (167a) 
and (4-(ethoxycarbonyl)phenyl)(mesityl)iodonium trifluoromethanesulfonate (46n) (326 
mg, 0.600 mmol) for 16 h. Purification of the crude product by column chromatography 
on silica gel afforded the product as an orange solid (80.0 mg, 0.260 mmol, 52%). M. p. 
166-168 °C. Rf  = 0.40 (hexane-ethyl acetate, 5:3). 1H NMR (250 MHz, CDCl3) δ 8.15 (d, 
J = 8.1 Hz, 1H), 7.68 (t, J = 7.3 Hz, 1H), 7.58 (d, J = 8.0 Hz, 1H), 7.37 (t, J = 7.4 Hz, 
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1H), 7.28 (d, J = 8.2 Hz, 1H), 4.33 (q, J = 14.1, 7.0 Hz, 2H), 2.14 (s, 3H), 1.33 (t, J = 7.1 
Hz, 3H); 13C NMR (62.5 MHz, CDCl3) δ 165.9, 162.4, 153.7, 147.8, 142.1, 135.1, 131.9, 
131.7, 128.7, 127.4, 127.3, 127.2, 121.0, 61.8, 24.7, 14.7 ; IR νmax/cm-1 (solid): 2923, 
1709, 1689, 1590, 1569, 1344, 1268, 1104, 1019, 770, 699, 662, 627, 505; HRMS m/z 
[M+H]+ Calculated for C18H17N2O3: 309.1234; found 309.1232. 
(Z)-2-(tert-butyl)-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168ea) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)pivalamide (167e) 
(101 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate (46a) 
(283 mg, 0.600 mmol) for 6 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a white solid (58.3 mg, 0.210 mmol, 
42%). M. p. 56-57 °C. Rf  = 0.40 (hexane-ethyl acetate, 15:1). 1H NMR (250 MHz, 
CDCl3): δ 8.15 (d, J = 7.7 Hz, 1H), 7.50 (t, J = 7.4 Hz, 1H), 7.42 – 7.19 (m, 5H), 7.05 (d, 
J = 8.2 Hz, 3H), 1.14 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 166.3, 147.1, 146.1, 143.1, 
133.9, 129.0, 128.3, 126.9, 126.6, 124.3, 122.8, 119.6, 38.3, 28.0, IR νmax/cm-1 (solid): 
2974, 2932, 1664, 1635, 1606, 1490, 1463, 1197, 1114, 1052, 1017, 773, 744, 696, 671, 
582; HRMS m/z [M+H]+ Calculated for C18H19N2O: 279.1492; found 279.1492. 
(Z)-N-phenyl-2-(trifluoromethyl)-4H-benzo[d][1,3]oxazin-4-imine (168fa) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)-2,2,2-
trifluoroacetamide (167f) (107 mg, 0.500 mmol) and mesityl(phenyl)iodonium 
triflouromethanesulfonate (46a) (283 mg, 0.600 mmol) for 12 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a white solid 
(27.0 mg, 0.093 mmol, 18%). M. p. 70-71 °C. Rf  = 0.60 (hexane-ethyl acetate, 10:1). 1H 
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NMR (250 MHz, CDCl3) δ 8.23 (d, J = 7.1 Hz, 1H), 7.60 (t, J = 7.5 Hz, 1H), 7.55 – 7.40 
(m, 2H), 7.30 (t, J = 7.5 Hz, 2H), 7.25 – 7.02 (m, J = 20.1, 6.8 Hz, 3H). 13C NMR (62.5 
MHz, CDCl3) δ 143.8, 142.4, 140.4, 134.4, 131.1, 129.3, 128.1, 127.5, 125.7, 123.5, 
121.1; IR νmax/cm-1 (solid): 1690, 1216, 1152, 1112, 1037, 1004, 945, 903, 773, 748, 725, 
695, 664, 564, 502; HRMS m/z [M+H]+ Calculated for C15H10F3N2O: 291.07; found . 
(Z)-2-(chloromethyl)-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168ga) 
 
Prepared according to the general procedure from 2-chloro-N-(2-cyanophenyl)acetamide 
(167g) (97.0 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate 
(46a) (283 mg, 0.600 mmol) for 6 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a drab solid (62.0 mg, 0.230 mmol, 
46%). M. p. 150-151 °C. Rf  = 0.25 (hexane-ethyl acetate, 3:1). 1H NMR (250 MHz, 
CDCl3) δ 8.21 (d, J = 6.4 Hz, 1H), 7.71 (s, 2H), 7.48 (s, 4H), 7.29 (s, 2H), 4.19 (s, 2H); 
13C NMR (62.5 MHz, CDCl3): δ 162.5, 151.9, 147.4, 136.3, 135.2, 130.3, 129.1, 128.4, 
128.1, 127.6, 121.7, 44.0; IR νmax/cm-1 (solid): 2922, 1682, 1602, 1587, 1568, 1471, 1278, 
1256, 1085, 1072, 1012, 779, 762, 752, 691, 639, 608, 506; HRMS m/z [M+H]+ 
Calculated for C15H12ClN2O: 271.0633; found 271.0629. 
(Z)-N-(2-phenyl-4H-benzo[d][1,3]oxazin-4-ylidene)aniline (168ia) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)benzamide (167i) 
(111 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate (46a) 
(283 mg, 0.600 mmol) for 6 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a drab solid (58.0 mg, 0.195 mmol, 
39%). M. p. 120-121 °C. Rf  = 0.35 (hexane-ethyl acetate, 15:1). 1H NMR (250 MHz, 
CDCl3): δ 8.22 (dd, J = 7.8, 1.1 Hz, 1H), 8.00 – 7.81 (m, 2H), 7.63 – 7.50 (m, 1H), 7.50 
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– 7.24 (m, 7H), 7.23 – 7.06 (m, 3H);  13C NMR (62.5 MHz, CDCl3): δ 155.3, 146.5, 146.0, 
143.4, 134.1, 132.5, 131.1, 129.3, 129.0, 128.6, 128.3, 127.2, 126.9, 124.6, 122.8, 119.9; 
IR νmax/cm-1 (solid): 3057, 2921, 1679, 1625, 1594, 1573, 1463, 1248, 1197, 1064, 1044, 
1026, 1016, 775, 766, 737, 688, 669, 583, 556, 539. 
(Z)-2-(4-chlorophenyl)-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168ja) 
 
Prepared according to the general procedure from 4-chloro-N-(2-cyanophenyl)benzamide 
(167j) (128 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate 
(46a) (283 mg, 0.600 mmol) for 6 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a white solid (78,0 mg, 0.235 mmol, 
47%). M. p. 158-160 °C. Rf  = 0.35 (hexane-ethyl acetate, 15:1). 1H NMR (250 MHz, 
CDCl3): δ 8.28 (d, J = 6.6 Hz, 1H), 7.91 (d, J = 7.1 Hz, 2H), 7.61 (d, J = 6.5 Hz, 1H), 
7.57 – 7.29 (m, 6H), 7.23 (d, J = 4.9 Hz, 3H); 13C NMR (62.5 MHz, CDCl3): δ 154.4, 
149.7, 146.2, 145.9, 143.2, 138.9, 134.2, 129.5, 129.3, 128.8, 128.3, 127.2, 127.0, 124.7, 
122.7, 119.8; IR νmax/cm-1 (solid): 3057, 3016, 1681, 1621, 1591, 1568, 1485, 1475, 1463, 
1252, 1086, 1069, 1047, 847, 777, 745, 718, 693, 668, 540, 464; HRMS m/z [M+H]+ 
Calculated for C20H14ClN2O: 333.0789; found 333.0781. 
(Z)-2-(4-nitrophenyl)-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168ka) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)-4-nitrobenzamide 
(167k) (134 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate 
(46a) (283 mg, 0.600 mmol) for 8 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a white solid (90,0 mg, 0.262 mmol, 
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52%). M. p. 220-222 °C. Rf  = 0.40 (hexane-ethyl acetate, 10:1). 1H NMR (500 MHz, 
DMSO): δ 8.35 (d, J = 8.8 Hz, 1H), 8.24 (d, J = 7.6 Hz, 1H), 8.12 (d, J = 8.7 Hz, 1H), 
7.80 (t, J = 7.6 Hz, 1H), 7.63 (d, J = 7.9 Hz, 1H), 7.59 (t, J = 7.6 Hz, 1H), 7.46 (t, J = 7.7 
Hz, 1H), 7.31 (d, J = 7.6 Hz, 1H), 7.21 (t, J = 7.3 Hz, 1H). 13C NMR (125 MHz, DMSO): 
δ 153.4, 149.9, 145.6, 145.4, 142.5, 136.7, 134.8, 129.8, 129.4, 129.1, 127.4, 126.6, 124.8, 
124.5, 122.8, 119.8; IR νmax/cm-1 (solid): 2917, 1678, 1592, 1519, 1486, 1345, 1315, 
1252, 1236, 1071, 1047, 1011, 863, 845, 776, 743, 709, 698, 668, 537; HRMS m/z 
[M+H]+ Calculated for C20H14N3O3: 334.1030; found 334.1024. 
(Z)-2-(4-fluorophenyl)-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168la) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)-4-fluorobenzamide 
(167l) (120 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate 
(46a) (283 mg, 0.600 mmol) for 10 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a white solid. (73,0 mg, 0,231 mmol, 
46%). M. p. 136-138 °C. Rf  = 0.35 (hexane-ethyl acetate, 15:1). 1H NMR (250 MHz, 
CDCl3): δ 8.29 (d, J = 7.4 Hz, 1H), 8.00 (t, J = 5.6 Hz, 2H), 7.75 – 7.58 (m, 1H), 7.52 (d, 
J = 7.8 Hz, 1H), 7.44 (t, J = 7.2 Hz, 3H), 7.23 (d, J = 6.7 Hz, 3H), 7.08 (t, J = 8.2 Hz, 
2H); 13C NMR (62.5 MHz, CDCl3): δ 154.4, 146.3, 146.0, 143.3, 134.2, 130.7, 130.5, 
129.3, 128.6, 127.1, 126.9, 124.7, 122.6, 119.7, 116.4, 116.0; IR νmax/cm-1 (solid): 3032, 
2922, 1681, 1623, 1591, 1576, 1505, 1485, 1474, 1251, 1236, 1222, 1198, 1151, 1068, 
1052, 1014, 849, 771, 734, 692, 668, 539, 520; HRMS m/z [M+H]+ Calculated for 
C20H14FN2O: 317.1085; found 317.1082. 
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(Z)-2-(4-methoxyphenyl)-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168ma) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)-4-
methoxybenzamide (167m) (126 mg, 0.500 mmol) and mesityl(phenyl)iodonium 
triflouromethanesulfonate (46a) (283 mg, 0.600 mmol) for 7 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a white solid. 
(85,2 mg, 0,260 mmol, 52%). M. p. 158-160 °C. Rf  = 0.30 (hexane-ethyl acetate, 10:1). 
1H NMR (250 MHz, CDCl3): δ 8.16 (d, J = 7.2 Hz, 1H), 7.82 (d, J = 7.8 Hz, 2H), 7.47 
(d, J = 6.7 Hz, 1H), 7.43 – 7.21 (m, J = 16.6, 7.8 Hz, 4H), 7.22 – 6.99 (m, 3H), 6.76 (d, J 
= 7.5 Hz, 2H), 3.70 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 163.2, 155.3, 146.7, 146.2, 
143.75, 134.1, 130.2, 129.2, 128.3, 128.0, 126.9, 124.5, 123.4, 122.8, 119.6, 114.4, 55.8; 
IR νmax/cm-1 (solid): 3058, 2933, 1668, 1619, 1593, 1568, 1509, 1486, 1465, 1420, 1245, 
1168, 1118, 1069, 1050, 1028, 1016, 764, 736, 693, 670, 542; HRMS m/z [M+H]+ 
Calculated for C21H17N2O2: 329.1285; found 329.1082. 
(Z)-N-phenyl-2-((E)-styryl)-4H-benzo[d][1,3]oxazin-4-imine (168na) 
 
Prepared according to the general procedure from N-(2-cyanophenyl)cinnamamide 
(167n) (124 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate 
(46a) (283 mg, 0.600 mmol) for 4 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a yellow solid. (61,2 mg, 0,189 
mmol, 38%). M. p. 105-107 °C. Rf  = 0.32 (hexane-ethyl acetate, 10:1). 1H NMR (250 
MHz, CDCl3): δ 8.13 (d, J = 7.6 Hz, 1H), 7.45 (t, J = 7.4 Hz, 1H), 7.40 – 7.03 (m, 13H), 
6.51 (d, J = 16.1 Hz, 1H); 13C NMR (62.5 MHz, CDCl3): δ 155.7, 146.3, 146.0, 143.6, 
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141.4, 135.1, 134.1, 130.5, 129.3, 129.2, 128.6, 128.3, 126.96, 126.95, 124.7, 123.0, 
119.9, 119.5; IR νmax/cm-1 (solid): 3023, 2922, 1665, 1632, 1590, 1570, 1487, 1463, 1446, 
1247, 1196, 1051, 1021, 984, 971, 769, 752, 687, 667, 481; HRMS m/z [M+H]+ 
Calculated for C22H17N2O: 325.1335; found 325.1331. 
(Z)-7-chloro-2-methyl-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168ba) 
 
Prepared according to the general procedure from N-(5-chloro-2-cyanophenyl)acetamide 
(167b) and mesityl(phenyl)iodonium triflouromethanesulfonate (46a) (283 mg, 0.600 
mmol) for 8 h. Purification of the crude product by column chromatography on silica gel 
afforded the product as a drab solid. (67.5 mg, 0.250 mmol, 50%). M. p. 153-155 °C. Rf  
= 0.30 (hexane-ethyl acetate, 3:1). 1H NMR (250 MHz, CDCl3): δ 8.16 (d, J = 7.1 Hz, 
1H), 7.59 (d, J = 30.8 Hz, 4H), 7.39 (d, J = 6.0 Hz, 1H), 7.26 (s, 2H), 2.23 (s, 3H). 13C 
NMR (62.5 MHz, CDCl3): δ 162.0, 156.0, 148.9, 141.1, 137.9, 130.5, 129.8, 128.9, 128.3, 
127.6, 126.8, 119.7, 24.9; IR νmax/cm-1 (solid): 2922, 1679, 1601, 1583, 1561, 1429, 1376, 
1342, 1317, 1270, 1070, 896, 874, 830, 776, 761, 699, 689, 680, 586; HRMS m/z [M+H]+ 
Calculated for C15H12ClN2O: 271.0633; found 271.0633. 
(Z)-6-chloro-2-methyl-N-phenyl-4H-benzo[d][1,3]oxazin-4-imine (168ca) 
 
Prepared according to the general procedure from N-(4-chloro-2-cyanophenyl)acetamide 
(167c) and mesityl(phenyl)iodonium triflouromethanesulfonate (46a) (283 mg, 0.600 
mmol) for 8 h. Purification of the crude product by column chromatography on silica gel 
afforded the product as a drab solid. (66.5 mg, 0.246 mmol, 45%). M. p. 162-164 °C. Rf  
= 0.30 (hexane-ethyl acetate, 2:1). 1H NMR (250 MHz, CDCl3): δ: 8.11 (s, 1H), 7.78 – 
7.33 (m, 5H), 7.18 (s, 2H), 2.14 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 161.6, 155.0, 
146.4, 137.9, 135.3, 132.7, 130.5, 129.9, 128.91, 128.3, 126.7, 122.2, 24.8; IR νmax/cm-1 
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(solid): 2922, 1688, 1587, 1566, 1470, 1340, 1313, 1269, 821, 765, 718, 697, 684, 640, 
538; HRMS m/z [M+H]+ Calculated for C15H12ClN2O: 271.0633; found 271.0634. 
(Z)-2-methyl-N-phenyl-4H-thieno[2,3-d][1,3]oxazin-4-imine (168da) 
 
Prepared according to the general procedure from N-(3-cyanothiophen-2-yl)acetamide 
(167d) (83.1 mg, 0.500 mmol) and mesityl(phenyl)iodonium triflouromethanesulfonate 
(46a) (283 mg, 0.600 mmol) for 3 h.Purification of the crude product by column 
chromatography on silica gel afforded the products as a yellow oil (71.0 mg, 0.293 mmol, 
59%). Rf  = 0.30 (hexane-ethyl acetate, 7:3).
 1H NMR (250 MHz, CDCl3): δ 7.65 – 7.48 
(m, 3H), 7.44 (d, J = 5.8 Hz, 1H), 7.32 – 7.21 (m, 2H), 7.18 (d, J = 5.8 Hz, 1H), 2.22 (s, 
3H); 13C NMR (62.5 MHz, CDCl3): δ 163.9, 159.1, 155.3, 137.9, 130.5, 129.8, 128.3, 
123.0, 122.9, 24.6; IR νmax/cm-1 (solid): 3083, 2924, 1674, 1553, 1513, 1489, 1417, 1286, 
1256, 737, 697, 626; HRMS m/z [M+H]+ Calculated for C13H11N2OS: 243.0587; found 
243.0586. 
(Z)-2-methyl-N-phenyl-6,7-dihydrocyclopenta[d][1,3]oxazin-4(5H)-imine (168oa) 
 
Prepared according to the general procedure from N-(2-cyanocyclopent-1-en-1-
yl)acetamide (167o) (75,1 mg; 0,500 mmol) and mesityl(phenyl)iodonium 
triflouromethanesulfonate (46a) (283 mg, 0.600 mmol) for 3 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a brown solid. 
(60,2 mg, 0,266 mmol, 53%). M. p. 124-126 °C. Rf  = 0.28 (hexane-ethyl acetate, 1:4). 1H 
NMR (250 MHz, CDCl3): 
1H NMR (250 MHz, CDCl3): δ 7.55 – 7.29 (m, 3H), 7.11 (d, J 
= 6.8 Hz, 2H), 2.94 – 2.61 (m, 4H), 2.07 (s, 3H), 2.00 (dd, J = 15.2, 7.6 Hz, 2H);13C NMR 
(62.5 MHz, CDCl3): δ=168.1, 161.2, 159.1, 138.2, 130.3, 129.6, 128.0, 123.0, 35.4, 28.2, 
24.6, 21.6; IR νmax/cm-1 (solid): 2923, 1687, 1517, 1493, 1430, 1367, 1258, 1092, 766, 
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758, 724, 696, 648, 500; HRMS m/z [M+H]+ Calculated for C14H15N2O: 227.1179; found 
227.1174. 
(Z)-2-methyl-N-phenyl-5,6,7,8-tetrahydro-4H-benzo[d][1,3]oxazin-4-imine (168pa) 
 
Prepared according to the general procedure from N-(2-cyanocyclohex-1-en-1-
yl)acetamide (167p) (82,1 mg; 0,500 mmol) and mesityl(phenyl)iodonium 
triflouromethanesulfonate (46a) (283 mg, 0.600 mmol) for 3 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid. 
(56.7 mg, 0,236 mmol, 47%). M. p. 142-144 °C. Rf  = 0.35 (hexane-ethyl acetate, 1:2). 1H 
NMR (250 MHz, CDCl3): δ 7.56 – 7.28 (m, 3H), 7.11 (d, J = 7.4 Hz, 2H), 2.70 – 2.50 
(m, 2H), 2.49 – 2.34 (m, 2H), 2.05 (s, 3H), 1.86 – 1.55 (m, 4H); 13C NMR (62.5 MHz, 
CDCl3): δ 163.0, 159.5, 155.4, 138.1, 130.3, 129.5, 128.0, 120.3, 31.9, 24.1, 22.7, 22.6, 
22.2; IR νmax/cm-1 (solid): 2926, 1660, 1603, 1536, 1486, 1431, 1377, 1359, 1262, 1237, 
1196, 1135, 768, 754, 693, 502; HRMS m/z [M+H]+ Calculated for C15H17N2O: 
241.1335; found 241.1338. 
(Z)-2-methyl-N-phenyl-6,7,8,9-tetrahydrocyclohepta[d][1,3]oxazin-4(5H)-imine 
(168qa) 
 
Prepared according to the general procedure from N-(2-cyanocyclohept-1-en-1-
yl)acetamide (167q) (127 mg; 0,500 mmol) and mesityl(phenyl)iodonium 
triflouromethanesulfonate (46a) (283 mg, 0.600 mmol) for 4 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid 
(348.0 mg, 0,134 mmol, 27%). M. p. 90-92 °C. Rf  = 0.28 (hexane-ethyl acetate, 1:21). 1H 
NMR (250 MHz, CDCl3): δ 7.42 (s, 1H), 7.12 (s, 1H), 2.72 (s, 1H), 2.04 (s, 1H), 1.90 – 
1.38 (m, 2H).; 13C NMR (62.5 MHz, CDCl3): δ 165.5, 163.3, 155.5, 138.5, 130.3, 129.5, 
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127.9, 124.8, 38.6, 32.7, 26.8, 25.7, 24.9, 24.2.; IR νmax/cm-1 (solid): 2921, 2851, 1655, 
1600, 1592, 1539, 1487, 1437, 1398, 1381, 1361, 1254, 1104, 958, 789, 751, 694, 506. 
7. 8. Synthesis and analytical data of indeno[2,1-b]quinoline 
derivative 172 
2-(2-(phenylethynyl)phenyl)acetonitrile (171) 
 
Prepared by Sonogashira reaction from 2-iodophenylacetonitrile (170) and 
phenylacetylene according to the modified procedure of Kotschy.140 2-
iodophenylacetonitrile (500 mg, 2.06 mmol), PdCl2(PPh3)2 (43.5 mg, 0.060 mmol, 3 
mol%) and copper(I)iodide (11.8 mg, 0.060 mmol, 3 mol%) were added to a 50 ml round 
bottom flask fitted with a rubber septum then the system was charged with argon. DIPA 
(20 ml) was added under argon atmosphere then phenylacetylene (315 mg, 3.09 mmol, 
339 µl) was added dropwise. The resulted mixture was stirred at 50 °C for 2 h. The 
reaction mixure was diluted with dichloromethane (20 ml) and distilled water (20 ml), 
neutralized with 2 M HCl solution, extracted with dichloromethane (4 x 20 ml). The 
combined organics were washed with distilled water (1 x 50 ml), with brine (1 x 50 ml), 
dried over anhydrous magnesium sulfate, filtered and evaporated. Purification of the 
crude product by column chromatography on silica gel afforded the product as a brown 
oil (445 mg, 2.05 mmol, 99%); Rf  = 0.30 (hexane-ethyl acetate, 10:1). 
1H NMR (250 
MHz, CDCl3) δ 7.67 – 7.48 (m, 4H), 7.46 – 7.30 (m, 5H), 3.98 (s, 2H); 13C NMR (62.5 
MHz, CDCl3) δ 132.8, 132.1, 132.0, 129.4, 129.3, 128.9, 128.6, 123.2, 122.9, 117.8, 96.1, 
86.4, 23.2. 
11-phenyl-6H-indeno[2,1-b]quinoline (172) 
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Prepared according to the synthesis of imino-1,3-benzoxazines from 2-(2-
(phenylethynyl)phenyl)acetonitrile (171) (109 mg, 0.500 mmol) and 
phenyl(mesityl)iodonium trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 16 
h. Purification of the crude product by column chromatography on silica gel afforded the 
product as a drab solid (55.0 mg, 0.188 mmol, 38%); Rf  = 0.20 (hexane-ethyl acetate, 
5:1). 1H NMR (250 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.62 – 7.39 (m, 6H), 7.31 (t, 
J = 6.6 Hz, 3H), 7.22 – 7.12 (m, 1H), 6.96 (t, J = 7.5 Hz, 1H), 6.54 (d, J = 7.8 Hz, 1H), 
4.10 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 165.9, 147.4, 142.3, 141.2, 139.5, 136.7, 
130.9, 129.6, 129.5, 129.2, 129.1, 128.9, 128.4, 127.7, 127.4, 126.6, 126.3, 125.6, 124.1, 
39.1. 
7. 9. Optimization studies of the ring closure of compounds 177a 
and 46a: implementation of the experiments 
General procedure for the optimization reactions 
2-((3-phenylprop-2-yn-1-yl)oxy)benzonitrile (177a) (44.3 mg, 0.125 mmol), 
phenylmesityliodonium triflate (46a) (70.9 mg, 0.150 mmol, 1.2 equiv.) and copper 
catalyst (0.013 mmol, 10 mol%) were added to a 4 ml vial then the system was charged 
with argon. Solvent 250 μl) was added under argon atmosphere then the reaction mixture 
was stirred at 75°C for the appropriate time. 
7. 10. Synthesis and analitical data of 2-(Prop-2-yn-1-
yloxy)benzonitriles 
General procedure for the synthesis of 2-(prop-2-yn-1-yloxy)benzonitriles 
2-(Prop-2-yn-1-yloxy)benzonitriles were synthesized from the appropriate 2-
hydroxybenzonitrile derivatives and propargyl bromide according to the procedure of 
Lingam.141 2-hydroxybenzonitrile (1.12 g; 10.0 mmol) and potassium carbonate (2.76 g; 
20.0 mmol) were added to a 100 ml round botton flask fitted with a rubber septum then 
the system was charged with argon. Dimethyl formamide (60 ml) was added under argon 
atmosphere then propargyl bromide (80% toluene solution) (1.93 g; 13.0 mmol; 1.45 ml) 
was added dropwise. After that the mixture was stirred at 50 °C for 16 h. Dichloromethane 
(50 ml) and distilled water (50 ml) were added to the reaction mixture, the aqueous phase 
was extracted with dichloromethane (3 x 50 ml), the combined organics were washed 
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with saturated LiCl solution (5 x 50 ml), dried over anhydrous magnesium sulfate, filtered 
and evaporated. The crude residue was purified by column chromatography. 
2-(Prop-2-yn-1-yloxy)benzonitrile (176a) 
 
Prepared according to the general procedure from 2-hydroxybenzonitrile (175a). 
Purification of the crude product by column chromatography on silica gel afforded the 
product as a white crystalline solid (1.48 g, 9.42 mmol, 94%). M. p. 77-78 °C; Rf  = 0.35 
(hexane-ethyl acetate, 5:1). 1H NMR (250 MHz, CDCl3): δ= 7.49 (dd, J = 10.1, 4.0 Hz, 
2H), 7.07 (d, J = 8.9 Hz, 1H), 6.98 (t, J = 7.6 Hz, 1H), 4.75 (d, J = 2.3 Hz, 1H), 2.50 (t, J 
= 2.2 Hz, 1H); 13C NMR (62.5 MHz, CDCl3): δ= 159.4, 134.6, 134.3, 122.1, 116.6, 113.4, 
102.9, 78.0, 77.6, 56.9; IR νmax/cm-1 (solid): 2941, 2573, 2237, 1600, 1490, 1454, 1290, 
1233, 1017, 740. 
5-Chloro-2-(prop-2-yn-1-yloxy)benzonitrile (176b) 
 
Prepared according to the general procedure from 5-chloro-2-hydroxybenzonitrile (500 
mg, 3.27 mmol). Purification of the crude product by column chromatography on silica 
gel afforded the product as a white crystalline solid (488 mg, 2.56 mmol, 78%). M. p. 
125-126 °C; Rf  = 0.60 (hexane-ethyl acetate, 4:1). 1H NMR (250 MHz, CDCl3) δ 7.51 (d, 
J = 8.1 Hz, 2H), 7.10 (d, J = 8.8 Hz, 1H), 4.82 (d, J = 1.9 Hz, 2H), 2.59 (s, 1H); 13C NMR 
(62.5 MHz, CDCl3) δ 158.1, 134.6, 133.5, 127.0, 115.2, 114.8, 104.3, 77.7, 77.1, 57.3; 
IR νmax/cm-1 (solid): 2930, 1488, 1285, 1266, 1234, 1135, 1018; HRMS m/z [M-H] 
Calculated for C10H5NOCl: 190.0060; found 190.0069. 
5-Bromo-2-(prop-2-yn-1-yloxy)benzonitrile (176c) 
 
Prepared according to the general procedure from 5-bromo-2-hydroxybenzonitrile (1.00 
g, 5.05 mmol). Purification of the crude product by column chromatography on silica gel 
afforded the product as a white crystalline solid (1.13 g, 4.81 mmol, 95%). M. p. 128-129 
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°C; Rf  = 0.32 (hexane-ethyl acetate, 5:1). 1H NMR (250 MHz, CDCl3) δ 7.66 – 7.52 (m, 
2H), 6.98 (d, J = 8.7 Hz, 1H), 4.76 (d, J = 2.4 Hz, 2H), 2.52 (t, J = 2.3 Hz, 1H); 13C NMR 
(62.5 MHz, CDCl3) δ 158.5, 137.4, 136.4, 115.10, 115.07, 113.7, 104.7, 77.8, 77.1, 57.2; 
IR νmax/cm-1 (solid): 2957, 1486, 1286, 1235, 1132, 1016; HRMS m/z [M-H] Calculated 
for C10H5NOBr: 233.9554; found 233.9565. 
7. 11. Synthesis and analitical data of 
Arylpropynyloxybenzonitriles 
General procedure for the synthesis of arylpropynyloxy-benzonitriles 
Arylpropynyloxy-benzonitriles were synthesized by Sonogashira reaction from the 
appropriate 2-(prop-2-yn-1-yloxy)benzonitrile derivative (176a-176c) and aryl iodide 
according to the modified procedure of Kotschy.140 2-(prop-2-ynyloxy)benzonitrile (390 
mg, 2.48 mmol), PdCl2(PPh3)2 (43.5 mg, 0.060 mmol, 3 mol%) and copper(I)iodide (11.8 
mg, 0.060 mmol, 3 mol%) were added to a 50 ml round bottom flask fitted with a rubber 
septum then the system was charged with argon. DIPA (20 ml) was added under argon 
atmosphere then the iodobenzene (422 mg, 2.07 mmol, 231 µl) was added dropwise. If 
the iodoarene was solid, it was added with the copper and palladium sources before the 
addition of DIPA. The resulted mixture was stirred at 30-45 °C for the appropriate time. 
The reaction mixure was diluted with dichloromethane (20 ml) and distilled water (20 
ml), neutralized with 2 M HCl solution, extracted with dichloromethane (4 x 20 ml). The 
combined organics were washed with distilled water (1 x 50 ml), with brine (1 x 50 ml), 
dried over anhydrous magnesium sulfate, filtered and evaporated. The crude residue was 
purified by column chromatography. 
2-(3-Phenylprop-2-ynyloxy)benzonitrile (177a) 
 
Prepared according to the general procedure from 2-(prop-2-yn-1-yloxy)benzonitrile 
(176a) and iodobenzene (422 mg, 2.07 mmol, 231 µl) at 40-45°C for 1 h. Purification of 
the crude product by column chromatography on silica gel afforded the product as a drab 
solid (327 mg, 1.40 mmol, 68%). M. p. 64-65 °C; Rf  = 0.42 (hexane-ethyl acetate, 5:1). 
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1H NMR (250 MHz,CDCl3) δ 7.65 – 7.51 (m, 2H), 7.48 – 7.39 (m, 2H), 7.37 – 7.26 (m, 
3H), 7.26 – 7.18 (m, 1H), 7.05 (t, J = 7.5 Hz, 1H), 5.06 (s, 2H);13C NMR (62.5 MHz, 
CDCl3) δ 159.7, 134.6, 134.3, 132.2, 129.4, 128.8, 122.2, 121.9, 116.8, 113.5, 102.9, 
88.7, 82.9, 57.8; IR νmax/cm-1 (solid): 2973, 2232, 1597, 1492, 1454, 1289, 1231, 1015, 
758, 737, 694. 
2-((3-(Thiophen-2-yl)prop-2-yn-1-yl)oxy)benzonitrile (177b) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 2-iodothiophene (434 mg, 228 µl, 2.07 mmol) for 40 min at 30-35°C. Purification of 
the crude product by column chromatography on silica gel afforded the product as a 
browny solid (465 mg, 1.95 mmol, 94%). M. p. 79-80 °C; Rf = 0.45 (hexane-ethyl acetate, 
4:1). 1H NMR (250 MHz, CDCl3) δ 7.56 – 7.42 (m, 2H), 7.19 (d, J = 5.2 Hz, 1H), 7.17 – 
7.06 (m, 1H), 6.97 (t, J = 7.6 Hz, 1H), 6.88 (dd, J = 5.0, 3.8 Hz, 1H), 4.97 (s, 2H); 13C 
NMR (62.5 MHz, CDCl3) δ 159.6, 134.6, 134.3, 133.6, 128.5, 127.5, 122.0, 116.7, 113.4, 
102.9, 86.9, 82.1, 57.8; IR νmax/cm-1 (solid): 2234, 1597, 1491, 1455, 1290, 1231, 1196, 
1167, 1113, 1004, 849, 701. 
2-((3-(pyridin-3-yl)prop-2-yn-1-yl)oxy)benzonitrile (177c) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 3-iodopyridine (424 mg, 2.07 mmol) for 20 min at 30 °C. Purification of the crude 
product by column chromatography on silica gel afforded the product as a light brown 
solid (340 mg, 1.45 mmol, 70%). Rf = 0.40 (hexane-ethyl acetate, 3:1).
 1H NMR (250 
MHz, CDCl3): δ= 8.53 (d, J = 23.7 Hz, 2H), 7.65 (d, J = 7.9 Hz, 1H), 7.56 – 7.45 (m, 
2H), 7.20 (t, J = 6.3 Hz, 1H), 7.12 (d, J = 8.3 Hz, 1H), 7.00 (t, J = 7.6 Hz, 1H), 5.00 (s, 
2H); 13C NMR (62.5 MHz, CDCl3): δ= 159.50, 152.45, 149.35, 139.45, 134.62, 134.35, 
123.58, 122.11, 116.57, 113.31, 102.97, 86.46, 85.23, 57.54. 
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2-((3-(quinolin-6-yl)prop-2-yn-1-yl)oxy)benzonitrile (177d) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 6-iodoquinoline (527 mg, 2.07 mmol). Purification of the crude product by column 
chromatography on silica gel afforded the product as a drab solid (538 mg, 1.90 mmol, 
92%). Rf = 0.35 (hexane-ethyl acetate, 1:1). 
1H NMR (250 MHz, CDCl3): δ= 8.89 (d, 1H, 
J = 2.5 Hz), 8.14 – 7.98 (m, 2H), 7.89 (d, 1H), 7.65 (dd, J = 8.7, 1.7 Hz, 1H), 7.61 – 7.51 
(m, 2H), 7.44 – 7.34 (m, 1H), 7.23 (d, J = 8.5 Hz, 1H), 7.05 (t, J = 7.3 Hz, 1H), 5.09 (s, 
2H); 13C NMR (62.5 MHz, CDCl3): δ= 159.65, 151.63, 148.13, 136.24, 134.62, 134.32, 
132.29, 132.14, 130.02, 128.19, 122.26, 121.99, 120.44, 116.67, 113.38, 102.94, 88.21, 
84.11, 57.73. 
2-((3-(p-Tolyl)prop-2-yn-1-yl)oxy)benzonitrile (177e) 
 
Prepared in a one-pot synthesis. 2-hydroxybenzonitrile (175a) (834 mg; 7.00 mmol) and 
potassium carbonate (1.94 g; 14.0 mmol) were added to a 100 ml round botton flask fitted 
with a rubber septum then the system was charged with argon. Dimethyl formamide (35 
ml) was added under argon atmosphere then propargyl bromide (80% toluene solution) 
(1.35 g; 9.10 mmol; 1.02 ml) was added dropwise then the mixture was stirred at 50 °C 
for 16 h. After that PdCl2(PPh3)2 (123 mg; 0.175 mmol; 3 mol%) and copper(I)iodide 
(33.3 mg; 0.175 mmol; 3 mol%) dissolved in diisopropylamine (3 ml) were added under 
argom atmosphere to the reaction mixture then 4-iodotoluene (1.27 g; 5.83 mmol) 
dissolved in diisopropylamine (1.5 ml) was added dropwise under argom atmosphere. 
The resulted mixture was stirred at 40-45 °C for 3 h. The workup is according to the steps 
written in the general procedure. Purification of the crude product by column 
chromatography on silica gel afforded the product as a light brown solid (637 mg, 2.58 
mmol, 44% for the two steps). M. p. 37-38 °C; Rf  = 0.32 (hexane-ethyl acetate, 7:1). 1H 
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NMR (250 MHz, CDCl3) δ 7.64 – 7.51 (m, 2H), 7.31 (d, J = 8.1 Hz, 2H), 7.22 (d, J = 8.7 
Hz, 1H), 7.11 (d, J = 8.0 Hz, 2H), 7.04 (t, J = 7.6 Hz, 1H), 5.03 (s, 2H), 2.33 (s, 3H); 13C 
NMR (62.5 MHz, CDCl3) δ 159.8, 139.6, 134.6, 134.2, 132.1, 129.5, 121.8, 119.1, 116.8, 
113.5, 102.8, 88.9, 82.3, 57.8, 21.9; IR νmax/cm-1 (solid): 2231, 1597, 1508, 1492, 1453, 
1371, 1291, 1230, 1169, 1110, 1011, 820. 
2-((3-(4-Methoxyphenyl)prop-2-yn-1-yl)oxy)benzonitrile (177f) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 4-iodoanisole (484 mg, 2.07 mmol). for 45 min at 45 °C. Purification of the crude 
product by column chromatography on silica gel afforded the product as a reddish-brown 
solid (325 mg, 1.24 mmol, 60%). M. p. 58-59 °C; Rf = 0.32 (hexane-ethyl acetate, 4:1).1H 
NMR (250 MHz, CDCl3) δ 7.56 – 7.37 (m, 2H), 7.25 (d, J = 8.7 Hz, 2H), 7.12 (d, J = 8.9 
Hz, 1H), 6.93 (t, J = 7.6 Hz, 1H), 6.72 (d, J = 8.7 Hz, 2H), 4.92 (s, 2H), 3.68 (s, 3H); 13C 
NMR (62.5 MHz, CDCl3) δ 160.5, 159.8, 134.6, 134.2, 133.8, 121.8, 116.8, 114.4, 114.2, 
113.5, 102.8, 88.8, 81.6, 57.9, 55.7; IR νmax/cm-1 (solid): 2232, 1605, 1510, 1492, 1291, 
1249, 1231, 1175, 1034, 834; HRMS m/z [M+H]+ Calculated for C17H14NO2: 264.1025; 
found 264.1023. 
2-((3-(2-Chlorophenyl)prop-2-yn-1-yl)oxy)benzonitrile (177g) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 2-chloroiodobenzene (493 mg, 253 µl, 2.07 mmol) for 30 min at 40 °C. Purification 
of the crude product by column chromatography on silica gel afforded the product as a 
drab solid (344 mg, 1.29 mmol, 62%). M. p. 82-83 °C; Rf = 0.30 (hexane-ethyl acetate, 
4:1). 1H NMR (250 MHz, CDCl3) δ 7.48 (t, J = 7.3 Hz, 2H), 7.37 – 7.06 (m, 5H), 6.96 (t, 
J = 7.5 Hz, 1H), 5.01 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 159.6, 136.6, 134.6, 134.2, 
134.0, 130.5, 129.7, 126.9, 122.2, 122.0, 116.7, 113.7, 102.9, 88.0, 85.5, 57.7; IR νmax/cm-
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1 (solid): 2232, 1600, 1492, 1475, 1455, 1290, 1231, 1015, 759, 739; HRMS m/z [M+H]+ 
Calculated for C16H11NOCl: 268.0524; found 268.0529. 
2-((3-(4-Chlorophenyl)prop-2-yn-1-yl)oxy)benzonitrile (177h) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 4-chloroiodobenzene (493 mg, 2.07 mmol) for 30 min at 40 °C. Purification of the 
crude product by column chromatography on silica gel afforded the product as a drab 
solid (460 mg, 1.72 mmol, 83%). M. p. 128-129 °C; Rf = 0.62 (hexane-ethyl acetate, 7:3). 
1H NMR (250 MHz, CDCl3) δ 7.49 (t, J = 8.0 Hz, 2H), 7.22 (q, J = 8.6 Hz, 4H), 7.11 (d, 
J = 8.3 Hz, 1H), 6.98 (t, J = 7.6 Hz, 1H), 4.95 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 
159.6, 135.5, 134.6, 134.3, 133.4, 129.1, 122.0, 120.7, 116.7, 113.4, 102.9, 87.6, 83.9, 
57.7; IR νmax/cm-1 (solid): 2923, 2232, 1597, 1487, 1453, 1290, 1231, 1014, 827, 753; 
HRMS m/z [M+H]+ Calculated for C16H11NOCl: 268.0529; found 268.0528. 
2-((3-(3-Bromophenyl)prop-2-yn-1-yl)oxy)benzonitrile (177i) 
 
Prepared according to the general procedure 2-(prop-2-ynyloxy)benzonitrile (176a) and 
from 3-bromoiodobenzene (585 mg, 264 µl, 2.07 mmol) for 30 min at 35 °C. Purification 
of the crude product by column chromatography on silica gel afforded the product as a 
drab solid (614 mg, 1.97 mmol, 95%). M. p. 58-59 °C; Rf = 0.40 (hexane-ethyl acetate, 
4:1). 1H NMR (250 MHz, CDCl3) δ 7.66 – 7.52 (m, 3H), 7.46 (d, J = 8.0 Hz, 1H), 7.34 
(d, J = 7.7 Hz, 1H), 7.25 – 7.13 (m, 2H), 7.07 (t, J = 7.6 Hz, 1H), 5.04 (s, 2H); 13C NMR 
(62.5 MHz, CDCl3) δ 159.6, 134.9, 134.6, 134.3, 132.5, 130.8, 130.2, 124.1, 122.5, 122.0, 
116.6, 113.3, 102.9, 87.1, 84.2, 57.6; IR νmax/cm-1 (solid): 2236, 1600, 1558, 1490, 1474, 
1455, 1289, 1231, 1019, 786, 739, 683; HRMS m/z [M+H]+ Calculated for C16H11NOBr: 
312.0024; found 312.0028. 
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2-((3-(4-Bromophenyl)prop-2-yn-1-yl)oxy)benzonitrile (177j) 
 
Prepared according to the general procedure 2-(prop-2-ynyloxy)benzonitrile (176a) and 
from 4-bromoiodobenzene (585 mg, 2.07 mmol) for 45 min at 45 °C. Purification of the 
crude product by column chromatography on silica gel afforded the product as a drab 
solid (598 mg, 1.92 mmol, 93%). M. p. 108-109 °C; Rf = 0.40 (hexane-ethyl acetate, 4:1). 
1H NMR (250 MHz, CDCl3) δ 7.49 (t, J = 8.0 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 7.15 (dd, 
J = 18.8, 8.1 Hz, 3H), 6.98 (t, J = 7.4 Hz, 1H), 4.95 (s, 2H); 13C NMR (62.5 MHz, CDCl3) 
δ 159.6, 134.6, 134.3, 133.6, 132.0, 123.7, 122.0, 121.1, 116.7, 113.4, 102.9, 87.6, 84.1, 
57.7; IR νmax/cm-1 (solid): 2233, 1601, 1487, 1458, 1290, 1231, 1015, 826, 738; HRMS 
m/z [M+H]+ Calculated for C16H11NOBr: 312.0024; found 312.0027. 
2-((3-(4-Fluorophenyl)prop-2-yn-1-yl)oxy)benzonitrile (177k) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 4-fluoroiodobenzene (459 mg, 238 µl, 2.07 mmol) for 25 min at 30 °C. Purification 
of the crude product by column chromatography on silica gel afforded the product as a 
drab solid (378 mg, 1.51 mmol, 73%). M. p. 64-65 °C; Rf = 0.63 (hexane-ethyl acetate, 
7:3). 1H NMR (250 MHz, CDCl3) δ 7.56 – 7.42 (m, 2H), 7.31 (dd, J = 8.7, 5.4 Hz, 2H), 
7.12 (d, J = 8.8 Hz, 1H), 7.02 – 6.83 (m, 3H), 4.95 (s, 2H); 13C NMR (62.5 MHz, CDCl3) 
δ 159.7, 134.6, 134.3, 134.1, 121.9, 118.30, 118.25, 116.7, 116.3, 115.9, 113.4, 102.9, 
87.7, 82.7, 57.70; IR νmax/cm-1 (solid): 2227, 1700, 1559, 1541, 1508, 1491, 1458, 1231, 
1017, 838; HRMS m/z [M+H]+ Calculated for C16H11NOF: 252.0825; found 252.0820. 
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2-((3-(4-Iodophenyl)prop-2-yn-1-yl)oxy)benzonitrile (177l) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 1,4-diiodobenzene (340 mg, 1.03 mmol) for 30 min at 35 °C. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (114 
mg, 0.32 mmol, 31%). M. p. 123-125 °C; Rf = 0.64 (hexane-ethyl acetate, 4:1). 1H NMR 
(250 MHz, CDCl3) δ 7.64 – 7.44 (m, 4H), 7.16 – 6.93 (m, 4H), 4.95 (s, 2H). 13C NMR 
(62.5 MHz, CDCl3) δ 159.63, 137.94, 134.57, 134.32, 133.63, 121.98, 121.67, 116.63, 
113.38, 102.98, 95.49, 87.79, 84.31, 57.72. 
2-((3-(4-nitrophenyl)prop-2-yn-1-yl)oxy)benzonitrile (177m) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 1-iodo-4-nitrobenzene (515 mg; 2.07 mmol) for 30 min at 40 °C. Purification of the 
crude product by column chromatography on silica gel afforded the product as a light 
brown solid (535 mg, 1.92 mmol, 93%). M. p. 120-121 °C; Rf  = 0.24 (hexane-ethyl 
acetate, 4:1). 1H NMR (250 MHz, CDCl3): δ 8.09 (d, J = 8.8 Hz, 2H), 7.61 – 7.42 (m, 
4H), 7.11 (d, J = 8.5 Hz, 1H), 7.01 (t, J = 7.6 Hz, 1H), 5.01 (s, 1H); 13C NMR (62.5 MHz, 
CDCl3): δ 159.47, 147.91, 134.68, 134.42, 133.00, 128.94, 123.96, 122.26, 116.53, 
113.31, 103.06, 88.04, 86.61, 57.54. 
2-((3-(4-Acetylphenyl)prop-2-yn-1-yl)oxy)benzonitrile (177n) 
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Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and 4-iodoacetophenone (509 mg, 2.07 mmol) for 30 min at 40 °C. Purification of the 
crude product by column chromatography on silica gel afforded the product as a drab 
solid (508 mg, 1.85 mmol, 89%). M. p. 88-89 °C; Rf = 0.26 (hexane-ethyl acetate, 3:1). 
1H NMR (250 MHz, CDCl3) δ 7.80 (d, J = 7.4 Hz, 2H), 7.51 (d, J = 7.1 Hz, 2H), 7.41 (d, 
J = 7.3 Hz, 2H), 7.12 (d, J = 8.1 Hz, 1H), 6.99 (t, J = 6.8 Hz, 1H), 4.99 (s, 2H), 2.50 (s, 
3H); 13C NMR (62.5 MHz, CDCl3) δ 197.6, 159.6, 137.2, 134.6, 134.3, 132.3, 128.6, 
126.9, 122.1, 116.6, 113.4, 102.9, 87.8, 86.1, 57.6, 27.0; IR νmax/cm-1 (solid): 2233, 1685, 
1603, 1492, 1290, 1257, 1230, 1017, 844, 835, 734; HRMS m/z [M+H]+ Calculated for 
C18H14NO2: 276.1025; found 276.1018. 
4-(3-(2-Cyanophenoxy)prop-1-yn-1-yl)phenyl acetate (177o) 
 
Prepared according to the one-pot synthesis described for compound 177e from 2-
hydroxybenzonitrile (175a) and 4-iodophenyl acetate (611 mg, 2.33 mmol) for 5 h at 45 
°C. Purification of the crude product by column chromatography on silica gel afforded 
the product as a light brown solid (218 mg, 0.749 mmol, 32% for the two steps). M. p. 
102-103 °C; Rf  = 0.32 (hexane-ethyl acetate, 7:3). 1H NMR (250 MHz, CDCl3) δ 7.54 – 
7.41 (m, 2H), 7.33 (d, J = 8.6 Hz, 2H), 7.11 (d, J = 8.4 Hz, 1H), 7.03 – 6.90 (m, 3H), 4.94 
(s, 2H), 2.19 (s, 3H); 13C NMR (62.5 MHz, CDCl3) δ 169.5, 159.7, 151.4, 134.6, 134.3, 
133.4, 122.2, 121.9, 119.8, 116.7, 113.5, 102.8, 87.9, 83.0, 57.7, 21.5; IR νmax/cm-1 
(solid): 2234, 1769, 1599, 1506, 1492, 1229, 1198, 1016, 737; HRMS m/z [M+Na]+ 
Calculated for C18H13NO3Na: 314.0793; found 314.0791. 
Methyl 4-(3-(2-cyanophenoxy)prop-1-yn-1-yl)benzoate (177p) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and methyl-4-iodobenzoate (542 mg, 2.07 mmol) for 30 min at 35 °C. Purification of the 
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crude product by column chromatography on silica gel afforded the product as a drab 
solid (531 mg, 1.82 mmol, 88%). M. p. 94-95 °C; Rf = 0.50 (hexane-ethyl acetate, 7:3). 
1H NMR (250 MHz, CDCl3) δ 7.88 (d, J = 8.4 Hz, 2H), 7.49 (t, J = 7.7 Hz, 2H), 7.38 (d, 
J = 8.4 Hz, 2H), 7.12 (d, J = 8.5 Hz, 1H), 6.98 (t, J = 7.6 Hz, 1H), 4.98 (s, 2H), 3.82 (s, 
3H); 13C NMR (62.5 MHz, CDCl3) δ 166.7, 159.6, 134.6, 134.3, 132.1, 130.6, 129.8, 
126.8, 122.0, 116.6, 113.4, 102.9, 87.8, 85.8, 57.6, 52.7; IR νmax/cm-1 (solid): 2235, 1723, 
1601, 1491, 1287, 1231, 1111, 1020, 860, 737.698; HRMS m/z [M+H]+ Calculated for 
C18H14NO3: 292.0974; found 292.0975. 
N-(2-(3-(2-Cyanophenoxy)prop-1-yn-1-yl)phenyl)acetamide (177q) 
 
Prepared according to the general procedure from 2-(prop-2-ynyloxy)benzonitrile (176a) 
and N-(2-iodophenyl)acetamide (362 mg, 2.30 mmol) for 2 h at 30-35 °C. Purification of 
the crude product by column chromatography on silica gel afforded the product as a drab 
solid (400 mg, 1.38 mmol, 60%). M. p. 119-120 °C; Rf = 0.35 (hexane-ethyl acetate, 3:2); 
1H NMR (250 MHz, CDCl3) δ 8.24 (d, J = 8.3 Hz, 1H), 7.64 (s, 1H), 7.57 – 7.46 (m, 2H), 
7.33 – 7.20 (m, 2H), 7.11 (d, J = 8.4 Hz, 1H), 6.97 (dt, J = 16.3, 7.5 Hz, 2H), 5.05 (s, 2H), 
1.99 (s, 3H); 13C NMR (62.5 MHz, CDCl3) δ 168.8, 159.4, 139.6, 134.7, 134.5, 132.3, 
130.7, 123.8, 122.3, 120.1, 116.5, 113.2, 110.9, 103.0, 89.8, 84.2, 57.7, 25.1; IR νmax/cm-
1 (solid); 2233, 1699, 1600, 1581, 1517, 1492, 1446, 1301, 1231, 1016761, 740; HRMS 
m/z [M+Na]+ Calculated for C18H14N2O2Na: 313.0953; found 313.0940. 
5-Chloro-2-(3-phenylprop-2-ynyloxy)benzonitrile (177r) 
 
Prepared according to the general procedure from 5-chloro-2-(prop-2-
ynyloxy)benzonitrile (176b) (382 mg, 2.00 mmol) and iodobenzene (340 mg, 1.67 mmol, 
186 µl) for 30 min at 30-35 °C. Purification of the crude product by column 
chromatography on silica gel afforded the product as a drab solid ( 236 mg, 0.884 mmol, 
44%). M. p. 79-80 °C; Rf  = 0.38 (hexane-ethyl acetate, 7:1). 1H NMR (250 MHz, CDCl3) 
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δ 7.49 – 7.37 (m, 2H), 7.37 – 7.29 (m, 2H), 7.28 – 7.20 (m, 3H), 7.09 (dd, J = 8.2, 1.2 Hz, 
1H), 4.95 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 158.4, 134.6, 133.5, 132.2, 129.5, 
128.8, 126.8, 122.0, 115.4, 114.9, 104.3, 89.2, 82.4, 58.2; IR νmax/cm-1 (solid): 2237, 
1485, 1285, 1235, 1138, 1010, 1000, 817, 738, 694; HRMS m/z [M+Na]+ Calculated for 
C16H10NOClNa: 290.0349; found 290.0359. 
5-Bromo-2-(3-phenylprop-2-ynyloxy)benzonitrile (177s) 
 
Prepared according to the general procedure from 5-bromo-2-(prop-2-
ynyloxy)benzonitrile (176c) (354 mg, 1.50 mmol) and iodobenzene (255 mg, 1.25 mmol, 
140 µl) for 30 min at 30-35 °C. Purification of the crude product by column 
chromatography on silica gel afforded the product as a white crystalline solid (225 mg, 
0.723 mmol, 58%). M. p. 86-87 °C; Rf  = 0.33 (hexane-ethyl acetate, 5:1). 1H NMR (250 
MHz, CDCl3) δ 7.66 – 7.50 (m, 1H), 7.39 – 7.27 (m, 1H), 7.28 – 7.15 (m, 1H), 7.09 – 
6.97 (m, 1H), 4.95 (s, 1H); 13C NMR (62.5 MHz, CDCl3) δ 158.9, 137.4, 136.4, 132.2, 
129.5, 128.8, 121.9, 115.3, 113.5, 104.7, 89.2, 82.3, 58.1; IR νmax/cm-1 (solid): 2960, 
2234, 1487, 1285, 1233, 1133, 1011, 813, 692; HRMS m/z [M+Na]+ Calculated for 
C16H10NOBrNa: 333.9843; found 333.9856. 
4-Bromo-2-(3-phenylprop-2-ynyloxy)benzonitrile (177t) 
 
Prepared according to the one-pot synthesis described for compound 177e from 4-bromo-
2-hydroxybenzonitrile (500 mg, 2.53 mmol) and iodobenzene (396 mg, 1.94 mmol, 217 
µl) for 3 h at 45-50 °C. Purification of the crude product by column chromatography on 
silica gel afforded the product as a drab solid (112 mg, 0.360 mmol, 20%). M. p. 114-115 
°C; Rf  = 0.36 (hexane-ethyl acetate, 5:1). 1H NMR (250 MHz, CDCl3) δ 7.41 – 7.28 (m, 
4H), 7.27 – 7.15 (m, 4H), 7.15 – 7.05 (m, 1H), 4.94 (s, 2H); 13C NMR (62.5 MHz, CDCl3) 
δ 160.0, 134.9, 132.3, 129.6, 129.0, 128.8, 125.3, 121.9, 117.4, 116.0, 102.0, 89.5, 82.1, 
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58.2; IR νmax/cm-1 (solid): 2234, 1587, 1484, 1230, 1012, 1000, 854, 815, 738, 693; 
HRMS m/z [M+Na]+ Calculated for C16H10NOBrNa: 333.9843; found 333.9853. 
4-((3-Phenylprop-2-yn-1-yl)oxy)-[1,1'-biphenyl]-3-carbonitrile (177u) 
 
5-Bromo-2-(3-phenylprop-2-ynyloxy)benzonitrile (177s) (156 mg, 0.5 mmol), 
phenylboronic acid (183 mg, 0.75 mmol), palladium acetate (5.61 mg, 0.025 mmol, 5 
mol%) and tri-tert-butylphosphonium tetrafluoroborate (7.25 mmol, 0.025 mmol, 5 
mol%) and potassium carbonate (138 mg, 1.00 mmol) were added to a 20 ml round 
bottom flask and the system was charged with argon. Tetrahydrofurane (2.50 ml) and 
distilled water (2.50 ml) were added dropwise under argon atmosphere then the reaction 
mixture was stirred at 50 °C for 1.5 h. The reaction mixure was diluted with distilled 
water (10 ml) and extracted with ethyl acetate (4 x 10 ml). The combined organics were 
washed with brine (1 x 30 ml), dried over anhydrous magnesium sulfate, filtered and 
evaporated. Purification of the crude product by column chromatography on silica gel 
afforded the product as a drab oil (135 mg, 0.438 mmol, 86%). Rf  = 0.35 (hexane-ethyl 
acetate, 5:1). 1H NMR (250 MHz, CDCl3) δ 7.70 – 7.61 (m, 2H), 7.43 – 7.37 (m, 2H), 
7.40 – 7.25 (m, 4H), 7.29 – 7.15 (m, 5H), 4.97 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 
159.0, 138.9, 135.3, 133.1, 132.6, 132.2, 129.5, 129.4, 128.8, 128.2, 127.1, 122.2, 116.7, 
113.9, 103.3, 88.9, 82.9, 58.0; IR νmax/cm-1 (solid): 2231, 1487, 1282, 1236, 1129, 1013, 
999, 763, 738, 692; HRMS m/z [M+Na]+ Calculated for C22H15NONa: 332.1051; found 
332.1059. 
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7. 12. Synthesis and analitical data of 7-Aryl-6H-chromeno[4,3-
b]quinolines 
General procedure 4 for the synthesis of 7-aryl-6H-chromeno[4,3-b]quinolines 
2-(3-Phenylprop-2-ynyloxy)benzonitrile (177a) (117 mg, 0.500 mmol), diaryl iodonium 
salt (0.600 mmol, 1.2 eq.) and copper(I)chloride (4.96 mg; 0.050 mmol, 10 mol%) were 
added to a 4 ml vial then the system was charged with argon. Ethyl acetate (1 ml) was 
added under argon atmosphere then the reaction mixture was stirred at 75°C for the 
appropriate time. Saturated sodium hydrogen carbonate solution (10 ml) was added to the 
mixture, the aqueous layer was extracted with dichloromethane (4 x 10 ml) the combined 
organics were washed with brine (1 x 25 ml), dried over anhydrous magnesium sulfate, 
filtered and evaporated. The crude residue was purified by column chromatography. 
7-Phenyl-6H-chromeno[4,3-b]quinoline (178aa) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and phenyl(mesityl)iodonium trifluoromethanesulfonate 
(46a) (283 mg, 0.600 mmol) for 1 h. Purification of the crude product by column 
chromatography on silica gel afforded the product as a drab solid (120 mg, 0.388 mmol, 
78%). M. p. 159-160 °C; Rf  = 0.45 (hexane-ethyl acetate, 10:1). 1H NMR (250 MHz, 
CDCl3) δ 8.42 (d, J = 6.7 Hz, 1H), 8.05 (d, J = 7.8 Hz, 1H), 7.62 – 7.48 (m, 1H), 7.46 – 
7.29 (m, 4H), 7.30 – 7.11 (m, 4H), 7.09 – 6.97 (m, 1H), 6.84 (d, J = 7.4 Hz, 1H), 4.96 (s, 
2H).; 13C NMR (62.5 MHz, CDCl3) δ 157.7, 149.1, 148.4, 144.1, 135.3, 132.3, 130.0, 
129.73, 129.65, 129.2, 128.9, 127.5, 126.6, 126.5, 126.21, 123.9, 123.2, 122.9, 117.6, 
67.1; IR νmax/cm-1 (solid): 2927, 2910, 1583, 1560, 1506, 1490, 1465, 1222, 1044, 769, 
737, 700; HRMS m/z [M+H]+ Calculated for C22H16NO: 310.1232; found 310.1236. 
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11-Methyl-7-phenyl-6H-chromeno[4,3-b]quinoline (178ab) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and 2-methylphenyl(mesityl)iodonium 
trifluoromethanesulfonate (46b) (292 mg, 0.600 mmol) for 5 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (52.0 
mg, 0.161 mmol, 32%). M. p. 124-125 °C; Rf = 0.30 (hexane-ethyl acetate, 30:1). 1H 
NMR (250 MHz, CDCl3): δ= 8.48 (dd, J = 7.7, 1.3 Hz, 1H), 7.39 (d, J = 5.6 Hz, 4H), 7.30 
– 6.98 (m, 7H), 6.84 (d, J = 8.1 Hz, 1H), 4.96 (s, 2H), 2.81 (s, 3H); 13C NMR (62.5 MHz, 
CDCl3): δ= 157.6, 147.6, 147.3, 144.2, 137.9, 135.8, 132.0, 129.9, 129.7, 129.1, 128.8, 
127.4, 126.3, 126.2, 124.5, 124.3, 122.8, 122.7, 117.5, 67.2, 18.6; IR νmax/cm-1 (solid): 
2928, 2365, 1588, 1489, 1394, 1369, 1222, 1040, 769, 741; HRMS m/z [M+H]+ 
Calculated for C23H18NO: 324.1388; found 324.1392. 
8-Methyl-7-phenyl-6H-chromeno[4,3-b]quinoline and 10-methyl-7-phenyl-6H-
chromeno[4,3-b]quinoline (178ac) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and 3-methylphenyl(mesityl)iodonium 
trifluoromethanesulfonate (46c) (292 mg, 0.600 mmol) for 20 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a drab 
solid (105 mg, 0.325 mmol, 65%). M. p. 99-100 °C; Rf = 0.35 (hexane-ethyl acetate, 25:1). 
1H NMR (250 MHz, CDCl3) δ 8.52 – 8.28 (m, 1H), 7.94 (d, J = 8.3 Hz, 0.5H), 7.84 (s, 
0.5H), 7.50 – 6.94 (m, 9H), 6.82 (t, J = 7.6 Hz, 1H), 4.94 (s, 1H), 4.77 (s, 1H), 2.40 (s, 
1.5H), 1.77 (s, 1.5H); 13C NMR (62.5 MHz, CDCl3) δ 157.7, 157.6, 149.6, 149.0, 148.6, 
147.9, 144.3, 144.0, 140.0, 139.4, 136.1, 135.5, 132.1, 130.3, 129.7, 129.5, 129.3, 129.2, 
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129.13, 129.06, 128.91, 128.87, 128.8, 128.6, 126.2, 126.1, 126.0, 125.5, 124.4, 124.0, 
123.6, 122.83, 122.78, 122.4, 117.5, 117.4, 67.2, 67.1, 24.5, 22.1; IR νmax/cm-1 (solid): 
2928, 2366, 2340, 1701, 1577, 1558, 1539, 1506, 1487, 1219, 1042, 738; HRMS m/z 
[M+H]+ Calculated for C23H18NO: 324.1388; found 324.1392. 
9-Methyl-7-phenyl-6H-chromeno[4,3-b]quinoline (178ad) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and 4-methylphenyl(mesityl)iodonium 
trifluoromethanesulfonate (46d) (292 mg, 0.600 mmol) for 30 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a drab 
solid (81.5 mg, 0.252 mmol, 50%). M. p. 193-194 °C; Rf = 0.35 (hexane-ethyl acetate, 
15:1). 1H NMR (250 MHz, CDCl3) δ 8.41 (d, J = 7.3 Hz, 1H), 7.96 (d, J = 8.5 Hz, 1H), 
7.53 – 7.29 (m, 4H), 7.28 – 6.96 (m, 5H), 6.84 (d, J = 8.0 Hz, 1H), 4.94 (s, 2H), 2.26 (s, 
3H); 13C NMR (62.5 MHz, CDCl3) δ 157.6, 148.2, 146.9, 143.5, 136.6, 135.5, 132.0, 
129.7, 129.2, 128.9, 127.4, 126.1, 125.4, 124.0, 123.2, 122.9, 117.5, 67.2, 22.2; IR 
νmax/cm-1 (solid): 2924, 2367, 2340, 1585, 1495, 1467, 1221, 1049, 1000, 831, 737; 
HRMS m/z [M+H]+ Calculated for C23H18NO: 324.1388; found 324.1390. 
9-Chloro-7-phenyl-6H-chromeno[4,3-b]quinoline (178af) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and (4-chlorophenyl)(mesityl)iodonium 
trifluoromethanesulfonate (46f) (302 mg, 0.600 mmol) for 2 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a white solid 
(95.0 mg, 0.277 mmol, 55%). M. p. 174-175 °C; Rf = 0.38 (hexane-ethyl acetate, 20:1). 
1H NMR (250 MHz, CDCl3) δ 8.47 – 8.25 (m, 1H), 7.95 (d, J = 8.9 Hz, 1H), 7.54 – 7.36 
(m, 4H), 7.30 (d, J = 2.1 Hz, 1H), 7.28 – 7.20 (m, 1H), 7.19 – 7.10 (m, 2H), 7.03 (t, J = 
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7.4 Hz, 1H), 6.84 (d, J = 8.1 Hz, 1H), 4.94 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 157.6, 
149.3, 146.8, 143.3, 134.6, 132.5, 132.4, 131.6, 130.6, 129.5, 129.4, 129.3, 128.1, 126.1, 
125.3, 124.0, 123.5, 122.9, 117.6, 67.0; IR νmax/cm-1 (solid): 2369, 1585, 1489, 1373, 
1223, 1047, 833, 737; HRMS m/z [M+H]+ Calculated for C22H15NOCl: 344.0842; found 
344.0844. 
8-Bromo-7-phenyl-6H-chromeno[4,3-b]quinoline and 10-bromo-7-phenyl-6H-
chromeno[4,3-b]quinoline (178ah) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and 3-bromophenyl(mesityl)iodonium 
trifluoromethanesulfonate (46h) (331 mg, 0.600 mmol) for 3 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (94.0 
mg, 0.243 mmol, 49%). M. p. 120-121 °C; Rf  = 0.40 (hexane-ethyl acetate, 20:1).1H 
NMR (250 MHz, CDCl3) δ 8.49 (d, J = 7.7 Hz, 1H), 8.36 (s, 0.4H), 8.17 (d, J = 8.0 Hz, 
0.6H), 7.72 (d, J = 7.5 Hz, 1H), 7.63 – 7.09 (m, 8H), 7.05 – 6.87 (m, 1H), 5.07 (s, 1H), 
4.94 (s, 1H); 13C NMR (62.5 MHz, CDCl3) δ 157.7, 157.6, 150.0, 149.9, 149.0, 148.8, 
144.19, 144.19, 136.8, 134.7, 134.3, 134.2, 132.68, 132.65, 132.2, 131.0, 129.94, 129.90, 
129.8, 129.6, 129.3, 129.2, 128.79, 128.75, 128.0, 126.3, 126.2, 125.8, 125.5, 125.1, 
124.0, 123.5, 123.1, 123.0, 122.9, 119.5, 117.6, 117.5, 67.3, 67.0; IR νmax/cm-1 (solid): 
2366, 2342, 1584, 1570, 1487, 1245, 1221, 1043, 737; HRMS m/z [M+H]+ Calculated 
for C22H15NOBr: 388.0337; found 388.0339. 
9-Bromo-7-phenyl-6H-chromeno[4,3-b]quinoline (178ai) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and (4-bromophenyl)(mesityl)iodonium 
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trifluoromethanesulfonate (46i) (331 mg, 0.600 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a white solid 
(90.0 mg, 0.232 mmol, 47%). M. p. 199-200 °C; Rf = 0.38 (hexane-ethyl acetate, 20:1). 
1H NMR (250 MHz, CDCl3) δ 8.38 (d, J = 7.4 Hz, 1H), 7.91 (d, J = 8.9 Hz, 1H), 7.60 
(dd, J1 = 7.5 Hz, J2 = 2.5 Hz, 1H), 7.52 – 7.34 (m, 4H), 7.25 (t, J = 7.6 Hz, 1H), 7.20 – 
7.10 (m, 2H), 7.04 (t, J = 7.4 Hz, 1H), 6.84 (d, J = 8.1 Hz, 1H), 4.95 (s, 2H); 13C NMR 
(62.5 MHz, CDCl3) δ 157.7, 149.4, 146.9, 143.3, 134.5, 133.2, 132.6, 131.6, 129.5, 129.4, 
129.3, 128.63, 128.59, 126.2, 124.0, 123.5, 123.0, 120.7, 117.6, 67.0; IR νmax/cm-1 (solid): 
2365, 2343, 1580, 1560, 1489, 1223, 1044, 832, 737; HRMS m/z [M+H]+ Calculated for 
C22H15NOBr: 388.0337; found 388.0342. 
8-Fluoro-7-phenyl-6H-chromeno[4,3-b]quinoline and 10-fluoro-7-phenyl-6H-
chromeno[4,3-b]quinoline (178ak) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and 3-fluorophenyl(mesityl)iodonium 
trifluoromethanesulfonate (46k) (294 mg, 0.600 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (106 
mg, 0.324 mmol, 65%). M. p. 141-142 °C; Rf  = 0.36 (hexane-ethyl acetate, 15:1).1H 
NMR (250 MHz, CDCl3) δ 8.52 (d, J = 7.7 Hz, 1H), 8.00 (d, J = 8.5 Hz, 0.4H), 7.81 (dd, 
J = 10.2, 2.7 Hz, 0.6H), 7.64 – 6.83 (m, 10H), 5.09 (s, 1H), 5.01 (s, 1H); 13C NMR (62.5 
MHz, CDCl3) δ 165.4, 157.8, 157.7, 150.2, 149.7, 144.3, 141.4, 137.7, 137.6, 135.0, 
132.7, 132.6, 129.54, 129.47, 129.32, 129.26, 129.1, 128.8, 128.7, 128.5, 128.21, 128.15, 
126.4, 126.33, 126.28, 124.8, 124.5, 123.6, 123.3, 122.9, 122.53, 122.50, 117.6, 116.9, 
116.5, 113.6, 113.3, 112.1, 111.7, 67.0, 66.7; IR νmax/cm-1 (solid): 2366, 2342, 1583, 
1487, 1468, 1222, 1137, 1043, 738; HRMS m/z [M+H]+ Calculated for C22H15NOF: 
328.1138; found 328.1139. 
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9-Fluoro-7-phenyl-6H-chromeno[4,3-b]quinoline (178al) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and (4-fluorophenyl)(mesityl)iodonium 
trifluoromethanesulfonate (46l) (294 mg, 0.600 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a light yellow 
solid (90.0 mg, 0.274 mmol, 55%). M. p. 140-141 °C; Rf  = 0.35 (hexane-ethyl acetate, 
15:1). 1H NMR (250 MHz, CDCl3)
 δ 8.35 (d, J = 7.6 Hz, 1H), 8.00 (dd, J = 9.1, 5.6 Hz, 
1H), 7.50 – 7.34 (m, 3H), 7.32 – 7.07 (m, 4H), 7.02 (t, J = 7.5 Hz, 1H), 6.94 (dd, J = 10.0, 
2.5 Hz, 1H), 6.82 (d, J = 8.1 Hz, 1H), 4.93 (s, 2H). 13C NMR (62.5 MHz, CDCl3) δ 162.8, 
158.8, 157.5, 148.6, 148.5, 145.4, 143.6, 143.5, 134.8, 132.4, 132.3, 129.5, 129.4, 129.2, 
128.3, 128.2, 126.0, 123.9, 123.6, 122.9, 120.0, 119.6, 117.6, 110.2, 109.8, 67.1; IR 
νmax/cm-1 (solid): 2367, 2339, 1558, 1489, 1222, 1044, 833, 769; HRMS m/z [M+H]+ 
Calculated for C22H15NOF: 328.1138; found 328.1144. 
7-Phenyl-6H-chromeno[4,3-b]quinoline-9-carboxylate (178an) 
 
Prepared according to the general procedure from 2-(3-phenylprop-2-
ynyloxy)benzonitrile (177a) and 4-ethoxycarbonyl(mesityl)iodonium 
trifluoromethanesulfonate (46n) (327 mg, 0.600 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (133 
mg, 0.341 mmol, 70%). M. p. 146-147 °C; Rf  = 0.30 (hexane-ethyl acetate, 10:1). 1H 
NMR (250 MHz, CDCl3) δ 8.40 (d, J = 7.8 Hz, 1H), 8.22 – 7.95 (m, 3H), 7.44 (s, 3H), 
7.31 – 7.10 (m, 3H), 7.04 (t, J = 7.1 Hz, 1H), 6.84 (d, J = 7.8 Hz, 1H), 4.98 (s, 2H), 4.22 
(q, J = 7.1 Hz, 2H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (62.5 MHz, CDCl3) δ 166.6, 157.9, 
151.0, 150.2, 145.5, 134.4, 132.9, 130.1, 129.6, 129.33, 129.27, 128.2, 126.7, 126.4, 
123.9, 123.5, 123.0, 117.7, 67.0, 61.6, 14.7; IR νmax/cm-1 (solid): 2928, 2370, 1715, 1586, 
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1467, 1293, 1251, 1226, 1103, 1048, 848, 737; HRMS m/z [M+H]+ Calculated for 
C25H20NO3: 382.1443; found 382.1444. 
7-(Thiophen-2-yl)-6H-chromeno[4,3-b]quinoline (178ba) 
 
Prepared according to the general procedure from 2-((3-(thiophen-2-yl)prop-2-yn-1-
yl)oxy)benzonitrile (177b) (120 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 40 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a yellow 
solid (75.0 mg, 0.238 mmol, 48%). M. p. 147-148 °C; Rf  = 0.35 (hexane-ethyl acetate, 
15:1). 1H NMR (250 MHz, CDCl3) δ 8.40 (dd, J = 7.8, 1.7 Hz, 1H), 8.05 (d, J = 8.4 Hz, 
1H), 7.66 – 7.49 (m, 2H), 7.44 (d, J = 5.1 Hz, 1H), 7.37 – 7.17 (m, 2H), 7.18 – 7.09 (m, 
1H), 7.05 (t, J = 7.5 Hz, 1H), 6.97 (d, J = 2.8 Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H), 5.09 (s, 
2H), 13C NMR (62.5 MHz, CDCl3) δ 157.6, 149.0, 148.3, 137.0, 134.6, 132.3, 130.0, 
129.9, 129.3, 128.2, 128.0, 127.9, 126.9, 126.3, 126.2, 125.2, 123.7, 122.9, 117.6, 67.2; 
IR νmax/cm-1 (solid): 2927, 2367, 2341, 1586, 1558, 1496, 1465, 1215, 1042, 768, 704; 
HRMS m/z [M+H]+ Calculated for C20H14NOS: 316.0796; found 316.0800. 
7-(p-Tolyl)-6H-chromeno[4,3-b]quinoline (178ea) 
 
Prepared according to the general procedure from 2-((3-(p-tolyl)prop-2-yn-1-
yl)oxy)benzonitrile (178e) (124 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 35 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a yellow 
solid (115 mg, 0.356 mmol, 71%). M. p. 137-138 °C; Rf  = 0.30 (hexane-ethyl acetate, 
15:1). 1H NMR (250 MHz, CDCl3) δ 8.60 (dd, J1 = 7.68 Hz, J2 = 1.25 Hz 1H), 8.22 (d, 
J = 8.4 Hz, 1H), 7.68 (t, J = 7.1 Hz, 1H), 7.55 (d, J = 8.1 Hz, 1H), 7.46 – 7.31 (m, 4H), 
7.27 – 7.13 (m, 3H), 7.01 (d, J = 8.0 Hz, 1H), 5.14 (s, 2H), 2.50 (s, 3H); 13C NMR (62.5 
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MHz, CDCl3) δ 157.7, 149.1, 148.4, 144.3, 138.8, 132.21, 132.20, 130.0, 129.9, 129.7, 
129.6, 127.7, 126.6, 126.5, 126.2, 124.0, 123.3, 122.9, 117.6, 67.2, 21.8; IR νmax/cm-1 
(solid): 2927, 2363, 2342, 1587, 1495, 1465, 1223, 1043, 769, 745; HRMS m/z [M+H]+ 
Calculated for C23H18NO: 324.1388; found 324.1395. 
7-(4-Methoxyphenyl)-6H-chromeno[4,3-b]quinoline (178fa) 
 
Prepared according to the general procedure from 2-((3-(4-methoxyphenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177f) (132 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 40 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a yellow 
solid (59 mg, 0.172 mmol, 34%). M. p. 164-165 °C; Rf  = 0.29 (hexane-ethyl acetate, 
10:1). 1H NMR (250 MHz, CDCl3) δ 8.42 (d, J = 7.7 Hz, 1H), 8.06 (d, J = 8.4 Hz, 1H), 
7.54 (t, J = 7.6 Hz, 1H), 7.42 (d, J = 8.3 Hz, 1H), 7.27 (t, J = 8.9 Hz, 2H), 7.16 – 6.98 (m, 
3H), 6.95 (d, J = 7.6 Hz, 2H), 6.86 (d, J = 7.8 Hz, 1H), 5.01 (s, 2H), 3.78 (s, 3H); 13C 
NMR (62.5 MHz, CDCl3) δ 160.1, 157.7, 149.1, 148.4, 144.0, 132.2, 130.9, 130.0, 129.7, 
127.8, 127.2, 126.6, 126.5, 126.2, 124.0, 123.5, 122.9, 117.5, 114.6, 67.2, 55.8; IR 
νmax/cm-1 (solid): 2908, 2368, 2341, 1519, 1499, 1248, 1042, 737; HRMS m/z [M+H]+ 
Calculated for C23H18NO2: 340.1338; found 340.1336. 
7-(2-Chlorophenyl)-6H-chromeno[4,3-b]quinoline (178ga) 
 
Prepared according to the general procedure from 2-((3-(2-chlorophenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177g) (134 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a yellow solid 
(125 mg, 0.364 mmol, 73%). M. p. 112-113 °C; Rf  = 0.29 (hexane-ethyl acetate, 15:1). 
1H NMR (250 MHz, CDCl3) δ 8.61 (d, J = 7.7 Hz, 1H), 8.24 (d, J = 8.4 Hz, 1H), 7.71 (t, 
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J = 7.6 Hz, 1H), 7.61 (d, J = 7.4 Hz, 1H), 7.54 – 7.26 (m, 6H), 7.21 (t, J = 7.6 Hz, 1H), 
7.02 (d, J = 8.1 Hz, 1H), 5.09 (q, J = 14.1 Hz, 2H); 13C NMR (62.5 MHz, CDCl3) δ 157.7, 
149.1, 148.5, 141.0, 134.2, 134.1, 132.3, 131.3, 130.6, 130.4, 130.2, 129.9, 127.6, 127.0, 
126.9, 126.2, 126.0, 123.8, 122.9, 117.7, 67.0; IR νmax/cm-1 (solid): 2927, 2366, 2339, 
1585, 1473, 1221, 1042, 769, 741; HRMS m/z [M+H]+ Calculated for C22H15NOCl: 
344.0842; found 344.0845. 
7-(4-Chlorophenyl)-6H-chromeno[4,3-b]quinoline (178ha) 
 
Prepared according to the general procedure from 2-((3-(4-chlorophenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177h) (130 mg, 0.489 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (277 mg, 0.587 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (121 
mg, 0.353 mmol, 75%). M. p. 202-203 °C; Rf  = 0.38 (hexane-ethyl acetate, 15:1). 1H 
NMR (250 MHz, CDCl3) δ 8.54 (d, J = 6.9 Hz, 1H), 8.19 (d, J = 7.9 Hz, 1H), 7.81 – 7.63 
(m, 1H), 7.55 (d, J = 7.1 Hz, 2H), 7.49 – 7.32 (m, 3H), 7.31 – 7.12 (m, 3H), 6.99 (d, J = 
7.5 Hz, 1H), 5.09 (s, 2H). 13C NMR (62.5 MHz, CDCl3) δ 157.6, 149.1, 148.3, 142.8, 
135.2, 133.6, 132.4, 131.1, 130.1, 129.9, 129.5, 127.2, 126.8, 126.2, 123.7, 123.2, 123.0, 
117.6, 67.0. IR νmax/cm-1 (solid):2973, 2370, 2341, 1588, 1488, 1221, 1090, 1044, 837, 
770; HRMS m/z [M+H]+ Calculated for C22H15NOCl: 344.0842; found 344.0844. 
7-(3-Bromophenyl)-6H-chromeno[4,3-b]quinoline (178ia) 
 
Prepared according to the general procedure from 2-((3-(3-bromophenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177i) (156 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 30 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a drab 
solid (129 mg, 0.333 mmol, 67%). M. p. 162-163 °C; Rf  = 0.33 (hexane-ethyl acetate, 
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15:1).1H NMR (250 MHz, CDCl3) δ 8.54 (d, J = 7.5 Hz, 1H), 8.19 (d, J = 8.3 Hz, 1H), 
7.68 (d, J = 7.3 Hz, 2H), 7.58 – 7.33 (m, 5H), 7.31 – 7.13 (m, 2H), 6.99 (d, J = 8.0 Hz, 
1H), 5.09 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 157.6, 149.1, 148.3, 142.3, 137.4, 
132.5, 132.4, 132.1, 130.8, 130.1, 129.9, 128.3, 127.0, 126.9, 126.18, 126.15, 123.7, 
123.4, 123.2, 123.0, 117.6, 66.9; IR νmax/cm-1 (solid): 2928, 2368, 2341, 1584, 1560, 
1472, 1223, 1044, 770, 701; HRMS m/z [M+H]+ Calculated for C22H15NOBr: 388.0337; 
found 388.0342. 
7-(4-Bromophenyl)-6H-chromeno[4,3-b]quinoline (178ja) 
 
Prepared according to the general procedure from 2-((3-(4-bromophenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177j) (156 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (140 
mg, 0.362 mmol, 72%). M. p. 183-184 °C; Rf  = 0.33 (hexane-ethyl acetate, 15:1).1H 
NMR (250 MHz, CDCl3) δ 8.54 (d, J = 7.4 Hz, 1H), 8.19 (d, J = 8.3 Hz, 1H), 7.70 (d, J 
= 7.7 Hz, 3H), 7.52 – 7.30 (m, 3H), 7.20 (d, J = 7.5 Hz, 3H), 6.99 (d, J = 8.0 Hz, 1H), 
5.09 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 157.6, 149.1, 148.3, 142.8, 134.1, 132.5, 
132.4, 131.3, 130.1, 129.9, 127.1, 126.8, 126.18, 126.16, 123.7, 123.3, 123.2, 123.0, 
117.6, 67.0; IR νmax/cm-1 (solid): 2928, 2366, 2341, 1487, 1222, 1043, 1014, 835, 771, 
701; HRMS m/z [M+H]+ Calculated for C22H15NOBr: 388.0337; found 388.0338. 
7-(4-Fluorophenyl)-6H-chromeno[4,3-b]quinoline (178ka) 
 
Prepared according to the general procedure from 2-((3-(4-fluorophenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177k) (81.0 mg, 0.323 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (183 mg, 0.387 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a yellow solid 
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(63.0 mg, 0.193 mmol, 60%). M. p. 181-182 °C; Rf  = 0.28 (hexane-ethyl acetate, 15:1). 
1H NMR (250 MHz, CDCl3) δ 8.55 (d, J = 6.8 Hz, 1H), 8.19 (d, J = 7.8 Hz, 1H), 7.79 – 
7.60 (m, 1H), 7.53 – 7.15 (m, 8H), 6.99 (d, J = 7.6 Hz, 1H), 5.09 (s, 2H). 13C NMR (62.5 
MHz, CDCl3) δ 157.6, 149.1, 148.3, 143.0, 132.4, 131.5, 131.4, 131.1, 131.0, 130.0, 
129.8, 127.4, 126.7, 126.2, 123.8, 123.4, 123.0, 117.6, 116.5, 116.2, 67.0; IR νmax/cm-1 
(solid): 2932, 2365, 2342, 1496, 1221, 1044, 847, 769, 735; HRMS m/z [M+H]+ 
Calculated for C22H15NOF: 328.1138; found 328.1139. 
7-(4-Fluorophenyl)-6H-chromeno[4,3-b]quinoline (178la) 
 
Prepared according to the general procedure from 2-((3-(4-iodophenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177l) (85.0 mg, 0.237 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (134 mg, 0.284 mmol) for 50 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a yellow 
solid (55.2 mg, 0.127 mmol, 54%). Rf  = 0.40 (hexane-ethyl acetate, 10:1). 
1H NMR (250 
MHz, CDCl3) δ 8.42 (dd, J = 7.7, 1.8 Hz, 1H), 8.07 (d, J = 8.4 Hz, 1H), 7.80 (dd, J = 9.0, 
2.6 Hz, 2H), 7.64 – 7.52 (m, 1H), 7.39 – 7.21 (m, 3H), 7.07 (t, J = 7.5 Hz, 1H), 6.91 (dd, 
J = 18.6, 8.2 Hz, 3H), 4.98 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 157.60, 149.10, 
148.40, 142.77, 138.39, 134.77, 132.34, 131.50, 130.12, 129.86, 127.03, 126.77, 126.16, 
123.77, 123.08, 122.96, 117.58, 94.99, 66.97. 
1-(4-(6H-chromeno[4,3-b]quinolin-7-yl)phenyl)ethan-1-one (178na) 
 
Prepared according to the general procedure from 2-((3-(4-acetylphenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177n) (176 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 75 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a yellow 
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solid (126 mg, 0.359 mmol, 72%). M. p. 185-186 °C; Rf  = 0.31 (hexane-ethyl acetate, 
5:1). 1H NMR (250 MHz, CDCl3) δ 8.53 (d, J = 7.7 Hz, 1H), 8.27 – 8.04 (m, 3H), 7.67 
(dt, J = 8.5, 4.2 Hz, 1H), 7.51 – 7.30 (m, 5H), 7.17 (t, J = 7.5 Hz, 1H), 6.96 (d, J = 8.1 
Hz, 1H), 5.05 (s, 2H), 2.70 (s, 3H); 13C NMR (62.5 MHz, CDCl3) δ 197.9, 157.6, 149.0, 
148.3, 142.8, 140.2, 137.5, 132.4, 130.1, 130.0, 129.1, 126.9, 126.8, 126.2, 126.1, 123.7, 
122.99, 122.96, 117.6, 66.9, 27.2; IR νmax/cm-1 (solid): 2928, 2364, 2341, 1685, 1586, 
1468, 1359, 1222, 1045, 769; HRMS m/z [M+H]+ Calculated for C24H18NO2: 352.1338; 
found 352.1342. 
4-(6H-chromeno[4,3-b]quinolin-7-yl)phenyl acetate (178oa) 
 
Prepared according to the general procedure from 4-(3-(2-cyanophenoxy)prop-1-yn-1-
yl)phenyl acetate (177o) (146 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 2 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a yellow solid 
(88.0 mg, 0.240 mmol, 48%). M. p. 124-125 °C; Rf  = 0.32 (hexane-ethyl acetate, 5:1). 1H 
NMR (250 MHz, CDCl3) δ 8.42 (dd, J = 7.7, 1.4 Hz, 1H), 8.06 (d, J = 8.4 Hz, 1H), 7.61 
– 7.48 (m, 1H), 7.37 (d, J = 8.2 Hz, 1H), 7.32 – 7.15 (m, 6H), 7.05 (t, J = 7.5 Hz, 1H), 
6.86 (d, J = 8.1 Hz, 1H), 4.98 (s, 2H), 2.24 (s, 3H); 13C NMR (62.5 MHz, CDCl3) δ 169.7, 
157.7, 151.2, 149.1, 148.4, 143.1, 132.7, 132.3, 130.8, 130.0, 129.8, 127.4, 126.7, 126.4, 
126.2, 123.9, 123.4, 122.9, 122.5, 117.6, 67.1, 21.6; IR νmax/cm-1 (solid): 2365, 1771, 
1751, 1495, 1200, 1045, 771, 730; HRMS m/z [M+H]+ Calculated for C24H18NO3: 
368.1287; found 368.1271. 
Methyl 4-(6H-chromeno[4,3-b]quinolin-7-yl)benzoate (178pa) 
 
Prepared according to the general procedure from methyl 4-(3-(2-cyanophenoxy)prop-1-
yn-1-yl)benzoate (177p) (146 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
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trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 1.5 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a yellow solid 
(146 mg, 0.398 mmol, 80%). M. p. 188-189 °C; Rf  = 0.44 (hexane-ethyl acetate, 5:1). 1H 
NMR (250 MHz, CDCl3) δ 8.54 (d, J = 7.6 Hz, 1H), 8.32 – 8.12 (m, 3H), 7.77 – 7.61 (m, 
1H), 7.47 – 7.31 (m, 5H), 7.17 (t, J = 7.5 Hz, 1H), 6.97 (d, J = 8.1 Hz, 1H), 5.06 (s, 2H), 
3.99 (s, 3H); 13C NMR (62.5 MHz, CDCl3) δ 167.0, 157.6, 149.0, 148.3, 142.9, 140.1, 
132.4, 130.8, 130.4, 130.1, 129.9, 129.8, 126.9, 126.8, 126.2, 126.1, 123.7, 123.0, 117.6, 
66.9, 52.8; IR νmax/cm-1 (solid): 2926, 2368, 1725, 1588, 1286, 1104, 1043, 769; HRMS 
m/z [M+H]+ Calculated for C24H18NO3: 368.1287; found 368.1291. 
Ethyl 7-(4-fluorophenyl)-6H-chromeno[4,3-b]quinoline-9-carboxylate (178kn) 
 
Prepared according to the general procedure from 2-((3-(4-fluorophenyl)prop-2-yn-1-
yl)oxy)benzonitrile (177k) (126 mg, 0.500 mmol) and 4-ethoxycarbonyl-
phenyl(mesityl)iodonium trifluoromethanesulfonate (46n) (327 mg, 0.600 mmol) for 1 h. 
Purification of the crude product by column chromatography on silica gel afforded the 
product as a drab solid (101 mg, 0.253 mmol, 51%). M. p. 202-203 °C; Rf  = 0.20 (hexane-
ethyl acetate, 15:1). 1H NMR (250 MHz, CDCl3) δ 8.42 (d, J = 7.1 Hz, 1H), 8.24 – 7.98 
(m, 3H), 7.30 (t, J = 7.9 Hz, 1H), 7.20 (d, J = 7.0 Hz, 4H), 7.08 (t, J = 7.6 Hz, 1H), 6.88 
(d, J = 8.1 Hz, 1H), 5.00 (s, 2H), 4.27 (q, J = 7.2 Hz, 2H), 1.28 (t, J = 7.2 Hz, 3H); 13C 
NMR (62.5 MHz, CDCl3) δ 166.5, 157.9, 151.0, 150.3, 144.3, 132.9, 131.6, 131.4, 130.2, 
129.3, 129.2, 128.4, 126.7, 126.4, 124.1, 123.4, 123.0, 117.6, 116.7, 116.4, 66.9, 61.7, 
14.7; IR νmax/cm-1 (solid): 2926, 2362, 2341; 1716, 1293, 1275, 1252, 1224, 1102, 1048, 
851, 734; HRMS m/z [M+H]+ Calculated for C25H19NO3F: 400.1349; found 400.1350. 
7-(4-(Methoxycarbonyl)phenyl)-6H-chromeno[4,3-b]quinoline-9-carboxylate 
(178pn) 
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Prepared according to the general procedure from methyl 4-(3-(2-cyanophenoxy)prop-1-
yn-1-yl)benzoate (177p) (146 mg, 0.500 mmol) and 4-ethoxycarbonyl-
phenyl(mesityl)iodonium trifluoromethanesulfonate (46n) (327 mg, 0.600 mmol) for 2.5 
h. Purification of the crude product by column chromatography on silica gel afforded the 
product as a yellow solid (148 mg, 0.337 mmol, 67%). M. p. 204-205 °C; Rf  = 0.25 
(hexane-ethyl acetate, 7:1). 1H NMR (250 MHz, CDCl3) δ 8.51 (d, J = 7.5 Hz, 1H), 8.34 
– 8.09 (m, 5H), 7.48 – 7.33 (m, 3H), 7.17 (t, J = 7.1 Hz, 1H), 6.97 (d, J = 8.0 Hz, 1H), 
5.07 (s, 2H), 4.34 (q, J = 6.6 Hz, 2H), 4.01 (s, 3H), 1.35 (t, J = 6.8 Hz, 3H); 13C NMR 
(62.5 MHz, CDCl3) δ 166.9, 166.4, 157.9, 151.0, 150.2, 144.2, 139.3, 133.0, 131.1, 130.6, 
130.2, 129.8, 129.5, 129.0, 128.5, 126.4, 126.1, 123.7, 123.3, 123.1, 117.7, 66.8, 61.7, 
52.8, 14.7; IR νmax/cm-1 (solid): 2930, 2365, 2342, 1720, 1290, 1252, 1104, 1047, 734 ; 
HRMS m/z [M+H]+ Calculated for C27H22NO5: 440.1498; found 440.1496. 
N-(2-(6H-chromeno[4,3-b]quinolin-7-yl)phenyl)acetamide (178qa) 
 
Prepared according to the general procedure from 4-(3-(2-cyanophenoxy)prop-1-yn-1-
yl)phenyl acetate (177q) (145 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 1.5 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a yellow solid 
(84.0 mg, 0.230 mmol, 46%). M. p. 83-84 °C; Rf  = 0.32 (hexane-ethyl acetate, 2:1). 1H 
NMR (250 MHz, CDCl3) δ 8.51 (d, J = 7.8 Hz, 1H), 8.20 (dd, J = 15.8, 8.3 Hz, 2H), 7.70 
(t, J = 7.3 Hz, 1H), 7.57 – 7.22 (m, 5H), 7.14 (d, J = 7.3 Hz, 2H), 7.02 – 6.82 (m, 2H), 
5.15 – 4.82 (m, 2H), 1.69 (s, 3H); 13C NMR (62.5 MHz, CDCl3) δ 169.0, 157.8, 149.5, 
148.6, 139.6, 135.8, 132.6, 130.3, 127.3, 126.9, 126.1, 125.9, 125.33, 125.26, 124.5, 
123.6, 123.3, 123.0, 117.7, 66.9, 24.6; IR νmax/cm-1 (solid): 1700, 1582, 1519, 1449, 1300, 
1230, 1044, 1004, 768, 731; HRMS m/z [M+H]+ Calculated for C24H19N2O2: 367.1447; 
found 367.1431. 
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2-Chloro-7-phenyl-6H-chromeno[4,3-b]quinoline (178ra) 
 
Prepared according to the general procedure from 5-chloro-2-(3-phenylprop-2-
ynyloxy)benzonitrile (177r) (134 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 30 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a drab 
solid (133 mg, 0.388 mmol, 78%). M. p. 164-165 °C; Rf  = 0.43 (hexane-ethyl acetate, 
10:1). ). 1H NMR (250 MHz, CDCl3) δ 8.52 (s, 1H), 8.18 (d, J = 8.3 Hz, 1H), 7.69 (t, J = 
7.2 Hz, 1H), 7.63 – 7.45 (m, 4H), 7.45 – 7.36 (m, 1H), 7.29 (d, J = 5.8 Hz, 3H), 6.91 (d, 
J = 8.6 Hz, 1H), 5.10 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 156.1, 148.3, 147.8, 144.4, 
135.1, 131.9, 130.0, 129.9, 129.6, 129.2, 129.1, 128.1, 127.6, 127.0, 126.5, 125.8, 125.1, 
122.7, 119.0, 67.2; IR νmax/cm-1 (solid): 2956, 2365, 2341, 1584, 1492, 1437, 1250, 1002, 
824, 768, ; HRMS m/z [M+H]+ Calculated for C22H15NOCl: 344.0842; found 344.0849. 
2-Bromo-7-phenyl-6H-chromeno[4,3-b]quinoline (178sa) 
 
Prepared according to the general procedure from 5-bromo-2-(3-phenylprop-2-
ynyloxy)benzonitrile (177s) (156 mg, 0.500 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (154 
mg, 0.398 mmol, 80%). M. p. 179-180 °C; Rf  = 0.34 (hexane-ethyl acetate, 15:1). 1H 
NMR (250 MHz, CDCl3) δ 8.55 (d, J = 2.5 Hz, 1H), 8.07 (d, J = 8.4 Hz, 1H), 7.64 – 7.53 
(m, 1H), 7.51 – 7.36 (m, 4H), 7.36 – 7.25 (m, 2H), 7.23 – 7.14 (m, 2H), 6.75 (d, J = 8.7 
Hz, 1H), 4.99 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 156.6, 148.3, 147.7, 144.4, 135.0, 
134.8, 130.02, 129.96, 129.6, 129.2, 129.1, 128.7, 127.6, 127.0, 126.5, 125.6, 122.7, 
119.5, 115.5, 67.2; IR νmax/cm-1 (solid): 2957, 2857, 2364, 2342, 1581, 1491, 1480, 1435, 
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1248, 1002, 824, 767, 702; HRMS m/z [M+H]+ Calculated for C22H15NOBr: 388.0337; 
found 388.0345. 
3-Bromo-7-phenyl-6H-chromeno[4,3-b]quinoline (178ta) 
 
Prepared according to the general procedure from 4-bromo-2-(3-phenylprop-2-
ynyloxy)benzonitrile (177t) (78 mg, 0.250 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (142 mg, 0.300 mmol) for 1 h. Purification of the crude 
product by column chromatography on silica gel afforded the product as a drab solid (65.0 
mg, 0.168 mmol, 67%). M. p. 184-185 °C; Rf  = 0.33 (hexane-ethyl acetate, 15:1). 1H 
NMR (250 MHz, CDCl3) δ 8.26 (d, J = 8.4 Hz, 1H), 8.02 (d, J = 8.4 Hz, 1H), 7.55 (t, J = 
7.6 Hz, 1H), 7.48 – 7.31 (m, 4H), 7.30 – 7.21 (m, 1H), 7.16 (d, J = 6.8 Hz, 3H), 7.03 (s, 
1H), 4.97 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 158.1, 148.4, 148.2, 144.3, 135.1, 
130.0, 129.9, 129.6, 129.2, 129.0, 127.5, 127.4, 126.8, 126.5, 126.1, 125.6, 122.9, 122.6, 
120.8, 67.4; IR νmax/cm-1 (solid): 2963, 2935, 2909, 2364, 2342, 2328, 1582, 1488, 1423, 
1217, 1041, 873, 769, 704; HRMS m/z [M+H]+ Calculated for C22H15NOBr: 388.0337; 
found 388.0351. 
2,7-Diphenyl-6H-chromeno[4,3-b]quinoline (178ua) 
 
Prepared according to the general procedure from 4-((3-phenylprop-2-yn-1-yl)oxy)-[1,1'-
biphenyl]-3-carbonitrile (177u) (77.3 mg, 0.250 mmol) and phenyl(mesityl)iodonium 
trifluoromethanesulfonate (46a) (142 mg, 0.300 mmol) for 30 min. Purification of the 
crude product by column chromatography on silica gel afforded the product as a green 
solid (67.5 mg, 0.175 mmol, 70%). M. p. 194-195 °C; Rf  = 0.30 (hexane-ethyl acetate, 
15:1). 1H NMR (250 MHz, CDCl3) δ 8.72 (s, 1H), 8.12 (d, J = 8.4 Hz, 1H), 7.69 – 7.50 
(m, 4H), 7.50 – 7.32 (m, 6H), 7.32 – 7.14 (m, 4H), 6.97 (d, J = 8.4 Hz, 1H), 5.06 (s, 2H); 
. 13C NMR (62.5 MHz, CDCl3) δ 157.2, 149.0, 148.4, 144.2, 141.1, 136.0, 135.3, 131.0, 
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130.0, 129.8, 129.6, 129.2, 129.1, 129.0, 127.5, 127.4, 126.6, 126.5, 124.6, 124.0, 123.1, 
118.0, 67.3; IR νmax/cm-1 (solid): 2962, 2363, 2342, 1560, 1506, 1488, 1460, 1251, 1227, 
1047, 1003, 767, 737, 700; HRMS m/z [M+H]+ Calculated for C28H20NO: 386.1545; 
found 386.1552. 
7. 13. Synthesis and analytical data of 12-phenyl-6H-
chromeno[3,4-b]quinoline (182) and 2-bromo-6H-chromeno[4,3-
b]quinoline (188) 
2-(2-iodophenoxy)acetonitrile (180) 
 
Prepared according to the modified procedure of Malinakova.145 Potassium carbonate 
(3.14 g, 22.7 mmol) and 2-iodophenol (179) (1.00 g, 4.55 mmol) were added to a 100 ml 
round bottom flask fitted with a rubber septum then the system was charged with argon. 
Acetone (45 ml) was added under argon atmosphere then 2-bromoacetonitrile (1.58 g, 
13.2 mmol, 918 µl) was added dropwise. The resulted mixture was stirred at 50 °C for 2-
3 h then at room temperature for 16 h. Potassium carbonate was filtered off and the 
reaction mixure was evaporated. Purification of the crude product by column 
chromatography on silica gel afforded the product as a brown oil (1.13 g, 4.36 mmol, 
95%); Rf  = 0.40 (hexane-ethyl acetate, 5:1).
 1H NMR (250 MHz, CDCl3) δ 7.75 (dd, J= 
7.8, 1.5, 1.5 Hz, 1H), 7.34 – 7.23 (m, 1H), 6.91 (dd, J = 8.2, 1.0, 1.0 Hz, 1H), 6.79 (td, J 
= 7.6, 1.1 Hz, 1H), 4.74 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 155.9, 140.6, 130.2, 
125.6, 115.1, 114.2, 87.1, 55.2. 
2-(2-(phenylethynyl)phenoxy)acetonitrile (181) 
 
Prepared by Sonogashira reaction according to procedure of 2-(2-
(phenylethynyl)phenyl)acetonitrile (171) from 2-(2-iodophenoxy)acetonitrile (180) (600 
mg, 2.32 mmol) and phenylacetylene (355 mg, 3.48 mmol, 382 µl) at 50 °C for 1 h. 
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Purification of the crude product by column chromatography on silica gel afforded the 
product as a brown oil (470 mg, 2.02 mmol, 87%); Rf  = 0.30 (hexane-ethyl acetate, 5:1). 
1H NMR (250 MHz, CDCl3) δ 7.61 – 7.52 (m, 3H), 7.41 – 7.32 (m, 4H), 7.17 – 7.01 (m, 
2H), 4.89 (s, 2H); 13C NMR (62.5 MHz, CDCl3) δ 157.3, 134.4, 132.1, 130.2, 198.0, 
128.8, 124.0, 123.4, 115.4, 114.9, 114.8, 95.1, 84.8, 55.2. 
12-phenyl-6H-chromeno[3,4-b]quinoline (182) 
 
Prepared according to the synthesis of 7-aryl-6H-chromeno[4,3-b]quinolines from 2-(2-
(phenylethynyl)phenoxy)acetonitrile (181) (117 mg, 0.500 mmol) and 
phenyl(mesityl)iodonium trifluoromethanesulfonate (46a) (283 mg, 0.600 mmol) for 16 
h. Purification of the crude product by column chromatography on silica gel afforded the 
product as a drab solid (23.0 mg, 0.074 mmol, 15%); Rf  = 0.30 (hexane-ethyl acetate, 
10:1). 1H NMR (250 MHz, CDCl3) δ 7.99 (d, J = 8.4 Hz, 1H), 7.60 (t, J = 7.5 Hz, 1H), 
7.46 (d, J = 5.5 Hz, 4H), 7.39 – 7.29 (m, 1H), 7.28 – 7.20 (m, 2H), 7.10 – 6.92 (m, 2H), 
6.57 (dt, J = 14.6, 6.9 Hz, 2H), 5.24 (s, 2H), 13C NMR (62.5 MHz, CDCl3) δ 157.0, 155.6, 
146.8, 143.5, 137.7, 130.1, 129.9, 129.8, 129.6, 129.3, 129.2, 128.8, 128.8, 127.0, 126.9, 
122.4, 122.0, 121.8, 118.2, 72.1. 
2-bromo-6H-chromeno[4,3-b]quinoline (191) 
 
Prepared according to the synthesis of 7-aryl-6H-chromeno[4,3-b]quinolines from 5-
bromo-2-(prop-2-yn-1-yloxy)benzonitrile (176c) (47.0 mg, 0.200 mmol) and 
phenyl(mesityl)iodonium trifluoromethanesulfonate (46a) (113 mg, 0.240 mmol) for 5 h. 
Purification of the crude product by column chromatography on silica gel afforded the 
product as a white solid (17.0 mg, 0.055 mmol, 28%); Rf  = 0.35 (hexane-ethyl acetate, 
10:1). 1H NMR (250 MHz, CDCl3) δ 8.52 (d, J = 2.5 Hz, 1H), 8.04 (dd, J = 8.5, 1.1 Hz, 
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1H), 7.78 (d, J = 1.2 Hz, 1H), 7.74 – 7.56 (m, 2H), 7.51 – 7.31 (m, 2H), 6.82 (d, J = 8.7 
Hz, 1H), 5.27 (d, J = 1.1 Hz, 2H); MS (EI, 70 eV): m/z (%): 311(100), 232(9), 203(50), 
176(22),116(55), 88(55), 63(24). 
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7. 14. Single crystal X-ray mesurements 
 178aa 178ea 178ka 
Empirical formula C22 H15 N O C23 H17 N O C22 H14 F N O 
Formula weight 309.35 323.38 327.34 
Temperature 292(2) 293(2) 293(2) 
Radiation and 
wavelength  
Mo-K,  =0.71075Å Mo-K,  =0.71073Å Mo-K,  =0.71073Å 
Crystal system triclinic triclinic monoclinic 
Space group P -1 P -1 P 21/c 
Unit cell dimensions a =5.7757(5)Å a =5.9402(4)Å a =8.9262(6)Å 
 b =11.9628(12)Å b =11.5058(10)Å b =7.7725(5)Å 
 c =11.9927(12)Å c =13.0682(10)Å c =23.1696(13)Å 
 70.251(3)° 106.220(2)° 90° 
 89.805(2)° 97.779(2)° 99.618(2)° 
 87.300(2)° 93.070(2)° 90° 
Volume 778.95(13)Å3 845.80(11)Å3 1584.89(17)Å3 
Z 2 2 4 
Density (calculated) 1.319 Mg/m3 1.270 Mg/m3 1.372 Mg/m3 
Absorption coefficient, 
  
0.081 mm-1 0.077 mm-1 0.092 mm-1 
F(000) 324 340 680 
Crystal colour colourless colourless colourless 
Crystal description chunk prism prism 
Crystal size 
egytizedesre! 
0.50 x 0.30 x 0.10 mm 0.50 x 0.30 x 0.20 mm 0.50 x 0.30 x 0.30 mm 
Absorption correction Numerical Numerical Empirical 
Max. and min. 
transmission 
0.9684 0.9891 0.9911 0.9720 1.0000 0.7770 
range for data 
collection 
3.449 27.430° 3.273 25.348° 3.149 27.484° 
Index ra ges -7  h  7;-15 k 15;-15 
 l  15 
-7  h  7;-13 k 13;-15 
 l  15 
-11  h  11;-10 k 10;-
30  l  30 Reflections collected 24463 37115 58690 
Completeness to 2 0.999 0.999 0.999 
Independent reflections 3552 [R(int) =0.0349] 3090 [R(int) =0.0297] 3633 [R(int) =0.0410] 
Reflections I>2(I) 2231 2161 2560 
Refinement method full-matrix least-squares 
on F2 
full-matrix least-squares 
on F2 
full-matrix least-squares 
on F2 Data / restraints / 
parameters 
3552 /0 /217 3090 /0 /227 3633 /0 /226 
Goodness-of-fit on F2 1.157 1.131 1.151 
Final R indices 
[I>2(I)] 
R1 =0.0549, wR2 =0.1539 R1 =0.0603, wR2 =0.1815 R1 =0.0502, wR2 =0.1434 
R indices (all data) R1 =0.0837, wR2 =0.1962 R1 =0.0753, wR2 =0.2058 R1 =0.0663, wR2 =0.1590 
Max. and mean 
shift/esd 
0.000;0.000 0.000;0.000 0.001;0.000 
Largest diff. peak and 
hole 
0.281;-0.187 e.Å-3 0.302;-0.143 e.Å-3 0.237;-0.243 e.Å-3 
Table S5a. Crystal data and structure refinement 
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 178ha 178ja 178la 
Empirical formula C22 H14 Cl N O C22 H14 Br N O C22 H14 I N O 
Formula weight 343.79 388.25 435.24 
Temperature 103(2) 293(2) 293(2) 
Radiation and wavelength  Mo-K,  =0.71075Å Mo-K,  =0.71073Å Mo-K,  =0.71073Å 
Crystal system triclinic triclinic triclinic 
Space group P -1 P -1 P -1 
Unit cell dimensions a =7.4903(4)Å a =7.6071(3)Å a =9.3211(16)Å 
 b =9.0845(4)Å b =9.2638(4)Å b =10.0363(16)Å 
 c =11.8757(5)Å c =12.1145(5)Å c =10.8596(18)Å 
 82.5440(10)° 82.5090(10)° 104.778(4)° 
 89.737(2)° 89.7080(10)° 105.031(4)° 
 87.3080(10)° 88.5560(10)° 108.640(4)° 
Volume 800.37(6)Å3 846.16(6)Å3 864.0(2)Å3 
Z 2 2 2 
Density (calculated) 1.427 Mg/m3 1.524 Mg/m3 1.673 Mg/m3 
Absorption coefficient,   0.248 mm-1 2.438 mm-1 1.862 mm-1 
F(000) 356 392 428 
Crystal colour colourless colourless colourless 
Crystal description prism prism prism 
Crystal size 0.20 x 0.20 x 0.20 mm 0.40 x 0.32 x 0.30 mm 0.50 x 0.30 x 0.20 mm 
Absorption correction Numerical Empirical Numerical 
Max. and min. 
transmission 
0.9611 0.9163 1.0000 0.6629 0.6160 0.3095 
range for data 
collection 
3.022 28.263° 3.168 27.452° 3.289 27.484° 
Index ra ges -9  h  9;-12 k 12;-15  l 
 15 
-9  h  9;-12 k 12;-15  l 
 15 
-12  h  12;-13 k 13;-14 
 l  14 Reflections collected 33703 33703 20650 
Completeness to 2 0.998 0.998 0.988 
Independent reflections 3921 [R(int) =0.0434] 3853 [R(int) =0.0338] 3848 [R(int) =0.0399] 
Reflections I>2(I) 3446 3125 3670 
Refinement method full-matrix least-squares on 
F2 
full-matrix least-squares on 
F2 
full-matrix least-squares on 
F2 Data / restraints / 
parameters 
3921 /0 /226 3853 /0 /226 3848 /0 /226 
Goodness-of-fit on F2 1.105 1.102 1.170 
Final R indices [I>2(I)] R1 =0.0382, wR2 =0.0993 R1 =0.0398, wR2 =0.0976 R1 =0.0366, wR2 =0.0900 
R indices (all data) R1 =0.0451, wR2 =0.1109 R1 =0.0501, wR2 =0.1085 R1 =0.0378, wR2 =0.0914 
Max. and mean shift/esd 0.001;0.000 0.001;0.000 0.001;0.000 
Largest diff. peak and hole 0.505;-0.324 e.Å-3 0.520;-0.376 e.Å-3 1.740;-0.358 e.Å-3 
Table S5b. Crystal data and structure refinement 
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Experimental 
 
Crystal data of 178aa: C22H15NO, Fwt.: 309.35, colourless, chunk, size: 0.5 x 0.3 x 0.1 
mm, triclinic crystal system, space group P-1, a = 5.7757(5)Å, b = 11.9628(12)Å, c = 
11.9927(12)Å,  = 70.251(3),  = 89.805(2),  = 87.300(2), V = 778.95(13)Å3, T = 
292(2)K, Z= 2, F(000) = 324, Dx = 1.319 Mg/m3,  0.081mm-1. A crystal of 178aa was 
mounted on a loop. Cell parameters were determined by least-squares using 13451 (3.45 
   27.43) reflections. Intensity data were collected on a diffractometer (graphite 
monochromator; Mo-K radiation,  = 0.71075Å) at 292(2) K in the range 3.449    
27.430.146 A total of 24463 reflections were collected of which 3552 were unique [R(int) 
= 0.0349, R() = 0.0238]; intensities of 2231 reflections were greater than 2(I). 
Completeness to  is 0.996. Numerical absorption correction (NUMABS)147 was applied 
to the data (the minimum and maximum transmission factors were 0.9684 and 0.9891). 
The structure was solved by direct methods.148149 Anisotropic full-matrix least-squares 
refinement on F2 for all non-hydrogen atoms yielded R1 = 0.0549 and wR2 = 0.1539 for 
1332 [I>2( I)] and R1 = 0.0837 and wR2 = 0.1962 for all (3552) intensity data, (number 
of parameters = 217, goodness-of-fit = 1.157, the maximum and mean shift/esd is 0.000 
and 0.000). The maximum and minimum residual electron density in the final difference 
map was 0.281 and -0.187e.Å-3. The weighting scheme applied was w = 
1/[2(Fo2)+(0.10990.0000P)2+0.0000P], where P = (Fo2+2Fc2)/3. Hydrogen atomic 
positions were located in difference maps. Hydrogen atoms were included in structure 
factor calculations but they were not refined. The isotropic displacement parameters of 
the hydrogen atoms were approximated from the U(eq) value of the atom they were 
bonded to. 
 
Crystal data of 178ea: C23H17NO, Fwt.: 323.38, colourless, prism, size: 0.5 x 0.3 x 0.2 
mm, triclinic, space group P -1, a = 5.9402(4)Å, b = 11.5058(10)Å, c = 13.0682(10)Å,  
= 106.220(2)  = 97.779(2),  = 93.070(2), V = 845.80(11)Å3, T = 293(2)K, Z= 2, 
F(000) = 340, Dx = 1.270 Mg/m
3,  0.077mm-1. A crystal of 178ea was mounted on a 
loop. Cell parameters were determined by least-squares using 23452 (3.28    27.49) 
reflections. Intensity data were collected on a(n) RAXIS-RAPID diffractometer ( 
monochromator; Mo-K radiation,  = 0.71073Å) at 293(2) K in the range 3.273    
25.348.146 A total of 37115 reflections were collected of which 3090 were unique [R(int) 
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= 0.0297, R() = 0.0141]; intensities of 2161 reflections were greater than 2 (I). 
Completeness to  = 0.998. Numerical absorption correction147 was applied to the data 
(the minimum and maximum transmission factors were 0.9720 and 0.9911). 
The structure was solved by direct methods.148 Anisotropic full-matrix least-squares 
refinement149 on F2 for all non-hydrogen atoms yielded R1 = 0.0603 and wR2 = 0.1815 
for 1332 [I>2 ( I)] and R1 = 0.0753 and wR2 = 0.2058 for all ( 3090) intensity data, 
(number of parameters = 227, goodness-of-fit = 1.131, the maximum and mean shift/esd 
is 0.000 and 0.000). The maximum and minimum residual electron density in the final 
difference map was 0.302 and -0.143e.Å-3. The weighting scheme applied was w = 
1/[2(Fo2)+(0.13480.0000P)2+0.0000P] where P = (Fo2+2Fc2)/3. Hydrogen atomic 
positions were located in difference maps. Hydrogen atoms were included in structure 
factor calculations but they were not refined. The isotropic displacement parameters of 
the hydrogen atoms were approximated from the U(eq) value of the atom they were 
bonded to. 
 
Crystal data of 178ka: C22H14FNO, Fwt.: 327.34, colourless, prism, size: 0.5 x 0.3 x 0.3 
mm, monoclinic, space group P 21/c, a = 8.9262(6)Å, b = 7.7725(5)Å, c = 23.1696(13)Å, 
 = 90,  = 99.618(2),  = 90, V = 1584.89(17)Å3, T = 293(2)K, Z= 4, F(000) = 680, 
Dx = 1.372 Mg/m
3,  0.092mm-1. A crystal of 178ka was mounted on loop. Cell 
parameters were determined by least-squares using 31127 (3.15   27.54°) reflections. 
Intensity data were collected on a(n) RAXIS-RAPID diffractometer ( graphite 
monochromator; Mo-K radiation,  = 0.71073Å) at 293(2) K in the range 3.149    
27.484 [CrystalClear]. A total of 58690 reflections were collected of which 3633were 
unique [R(int) = 0.0410, R() = 0.0173]; intensities of 2560 reflections were greater than 
2 (I). Completeness to  = 0.999. Numerical absorption correction147 was applied to the 
data (the minimum and maximum transmission factors were 0.7770 and 1.0000). 
The structure was solved by direct methods.148 Anisotropic full-matrix least-squares 
refinement149 on F2 for all non-hydrogen atoms yielded R1 = 0.0502 and wR2 = 0.1434 
for 1332 [I>2 ( I)] and R1 = 0.0663 and wR2 = 0.1590 for all ( 3633) intensity data, 
(number of parameters = 226, goodness-of-fit = 1.151, the maximum and mean shift/esd 
is 0.001 and 0.000). The maximum and minimum residual electron density in the final 
difference map was 0.237 and -0.243e.Å-3. The weighting scheme applied was w = 
1/[2(Fo2)+(0.08850.0568P)2+0.0568P] whereP = (Fo2+2Fc2)/3. Hydrogen atomic 
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positions were located in difference maps. Hydrogen atoms were included in structure 
factor calculations but they were not refined. The isotropic displacement parameters of 
the hydrogen atoms were approximated from the U(eq) value of the atom they were 
bonded to. 
 
Crystal data of 178ha: C22H14ClNO, Fwt.: 343.79, colourless, prism, size: 0.2 x 0.2 x 0.2 
mm, triclinic, space group P -1, a = 7.4903(4)Å, b = 9.0845(4)Å, c = 11.8757(5)Å,  = 
82.5440(10),  = 89.737(2),  = 87.3080(10), V = 800.37(6)Å3, T = 103(2)K, Z= 2, 
F(000) = 356, Dx = 1.427 Mg/m
3,  0.248mm-1. A crystal of 178ha was mounted on a 
loop. Cell parameters were determined by least-squares using 23766 ( 3.02    28.27) 
reflections. Intensity data were collected on a RAXIS-RAPID diffractometer ( graphite 
monochromator; Mo-K radiation,  = 0.71075Å) at 293(2) K in the range 3.022    
28.263.146 A total of 33703 reflections were collected of which 3921were unique [R(int) 
= 0.0434, R() = 0.0225]; intensities of 3446 reflections were greater than 2 (I). 
Completeness to  = 0.991. Numerical absorption correction147 was applied to the data 
(the minimum and maximum transmission factors were 0.9163 and 0.9611). 
The structure was solved by direct methods.148 Anisotropic full-matrix least-squares 
refinement149 on F2 for all non-hydrogen atoms yielded R1 = 0.0382 and wR2 = 0.0994 
for 1332 [I>2 ( I)] and R1 = 0.0451 and wR2 = 0.1109 for all ( 3921) intensity data, 
(number of parameters = 226, goodness-of-fit = 1.106, the maximum and mean shift/esd 
is 0.001 and 0.000). The maximum and minimum residual electron density in the final 
difference map was 0.505 and -0.324e.Å-3. The weighting scheme applied was w = 
1/[2(Fo2)+(0.05670.3622P)2+0.3622P] whereP = (Fo2+2Fc2)/3. Hydrogen atomic 
positions were located in difference maps. Hydrogen atoms were included in structure 
factor calculations but they were not refined. The isotropic displacement parameters of 
the hydrogen atoms were approximated from the U(eq) value of the atom they were 
bonded to. 
 
Crystal data of 178ja: C22H14BrNO, Fwt.: 388.25, colourless, prism, size: 0.40 x 0.32 x 
0.30 mm, triclinic, space group P -1, a = 7.6071(3)Å, b = 9.2638(4)Å, c = 12.1145(5)Å, 
 = 82.5090(10),  = 89.7080(10),  = 88.5560(10), V = 846.16(6)Å3, T = 293(2)K, 
Z= 2, F(000) = 392, Dx = 1.524 Mg/m
3,  2.438mm-1. A crystal of 178ja was mounted 
on a loop. Cell parameters were determined by least-squares using 23031 ( 3.17    
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27.45) reflections. Intensity data were collected on a(n) RAXIS-RAPID diffractometer 
(graphite monochromator; Mo-K radiation,  = 0.71073Å) at 293(2) K in the range 
3.168    27.452.146 A total of 33703 reflections were collected of which 3853 were 
unique [R(int) = 0.0338, R() = 0.0173]; intensities of 3125 reflections were greater than 
2 (I). Completeness to  = 0.998. Numerical absorption correction147 was applied to the 
data (the minimum and maximum transmission factors were 0.6629 and 1.0000). 
The structure was solved by direct methods.148 Anisotropic full-matrix least-squares 
refinement149 on F2 for all non-hydrogen atoms yielded R1 = 0.0398 and wR2 = 0.0976for 
1332 [I>2 ( I)] and R1 = 0.0501 and wR2 = 0.1084 for all (3853) intensity data, (number 
of parameters = 226, goodness-of-fit = 1.102, the maximum and mean shift/esd is 0.001 
and 0.000). The maximum and minimum residual electron density in the final difference 
map was 0.520 and -0.376e.Å-3. The weighting scheme applied was w = 
1/[2(Fo2)+(0.05680.2908P)2+0.2908P] whereP = (Fo2+2Fc2)/3. Hydrogen atomic 
positions were located in difference maps. Hydrogen atoms were included in structure 
factor calculations but they were not refined. The isotropic displacement parameters of 
the hydrogen atoms were approximated from the U(eq) value of the atom they were 
bonded to. 
 
Crystal data of 178la: C22H14INO, Fwt.: 435.24, colourless, prism, size: 0.5 x 0.3 x 0.2 
mm, triclinic, space group P -1, a = 9.3211(16)Å, b = 10.0363(16)Å, c = 10.8596(18)Å, 
 = 104.778(4),  = 105.031(4),  = 108.640(4), V = 864.0(2)Å3, T = 293(2)K, Z= 2, 
F(000) = 428, Dx = 1.673 Mg/m
3,  1.862mm-1. A crystal of 178la was mounted on a 
loop. Cell parameters were determined by least-squares using 15499 (3.29    27.49) 
reflections. Intensity data were collected on a RAXIS-RAPID diffractometer (graphite 
monochromator; Mo-K radiation,  = 0.71073Å) at 293(2) K in the range 3.289    
27.484.146 A total of 20650 reflections were collected of which 3848were unique [R(int) 
= 0.0399, R() = 0.0202]; intensities of 3670 reflections were greater than 2 (I). 
Completeness to  = 0.973. Numerical absorption correction147 was applied to the data 
(the minimum and maximum transmission factors were 0.616 and 0.3095). 
The structure was solved by direct methods.148 Anisotropic full-matrix least-squares 
refinement149 on F2 for all non-hydrogen atoms yielded R1 = 0.0366 and wR2 = 0.0900for 
1332 [I>2 ( I)] and R1 = 0.0378 and wR2 = 0.0914 for all ( 3848) intensity data, (number 
of parameters = 226, goodness-of-fit = 1.170, the maximum and mean shift/esd is 0.001 
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and 0.000). The maximum and minimum residual electron density in the final difference 
map was 1.740 and -0.358e.Å-3. The weighting scheme applied was w = 
1/[2(Fo2)+(0.05570.2347P)2+0.2347P] whereP = (Fo2+2Fc2)/3. Hydrogen atomic 
positions were located in difference maps. Hydrogen atoms were included in structure 
factor calculations but they were not refined. The isotropic displacement parameters of 
the hydrogen atoms were approximated from the U(eq) value of the atom they were 
bonded to. 
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